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Summary
The aim of this study was- to estimate the effects of stress on 
horses by measuring alterations in adrenocortical and sympathebic 
nervous acbivity. The effects on. the adrenocortical system were 
determined directly by measuring circulating levels of plasma 11 - 
hydroxycorticosteroids. The effects of stress on the sympathetic 
nervous system were assessed indirectly by recording changes in 
heart rate and circulating packed cell volume and in a few cases 
by direct measurement of circulating plt.sma catecholamine l?vels.
Plasma 11 - hydroxycorticosteroid levels were measured using 
a modified fluorometric technique. Etendard reliability criteria 
were used to validate the method. The range of corticosteroid 
levels in horses and ponies under various natural and experimentally 
induced conditions was established. Changes in adrenocortical and 
sympathetic nervous activity were measured during physical 
stimulation (either exercise or surgical trauma) and following 
administration of certain drugs. The significance as a means of 
quantifying stress of alterations in plasma 11 - hydroxycortico­
steroid levels and in sympathetic nervous activity was assessed.
A number of tranquillising drugs were compared both for their 
central nervous depressant and peripheral actions and the effects 
of these drugs on stress-induced changes in adrenocortical and 
sympathetic nervous activity were studied. Alterations in ppok-sd 
cell volume caused by tranquillising drugs was investigated.
Finally, changes in adrenocortical and sympathetic nervous
11
activity produced by the commonly used neuroleptanalgesic mixture 
of etorphine end acepromazine were studied and attempts were made 
tc modify tnese changes by incorporating various tranquillising 
and adrenoreceptor blocking drugs in the etorphine/acepromazine 
combination.
It was concluded from this study that alterations in adreno-- 
corbical and sympathetic nervous activity can be used as means of 
assessing stress in the horse. As the tranquillising drugs used 
however modified adrenoc^Pftical and sympathetic activity, changes 
in these systems could not be employed in assessing alleviation of 
stress by these compoimds. It was also concluded from these 
expieriiu-jnts that the marked effects of the etorphine/acepromazine 
mixture on sympathetic nervous activity could be modified by the 
central and peripheral actions of the various tranquillising drugs 
employed in this study.
GENERAL IFTRODUCTION
Ill
GENERAL INTRODUCTION
The term stress is widely used i^ both human and veterinary 
medicine and is employed in a great variety of contexts. While 
the definition of stress is vague, the factors which may pr'cduce 
stress are generally accepted. It is generally agreed that 
potentially harmful environmental stimuli can be resisted by a 
person or animal through a complex riuuber of interacting local and 
general anatomical, biochemical, physiological or behavioural 
responses.
Cannon (I929) reported on the similarity of body responses to 
a number of different types of environmental disturbance and noted 
the activity of the sympathetic nervous system and the secretion ox 
adrenaline in relation to these. He recorded that both these 
parameters increased during emotional disturbance and pain and that 
these elevations were responsible for a number of marked 
physiological changes. Selye (1958) on the other hand described 
stress as a general adaptation syndrome which was triggered by a 
number of stimuli such as trauma, cold and physical restraint.
In the veterinary field, stress has been used mainly where I,he 
physiological and biochemical alterations occurring have led to 
easily observable changes such as mortality, disease or reduced 
weight gain. For example, the ’acute stress syndrome’ in pigs 
is responsible for a high mortality rate and is commonly associated 
with transportation and handling of these animals. Similarly 
neonatal scours in calves and pigs have been linked to social and
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environmental disturbances during the first 2-3 days of life 
(Fraser, Ritchie and Fraser, 1975).
E’wbahk. (1973) suggested that the term stress should be 
restricted to the mechanisms by which an animal resists the effects 
of adverse stimuli. He also suggested that the stimuli provoking 
these stress responses should be referred to a,s stressors and can be- 
fur-bher classified as heat, sound, emotional, physical etc.
Any individual stressor may produce a specific local response 
but will probably also result in a more generalised reaction. It 
should be possible to assess whether or not a state of stress has 
occurred by measuring the changes in any of a number of systems.
In man the level of stress can be estimated to some extent by 
assessing his psychological state, but in animals objective criteria 
are required. Stress reactions are often considered to be 
deleterious to the animal (Bareham, 1973; Fraser et al, 1975) 2nd 
indeed under prolonged or intense stimulation many detrimental 
effects can occur. It can also be argued however that stress 
reactions are beneficial in that they allow the animal to adapt and 
survive changes in its environment.
Drugs, such as tranquillisers and sedatives, are widely used in 
man to alleviate mental stress and they do this by means of their 
central neir/ous depressant actions (Greenblatt and Shader, 1973; 
Goodman "ind Gilman, 1975). Similar types of drugs are used on many 
occasions x n animals usually to facilitate handling for minor 
operative procedures or for transportation. Measurement of certain 
pararaeTors such as heart rate and plasma corticosteroid concentrations
are frequently used as meai's of assessing f^e efficacy of 
tranquillisers and sedatives in animals because these drugs are 
considered to lower the stross response to various stimuli (Smith, 
Maikel and Brodie, 1963; Aitken and Sanford, 1972; Lahti and 
Barsulin, 1975).
Tile aim of this study was to measur/e the response in horses to 
a number of stressors of different types and to assess whether these 
responses constituted a reasonable method of estimating stress in the 
horse. The changes being measured were in the sympathetic nervous 
system and the central nervous system/pituitary adrenal system.
The same methods were also employed to assess tho usefulness 
of a numoer of tranquilliser end sedative drugs in alleviating 
stress reactions produced in horses.
ANIMALS USED
VI
ANIMALS USED
The animals used throughout this study are shoi-m in Table 0,1. 
Tie five Thoroughbreds end two heavy hunters were housed inside 
in indivj dual loose Do:ces throughout the experimental period.
They were allowed hay and water ad lib and wexe fed daily rations of 
oats, bran raid horse nuts.
The three ponies were kept outside all year except when required 
for experimental work. Outside they were fed additional hay during 
the winter end inside were allowed hay and water ad lib.
Table 0.1 Animals used
(I ears) ‘
V/eib-it
(lbs)Type SexNo
1100Gelding
960T.B Gel din,
960Gel din,
Mare 970
T.B 9U0
Gelding 1300
H.H 1230Mare
Pony Gelding 320
335Pony Gelding
U)0Pony Geldin,
T.B. = Thorou^bred
H.H. = Heavy Hunter
1. PHÎSIOLÛOTCAL m m S  OP
ASSESSING STRESS
1.1 Introduction
Many of the physiological responses to stress, both physical 
and emotional, are mediated by sympathetic nerves of the autonomic 
nervous system. The sympathetic ner'/ous system exerts widespread 
effects on body functions including heart rate, blood pressure, 
cellular metabolism and mental activity (Guyton, 197'0* When 
stimulated it permits man and animals +o perform physical activity 
and withstand certain disturbing stimuli to a much greater extent 
than normal.
Sympathetic activity is controlled by various centres in tho 
brain, especially the hypothalamus, and stimulation of any part of 
the system generally results in stimulation of the entire sympathetic 
pathway (Guyton, 1971 )• Direct assessment of sympathetic activity 
can be carried out by measuring plasma levels of circulating 
catecholamines (adrenaline and nor-adrenaline) but the techniques 
involved are difficult and indirect methods are more commonly 
employed.
Heart rate is controlled almost entirely by the vasomotor centre 
in the brain which transmits excitatory impulses via sympathetic 
fibres and inhibitory impulses via the parasympathetic vagus ner/e 
(Guyton, 1971j Eushmer, 1972). Generally, therefore, increased 
sympathetic activity will result in elevated heart rates but th^ 
mechanism is complicated- by a number of reflexes involving 
parasympathetic nerves e.g. increased blood pressure causing a 
decrease in heart rate because of stimulation of stretch receptors
In the aortic and carotid todies and vice versa (Rusliraer, 1972).
Although changes in heart rabe have been used as a means of 
assessing both physical effort and emotional stress in horses 
(Krzywpnek, Wittke, Bayer end Borman., 1970; Witherington, 1971; 
Aitken and Sanford, 1972) they are not an ideal means of evaluation 
because of these parasjanpathetically mediated reflexes.
Sympathetic activity can also be assessed by measuring changes 
in circa?.ating packed cell volumes. The spleen has been shovm in 
the horse to be the main reservoir of red cells (Persson, 19^7) and 
the splenic capsule is rich in anrenoreceptors (Davies and 
Vithrington, 1973). Increased-sympathetic tone resulting from 
many condibionsincluding exercise, .cright and adrenaline infusion 
leads to splenic contraction and expulsion of red cells into the 
circulation.
In these experiments, heart rat^s and packed cell volumes were 
measured and assessed as methods of estimating stress.
1,2 MlAolIlBlviEN’i. OF HEART RITE
Heart rate can be measured either d?reoti%r by aupciiltarion 
or indirectly by radioteleme Lry,
The former involves direct recording of the heart sounds
occurring during closing of the semilunar and atrial values, and
the latter, recording of the electrical impulses generated during 
contraction of the atria and ventricles.
Matériels
EGG transmitter : TM 2T M.I.E, Tasman Vaccine Laboratory
(U.K.) Ltd., Suffolk.
EGG receiver : TM 2R M.l.E. Tasman Vaccine Laboratory
(U.K.) Ltd., Suffolk.
Devices, two channel pen-recorder Devices Ltd., England.
Neilson heart rate meter Devices Ltd., England.
Methods
1) Auscultation
Heart rates were recorded using a stetncscope and counting the 
number of beats over a 30 second period..
2) Radiotelemetry
Two metal discs approximately pnmi in diameter were applied to 
areas of shaved skin, one in front of the anterior angle of 
the scapula and one in midi 1no eve]" the xiphoid cartilage.
The sites of application were thci, ■=■ advocated by Holmes, Alps 
and Darke (1966) and the electrodes were secured by means of 
elastoplast and collodion glue.
The electrodes were, connected by two fine wires (which also 
acted as aerials) to the transmitter which was strapped to the 
withers of the horsoa by a surcingle. When heart rates were 
recorded during exercise the transmitter was strapped onto the left 
leg of the rider.
Signals from the transmitter were picked up on the radio­
receiver, passed through a preamplifier and the Electrocardiogram 
(E.G.G.) recorded on a oeii-recorder.
In initial experiments, carried out on resting animals in 
loose-boxes, records of heart rate were also made using a Neilson 
heart-rate meter.
Tlais instrument gives a steady output between pulses 
representing the repetition frequency of the two previous pulses.
If the rate becomes lower, the ratemeter anticipates this drop and 
the output falls, A continuous recording of heart rat-= is produced. 
However during and after exercise there is a considerable amount of 
spurious electrical activity due mainly to muscle movement and it was 
found that more reliable he^ irb rates could be obtained by manually 
counting the number of ventricular beats over a fixed period (either 
30 or 60 seconds) on the pen recording.
KrO'Ulcs
Heart rates recorded by auscultation, and radiotelemetry at 
various times in the seven horses included in this study are reported 
in Table 1.1.
Records obtained by radiotelemetry from one of the ponies 
(No 1) unrestrained in a loose box and from horse No. 2 during 
and immediately after exercise are shown in Rig. 1.1.
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1 .3  MEASUKEMENT OF PACIŒID OELL VOLIÏÏ^
The packed cell volime represents the percentage of
whole hlooc! which consists of erytlrrocytes and leacocyctos. hy 
centrifuging whole blood at high speeds it separates inLo t'^ o 
distinct layer’s - the erythrocyte/lencocyke mass and the blood 
plasma. The former is expressed as a percentage of the total 
volume.
Materials
Heparinised tubes (for Hawksley microhaematocrit centrifuge)
Gelman - Hawksley Ltd., Englana.
Hawksley microhaematocrit centrifuge 
Gelman - Hawksley Ltd., England.
Methods
The method of P.C.V. determination used in this study was the 
macrohaematocrit method.
Heparinised blood was drawn into capillary tubes and one end 
was sealed in a flame. The tubes were then spun at i|,000 r.p.m. 
for I4-5 min and read on a Hawksley Micro-haematocrit reader.
Samples were always measured in duplicate and the mean of the 
two values recorded.
Results
Ranges of packed cell volumes recorded during the course of
this study in horses and ponies under various conditions are 
expressed in Table 1,2.
I
-p
■go
-p
I
a
I
I
FH
m0
1
CQQ>01I
a
H
>
m
0
fd
1
ono
VD
(D
-P . ~=rm 03
q CM o
pci+l
+  1 +1
9  § CO
03
0>
•H
O (D
0> 03
P h fH
CO O
W
CM
%
I
M  
CO 
I— I
0
1
I
I
g
5-
to
g
II
g
M
g
toDM
1-3
I
CO
'%K-
CM
0)
I
1. Ij. Discussion
Heart rates in horses have been recorded by numerous aethers 
using both auscultation and radiotelemetry (Littlewort and Hickm.an. 
1969; Krzywanek et al, 1970; Wither!agton, 1971; Aitkeii and 
Sanford, 1972).
The latter method is considered to be the more accurate since 
Witherington (1971) pointed out the difficulties which may be 
encountered in distinguishing heart from respiratory sounds in some 
horses. This effect was noticed occasionally in the two hoa-yy
hunters included in these studies especially when resting heart
rates were being recorded.
Another advantage of radiotelemetry is that there is no 
interference with the animal at the time when the recording is made. 
Aitken and Sanford (1972) have reported that auditory and visual
stimuli could induce increases in heart rate of up to 200 per cent
and thus it is possible that auscultation itself would produce 
elevations in heart rate especially when levels had fallen below 
certain values.
Heart rates recorded immediately after exercise by auscultaTîon 
were' lower than those recorded by radiotelemetry. This difference 
is due to two factors. Firstly, rates recorded by radiotelemetry 
are obtained immediately after exercise stops and the time constant 
using this method is much shorter than using auscultation.
Secondly, heart rates have been shown to decrease very rapidly wi thin 
the first 1-2 min after exercise (Aitken, Anderson, HacKenzie and
Sanford, 1975; Hall, Steel an^ Stewart, I97^) and any delay in 
recording will lead to falsely low results.
It proved difficult to record aeart rates during exercise in 
these studies although several workers have reported suih results 
(Marsland, I968; Lindholm and Sal tin, 197L; Hall at ■^ >7^  h
Difficulties were encountered hecause at times during the 
exercise regime the horses and radiotran^nitter were too far from 
the radioreceiver. During prolonged exercise, when the animals 
began to sweat, it was also noticed that the contact between the 
electrode and the skin was poor and in some instances contact was 
lost completely.
For several years the microhaen.atocrit method of packed cell 
volume determination has been used for routine blood samples in 
many laboratories (Allen and Archer, 1973)« The method is 
considered to be more accurate and reproducible, less time consuming 
and to use less blood than is required for the Wintrobe (1933) 
haematocrit method (Schalm, Jain,and Carroll, 1975)* The rarjges 
of values recorded throughout these studies were within those 
reported in the same species by other workers and the various 
alterations noted are discussed in the appropriate chapters.
Summary
From these results it was decided to use radiotelemetry to 
record heart rates from the horses and ponies on all occasions 
when experimental work was being carried out indoors. During the
10
üxorcise pi-^grammes, racliotelemeir/ was used wherever possible to 
obtain recordings during and inunadiately after exercise. When 
this proved difficult however heart rates were measured by 
auscultation.
Packed cell volumes were measured on all occasions by the 
micrchae.Giatocrit method.
2. BIOCHSivIIC'L MSAHS OF 
ASSESSING CTFEOS
11
2.1 Introduction
The adrenal gland, wh^cn in part of the endocrine system, 
secretes hormones which play a large part in the regulation of body 
metabolism ai'd are produced by this gland in response to stressful 
stimuli.
In the horse, as in man, all the corticosteroids are produced 
in the cortical region of the adrenaJ.. gland. By definition, the 
corticosteroids are those -0 - 21 steroids containing tliree or more 
o^cygen atoms and which can be found in tl:e adrenal glands, the blood 
and the urine.^ (Borth, 195^).
basic structure of the corticosteroid molecule is diown in
1
Fig, 2.1. All the steroids possess n ^  ^ ~ 3 - ketone group 
which is believed to be essential for biological activity (Lorraine 
and Bell 1971).
Generally, corticosteroids are defined as either glucocort- 
icosteroids or mineraloc&eticosteroids depending on their relative 
effects on carbohydrate and electrolyte mecabolism. The structural 
formulais of the three glucocortioostercids present in greatest amounts 
in human plasma are shown in Fig, 2,1. These compounds are known 
collectively as the 11- hydroxycorticosteroids (11-OHCS) because 
they all have substituted groups on C - 1^.
The glucocorticosteroids are synthesised in the two inner zones 
of the adrenal cortex namely the zoim f'.,sc: culata and the zona 
reticularis from acetate via cholesterol Fig. 2.2.
PIG, 2.1 STRUCTUEAL FORMULAE OP
CORTISOL, CORTISONE AND CORTICOSTERONE
C H g O h CH ,0HI 2
o
■CL-OH
O
CORTiSOL CORTISONE
HO
C H j O H
CO
CORTICOSTERONE
1 2
Acetaie
Cholesterol
1
Pre^enclonc .
/  \ 2
17 - hydronc^ r ~ pregnerjolonc Progesterone
Deoxycorticosterone
17 - hydroxy - progesterone
I
Corticosterone
11- Deoxyooitisol
I 3
Cortisol
Cortisone
The main enzyme systems involved at certain points in the 
metabolism are shown;-
1. Side chain cleavage enzymo
2. "Reductase isomerase
3. 11 - hydroxylase
In the horse, it has been shown that rhe formation of 17 
hydroxyprogesterone from both 17 hydro'fypregnenolone and progesterone 
is rate-limiting and also that this reaction occurs more rapidly in 
the fasicicular than in the reticular tissue (Cameron and Grant, 
1967). However more recent studies in m m  have suggested that the 
rate-limiting step in corticosteroid biosynthesis is the conversion 
of .cholesterol to pregnenolone. (Bchulster, Burstein and Cooke,
1976).
The entire biosynthetic pathway •^ akes place within the cortical
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cells:-
1) cholesterol — > pregnenolone occurring within the 
cellular mitochondria.
2) pregnenolone — > 11 - deoxycortisol in the cytoplasm.
3) 11 - deoxycortisol— > cortisol in the cellular 
mitochondria.
The rate at which corticosteroids are synthesised is controlled 
"by specific hormone adrenocorticotrophin (ACTH) which is secreted 
from the anterior pituitary gland in response to stimuli from 
higher centres in the central nervous system. The points at 
which ACTH acts in the biosynthetic pathway are thought to be at 
the level of cholesterol conversion to pregnenolone. The AOTH 
acts in the adrenal cell membranes, stimulating production of the 
enzyme adenyl cyclase which in turn stimulates an increase i.n cyclic 
adenylmonophosphate (AMP) concentrations. Cyclic AIVIP inside tije 
cell binds to its specific receptor protein which exists as a 
regulatory complex with protein kinase and causes the release of the 
protein kinase from the receptor. The protein kinase in turn 
increases the production of free cholesterol in the lipid droplets 
(Garren, Gill, Masui and Walton, 1971 )• It is also possible hov;e'v3r 
that ACTH may influence directly the enzyme system responsible for 
the side-chain cleavage of cholesterol (Schulster at ad, 1976).
The major glucocorticoid circulating in the plasma of the horse 
is cortisol with corticosterone and cortisone as minor steroids 
(Zolovick, Upson and Eleftheriou, I966; James, Horner, Moss and 
Rippon, 1970). Cortisol is also the major glucocorticoid present 
in the plasma of man (Dixon, Booth and Butler, I967; Horsham, I96:),
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ACTH is ■"eleased from the anterior pituitary which is under the 
control of the hypothalamic area of the brain (Nelson 1972). The 
hypothalamus forms the floor of the 3rd ventricle of the brain arû 
has many functions including the control of appetite, temperature 
and regulation of the pituitary gland (Martini and Ganong I966; 
Sawin, I969).
The anterior pituitary is formed from the oral region and has 
few direct neural links with the hypothalamus. Control of its 
secretions is exerted by means of chemical agents (peptides) 
secreted from the hypothalamus into the numerous portal-hypophyseal 
vessels carrying blood from the capillaries of the ventral 
hypothalamus directly to the anterior lobe (Green and Harris, 19U9> 
Worthington, I96O and I963).
The chemical agent or releasing factor initiating the release 
of ACTH is called corticotrophin releasing factor (CEP) and the 
activity of the neurones producing CEP in the hypothalamus comes 
under the control of afferent impulses from higher centres in the 
brain (Hodges, 1976). The cerebral cortex midbrain, amygdala and 
hippocampus are all known to exert stimulatory or inhibitory effects 
on the mechanisms controlling CEP and hence ACTH release (Mangili, 
Motta and Martini, I966). ■
.Basal levels of circulating corticosteroids are controlled by a 
negar.lve feedback system, with ACTH secretion being inhibited by 
increased plasma cortisol and cortisone levels and vice versa 
(Williams, I968). Alterations in circulating levels of plasma 
11-OHCS are thought to influence the rate of secretion of CEP from
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the hypothalamus (Sawin, 19^9? James and Landon, 1976) rather than 
to act directly on the pituitary since it has beer shown (Sawin,
1969) that implan,ts of corticosteroids in the hypothalamus will 
subsequently decrease ACTH secretion wherea,s similar impiants in 
the pituitary do not produce this effect.
Apart from the negative feedback mechanism there is also a 
much more complicated control system responsible for the circadian 
rhythm of ACTH and 11-OHCS secretion. Circadian rhythm, has been 
described in man, horses and other species (James and Landon, 1976; 
Krieger, Allen, Hizzo and Kiûeger, 1971- Campbell and Watts, '973; 
Zolovick et a2, 1966; Krieger, Silverberg, Rizzo and Krieger, I968). 
Five to ten episodic bursts of ACTH secretion occur throughout the 
2J7 hour period in man (Krieger ejt al, 1971; Ney, Shimizu, Nicholson, 
Island and Liddle, I963) and are reflected in similar changes of 
plasma 11-OHCS levels. These alterations in both ACTH and plasma 
11-OHCS levels have been related to a number of causes. SleepA/ake 
cycles, light/dark cycles, general activity cycles and feeding 
cycles have all been studied as causes of the fluctuations (Orth, 
Island and Liddle, 1967; Krieger, 197U; Hatelson, Holaday,
Meyerhoff and Stokes, 19750*
The circadian pattern of corticosteroid and ACTH secretion can. 
be abolished by diffuse CHS disease or focal hypothalamic lesions 
(Krieger and Krieger, I966; Slusher, I96I4-) and by the adminisrarion 
of certain drugs e.g. atropine (Krieger and Krieger, I966) and 
betamethasone (Hodges and Mitchley, 1970).
The atropine effect would suggest that cholinergic mechanisms 
in the CHS are involved in the circadian release of ACTH over the
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21}. hour pernod. Since aboli bioi. of the circadian, pattern did. not 
result in an impaired response to either insulin-induced hypogly- 
caemic or lysine vasopressin (Krieger et I968) it would also 
suggest that different CMS mechanisms and/or structures are involved 
in the regulation of circadian periodicity of 11-OHCS levels as 
opposed to stress initiated adreno-corticol responses,
A third controlling mechanism of the hypothalamic-pituitary- 
adrenal system is that which operates when external stimuli, such 
as exercise, trauma and surgical procedures, or any deviations from 
normal, within the body, such as hypotension, haemorrhage and disease 
produce changes in corticosteroid levels independent of the feedback 
mechanism. It has been suggested therefore that there are two 
distinct areas in the hypothalamus mediating CHI’ secretion - one 
inhibiting it and the other stimulating .it (Grizzle, Hallman, Schramm 
and Gann, 197^ 4-).
The effects of glucocorticoids are varied and widespread. They 
increase gluconeogenesis in the liver by increasing the conversion 
of amino acids to glucose (Cahill, 1971) and in turn decrease the 
amino acid uptake and incorporation inbo protein in muscle. They 
also increase lipolysis in adipose tissue resulting in release of 
glycerol and free fatty acids (Baxter and Torsham, 1972; Leung 
and Munck, 1975)*
After secretion from the adrenrj. cortex, most of the cortico­
steroids are transported in the blocc I ouad to protein. The 
greater proportion in man (about bOic) is bound to a specific binding 
globulin ’transcortin’ and seme of the remaining 20% to albumin.
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(Sawin, 1969) Only a very small amount ol the total corticosteroids 
produced (10%) is therefore 'free' in the plasma to bring about the 
various physiological actions on tho body tissues (Sawin, 1969)
James and Landon, 1976),
In men fchs plasma half-life cortisol is between 60 end 90 
min (Heilman, Nakada, Curti, Weitzman. Kream, Roffwarg, Ellman, 
Eukushema and Gallagher, 1970; Few, 197U- James and Landon, 1976) 
and a similar half-life has been recorded in the horse (James, Hoxner, 
Moss and Rippon, 1970).
A small amount of free cortisoj is excreted unchanged by the 
kidneys, the remainder is metabolised mainly by the liver and 
excreted via the kidneys as inactive metabolites (50%) or as 
conjugated forms of these (30%) i.e, as cortols and cortolones 
(Fukushima, Bradlow, Heilman, Zumoff and Gallagher, I96O; Romanoff, 
Morris, Welch, Rodriguez and Pincus, I96I).
Fig. 2.3
Cortisol . Cortisone Blood
I i
Dihydrocortisol Dihydrocortisone
I I
Tetrahydrocortisol Tetrahydrocortisone ^ Urine
Cortol Cortolone
The metabolic pathways of cortisol and cortisone in man are 
shown in Fig. 2.3, the metabolism of corticosterone occurring in a 
similar manner.
2, 2 ESTIMATION OF CORTICOSTEROIDS
2.2.1 Introduction
The metabolites of the corticosteroids found in urine can be 
measured by a number of methods. Unfortana.bely none of these are 
very specific since thov estimate groups of metabolites rather than, 
individual compounds and since most of bhe methods are based on a 
colour reaction nonsteroid substances can interfere and produce 
falsely high results. The small proportion of 'free' cortisol in 
urine can also be estimated using either a fluorometric technique 
similar bo that used for plasma or a competitive binding method 
(Beardv/ell, Burke and Cope, 1968).
A method similar to that used for the assay of urinary 
corticosteroids has been devised for plasma utilising the Porter- 
Silber colourometric technique (Nelson and Samuels, 1952). Steroids 
measured by this method include cortisol, cortisone, 11-deoxycortisol, 
some metabolites of corticosteroids and other synthetic steroids such 
as prednisone and prednisolone. Corticosterone is not estimated by 
this technique. As in the colourometric reactions when applied to 
urine, lack of specificity of this method means that the materials 
assayed are referred to as 'Porter - Silber' chromogens, rather than 
cort.i costeroids.
PZuLrnmnbric methods of estimating plasma corticosteroid levels 
are also used, the most common one being that of Mattingly (1962), 
These bo cliniques depend upon an ethanol--sulphuric acid induced
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xluorascenoe of the 11-OECf after their extraction from plasma with 
methylene chloride. Unlike the Porter - Cilber reaction, this 
method does estimate corticosterone. While the fluorometric 
technique is simpler aiid requires less plasma than do the colouro­
metric techniques, there is a disadvantage in that both methods are 
prone to interference from non-steroid materials.
The specificity of the fluorometric method has been assessed 
by a number of authors (be Moor, Steeno, Raskin, Hendriloc, I96O; 
Mattingly, I962) and it has been shc:m that synthetic steroids 
including prednisone,prednisolone and dexamethasone produce only 
minimal interference.
One of the more recent methods developed for corticosteroid
estimation is the competitive protein binding assay - C.P.B.assay
7 ^
(Baum, Ihdor and Landon, 197^). This technique uses selenium 
labelled cortisol and rabbit serom end is a modified version of the 
competitive protein binding method of Murphy (196?) in which tritium 
labelled cortisol was used. The competitive protein binding assays 
are more specific than the fluorometric methods as they do not 
estimate any.non-steroid material. However competition for binding 
sites on the binding protein between cortisol, corticosterone, cort­
isone, progesterone and 11-deoxycortisol can occur, (Murphy, I967). 
Also, other steroids such as prednisolone hove been found to cause 
high results with the competitive protein binding assay (Crawley, 
Garbien and Tuttlebee, 1975).
Another method recently developed for pla.sma, cortisol 
estimation is that of radioimmunoassov ... R . i . A .  (Parr.aer and Pierce,
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107i^ ), This tedrmiquG is more time consuming than any of the 
otners but t^ n^ds to be more specific because of the anti-sera used. 
Problems can arise due to cross-reactions of the anti-sera (Paa.mer 
and Pierue, 1975) or due to interference from the organic solvents 
and chromâtograpiiic materials used (Pizzaro and Kolanowski, 1972).
Although the R.I.A, method compares favourably with the C,P,L. 
Method (Farmer and Pearce, 197U) the former is generally considered 
to be too complicated a procedui’e for numerous routine applications.
All the methods outlined have been developed for the assay of 
corticosteroids in human plasma but have been used to estimate 
corticosteroid levels in animals. As can be seen later in this 
Chapter in Table 2,5, the plasma levels of corticosteroids in horses, 
as measured by the different methods, vary considerably.
Many comparative studies have been made of the various assay 
procedures. All of these however have been carried out using human 
plasma (Paum _et 1974; Crowley et ad, 1975; Gore and Lester,
1975)j Bruton, Li and Smith (1973) recorded very poor correlation 
between the fluorometric method of Clark and Rubin (I969) and the 
Porter ^nd Silber technique. They related this to the poor specific­
ity of the colourometric procedure.
Having considered all these facts and compared the costs of the 
various assays, it was decided to use the fluorometric technique of 
Mattingly (1962) for all corticosteroid estimations in this study.
The f'oll.owing study was therefore carried out to establish . 
the fluorcvatric assay method and validate its application to the 
estimation of plasma 11-OHCS levels in the horse.
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2.2.2 Materials
Glass extraction tubes (15 ml.)., Qaickfit.
Automatic pipette, Eppendorf, West Germany,
15 ml. glass extraction babes, modified to form 2.5 ml. cuvette.
J. J. McCulloch, Glasgow,
Spectrofkiorometor with modified lamp holder to contain extraction 
tube/cuvettes. Aiiinco-Bowman, Gpectropbotofluorcmeter, 
American Instrument Go, Inc., Maryland, U,S,A,
Liquid Scintillation Spectrometer, Parkard Tri Garb, 3255* 
Scintillation vials - plastic (22 nan). Metal Box Limited, 
Plastics Group,
Chemicals
Bichloromethane. P.D.P.C. (B„I),H. )
0.2 N NaOH, Volucon, (B.D.H.)
Ethanol. Analar, Burroughs
Concentrated sulphuric acid. Analar. (B.D.H. )
Cortisol standard : hydrocortisone standardised vial (50 mg)
Sigma Chemical Company.
The initial dilution to 28 rr\mol/litre was made in ethanol, 
subsequent dilutions to I68O, 1120, 560, 1^ 20, 280 and II4O n mol/ 
litre were made in distilled water.. S+andards were stored in the 
dark at 4° 0.
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Quality Control Serum 
a ) Velloomtrol 1 (Bovine Serum) :
estimated cortisol -value 3*66 n mol/litre 
E) Wellcomtrol 2 (Horse Serum) :
Estimated cortisol valne batch i) 311 n mol/litre
batch ii) 400 n mol/litre 
The Wellcome Foundation Limited.
(1, 2, 6, 7 In) ^H) Cortisol : supplied in a benzene/ethanol 
solution (9:1 V/V), 1 ml. contain;ng 1m Hi activity, 
Padiochemical Centre, Amershain 
Liquid Scintillator ELS 93» Koch-Light Laboratories Ltd.
Becon ^0 t cleaning fluid. B.B.H,
Corticosterone. Sigma Chemical Company.
Hydroconisone. Sigma Chemical Company.
Heparin BP (mucoid.) 1000 units/ml. Evans Medical Limited, 
Instagel, Koch-Light Laboratories Ltd.
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2.2.3 PJETHCDS
Collection and preparation of blood for M-hydroxycorticosteroid 
(11-OHCS) analysis
Blood samples were obtained on all occasions from the jugular 
vein of the horses and ponies used during this study. When repeated 
sampling was necessary, a cannula was inserted into the jugular vein 
through a 16 gauge 1-g" needle and held in place by surgical tape 
around the neck, once the needle had been witndrawn.
During these procedures the andmais were restrained by means of 
a head collar and showed little or nc signs of excitement or 
discomfort.
■ Blood was collected into heparinised plastic tubes and stored 
at 4° G until centrifugation (2,500 r.p.m.) wh^ch was generally 
within 30 minutes of collection. The plasma was removed and stored 
at -15° C until assay.
During sampling, the cannula wa,s kept patent by flushing with 
1-2 ml. of heparinised saline after each blood sample. The initial 
3 ml. of each sample was discarded.
Collection and preparation of blood for ACTE estimation
Blood was collected from the Jugxlar vein by venepuncture or 
through an indwelling cannula. It plEioed immediately in plastic 
heparinised tubes on ice and thencentrifuged at 4° C. ' The plasma 
was removed and stored in plastic tubes at -15° C until assay. Care
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was taken to ensure that the samples did not come into contact with 
glass at any time, as ACTH adsorbs onto this substance (Landon, 
James, Wharton and Friedman, 1967)»
Estimation of ACTH levels in plasma
A large number of bioassays have been developed to determine 
levels of circulating ACTH in plasma and In other body tissues but 
they are generally complicated, time consuming and not ideal for 
routine clinical purposes (Vernikas - Lai'inellis, Anderson and Trigg,
1966).
A readioimmunoassay has also been developed which is much n ore
practical, sensitive and easy to use. The basic method is that of
"j 9 0
Landon and Greenwood (1968) using I labelled antigen (Greenwood, 
Hunter and Glover, 19^3) and anti-sera prepared in rabbits. 
Preparation of the fluorescent reagent for plasma 11-OHCS estimation
Seven volumes of concentrated sulphuric acid were added slowly 
to three volumes of ethanol in a flask cooled to 0° C. The mixture 
was stirred continuously using a magnetic stirrer and stored in the 
dark at room temperature.
Statistical Analyses
All statistical analysis in this study were carried out usicg 
the paired 't ' test and correlation coefficient.
Assay Method
The method was that of Mattingly (1962) with a few minor
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modifications.
All glassware was soaked ove:might in a commercial detergent 
solution (becon 90) and rinsed tboroughly in distilled water before 
use.
1 ml, a/liquots of thawed plasma were pipetted into 15 ml. 
extraction tubes containing 1 m] of distilled water.
1 ml. volumes of quality control serum and of each standard 
concentration (II4O, 280, 420, 560, 1120,and I68O n mol cortisol/ 
litre distilled water) were treatedin the same manner. All five 
standards and the one quality control were assayed in duplicate and 
two 2 ml. distilled water blanks were also included.
A flow diagram representing the assa,y method is presented in 
Fig. 2.4
Tlie modified spectrofluorometrio tubes allowed them to be used 
for both the fluorometric step and for the reading of the fluorescence 
without transfer of the extract.
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Fig. 2.4 Flow Diagrajfi for 11-llydroxycorticosteroid Assay
Venous Blood
Plasma 
(1 ml.)
1 ml. distilled water 
10 ml. Bichloromethane
shaken for "i 5 min
plasma layer 
aspirated off
aqueous layer 
aspirated off
shaken for 
20 sec (by hand)
1 ml. 0.2N NaOH 
shaken for 5 min
5 mj - Extract into fluorometric tubes
2.5 ml. fluorescent agent
Read on Spectrofluorometer 
13 min later
Because of the critical timing involved (Mattingly, (1962) 
described thirteen minutes as the time when interference from other 
fluorescing bodies was at a minimum) twenty-six tubes could be 
handled in this way per assay.
Readings of Relative Fluorescent Intensity (R.F.I.) were made 
(by multiplying the metKp reading by the rain setting on the 
photomultiplier) at wavelengths of b.Y2 excitation and 520 yu 
emission. These settings were ascertained by scanning a standard 
cortisol sample and setting the fluoj‘■'me+.or to the peak excitation 
and emission wavelengths.
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All readings were corrected by subt^-acting the disrillsd waoer 
blank. A standard curve of the fluorescence of the standard 
cortisol samples was plotted and the concentrations of the utfaiown 
samples read off from this scale.
Concentrations of the standard cortisol sam%)les were fr^ und to 
remain stable for a period of at least two weeks when stored in the 
dark at 4° C.
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2.2.il Determination of the level of sensitivity of the assay
Borth ('1957) had defined sensi bivity as being the smallest 
single resalt which can be distinguished from zero.
Standai'd solutions of hydrocortisone (Bigma) were made up in 
ethanol and water concentrations rang^ng from 28 to 280 n mol/litre. 
Four samples of each concentration were assayed along woth duplicate 
water blaijks. After subtraction of the average blank Ji.F.I. 
values from the standard results the significance of the differences 
between consecutive concentrations was calculated.
Determination of the specificity of the assay
The specificity of the assay is defined as the ability of hhc 
method to determine solely the compound it purports to measure 
(Whitby, Mitchell and Moss,
In initial assays, the dichloromethene extract of the quality 
control serum samples exhibited a strong green colour, and it Wo,s 
noticed that on these occasions the recorded 11~0HCS levels were 
higher than those quoted for the quality control sera. Mattingly 
(1962) successfully reduced non-specific fluorescence in plasma by 
adding a washing step with 0.1h sdium hydroxide and this^Wa^sbep 
included in our assay. Estimated values of 11-OïïCS in V/ellcomtrol 
2 (Batch ii) were compared with quoted values before and after 
inclusion of a NaOH wash following dichloromethane extraction. 
Determination of the accuracy of the assay
— — M M I I — P III 'I I II II I ■ ! «  —  l I M I M I M W m m  I I ir I V  H I. . . . . . . ■! I !■ IBlWlI gl » m  M M V lUi
The accuracy of the method is defined as the concordance betv/'^ en
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it and the true or most probable value oz the quantity measured 
(Whitby et 19^7)»
Plasma was taken from a horse breated with dexametha.sone twelve 
hours previously. This was assumed to be blank plasma since the 
levels of plasma H-OHCS recorded in it wore belo'Vi the limit of 
detection of the assay.
A standard solution of cortisol (nydrocortiscne) was made up in 
ethanol to a concentration of 1 mg/ml. Volumes of this standard 
equivalent to concentrations of 1680, 1120, 6^0 and 280 n mol/lrrro 
were then added to glass extraction tubes and blown dry under air at 
55^ 0, 1 ml. of the blank plasma ,ras added to each tube which was
then mixed thoroughly and left at room temperature for 30 minutes.
The plasma samples, duplicate standards and distilled water 
blanks were then assayed as normal.
Determination of the precision of the assay
The precision of the assay is defined as the concordance of 
a series of measurements of the same quantity (Whitby ^  al,
1967).
Two quality control samples of the same value were included in 
every assay, Wellcomtrol 1 is a control serum giving a high 11-0ÏÏ0S 
reading and the Wellcomtrol 2 (Batch ii) a low 11-OHGS reading.
Precision was calculated over a number of assays in which both 
types of Wellcomtrol sera had been used. Standard deviations were 
estimated using the formula:- (V/hitby e_t ad, 19^7)
i2
SB = \ / ^  (d,
■ iMTi n 11 !.■ \ i.. J
2N
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where ’d ’ is the difference between duplicate readings and h the 
number of duplicate determinations performed.
The coefficient of variation was then calculated for each seb 
of results using the formula;-
qi)
G.V. = — —  X 100 
mean
Pesuits
S E N S IT in T l ( ta ble  2 . 1 )
Table 2.1 presents details of the significance of the 
differences amongst points of the hydrocortisone standard curve.
It is apparent that the sensitivity of the standard curve lies at 
worsb between 28 and ^6 n mol/litre. It may be that a significant 
difference could also have been detected below the 28 n mol/litre 
level but for practical purposes in this thesis, the working range 
of the assay standard was considered to extend upwards from 6^ 
n mol/litre.
SPECIFICITY (TABLE 2.2)
Initially, the assays carried out including Wellcomtrol 2 (Batch 
ii) quality controls produced high readings of plasma 11-OEGS levels 
compared to those quoted by the manufacturer. These high readings 
were accompanied on each occasion by a strong green discolouration 
of the Qichioromethane extract and of the fluorescent mixture.
The inolusioi' of a sodium hydroxide wash in the assay after the 
extraction step, successfully removed this green colour and reduced 
the qua±iI^ control readings to nearer the stated ones. NaOH
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Table 2,2 Plasma 11-OHCS levels found in Quality Control 
Serum
Quality Control Serum (Wellcomtrol 2)
Assayed Level 11-CKCS Assayed Level 11-CHCS
Value Cortisol before îTaOH wasn after NaOH wash
311 n mol/l U39 n mol/l 30I4 n mol/l
I4I4O n mol/l 322 n mol/l
311 n mol/l 390 n mol/l 327 n mol/l
395 n mol/l 322 n mol/l
311 n mol/l 363 n mol/l 318 n mol/l
377 n mol/l 322 n mol/l
3'l1 n mol/l i|l8 n mol/l 318 n mol/l
lj.27 n mol/l 318 n mol/l
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washes were consequently included in all assays.
ACCURACY
Tlie ability of the assay to determine accurately the amount of 
cortisol in horse plasma, is shown in Fig. 2.5. The fluorescence 
values of the 'blank' plasma alone were subtracted from those of 
plasma plus cortisol in order to reduce any interference from 
endogenous cortisol.
'Hie correlation coefficient was calculated and the equation 
of the line of the graph recorded.
r = 0.9973 
y - - 0.957 + 1.17 X
PiïECIClO'd
Standard deviations were calculated for each Wellcomtrol value 
over approximately sixty assays. The overall results are shown in 
Table 2,3i the Coefficient of variation having been calculated 
separately for each of the two groups - Wellcomtrols 1 and 2 (ii).
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Table 2.3 Mean values and standard deviations of 11-OHCS in 
Quality Control Serum samples
Wellcomtrol 1 Wellcomtrol 2
Quoted levels 
cortisol present 566 n mol/l 1|00 n mol/l
-  ... , 1
Mean levels 
11-OHGS found 
(No. sairiples 
analysed)
5 9 9 n mol/l 
(30)
398.9 n mol/l
(37)
I
1
Standard
Deviation 12
I
+ 12.8
Coefficient 
of Variation 2.0%
11
3.2%
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2.2,5 Recovery of (1, 2, 6, 7, (n) ^ l a b e l l e d  cortisol from 
horse plasma
The fluorometric method of Mattingly (1962) has been evaluated 
previously using human plasma. It was important to assess the 
ability of this technique to extract 11~0ECS from horse plasma 
before applying the method.
Experimental procedure
The tritium labelled cortisol was supplied in a benzene/ethanol
solution l9:1 V/V), 1 ml. containing 1m Ci activity,
0.1 ml, of this initial concentration was diluted in 100 ml. 
distilled water .and 1 ml, of this solution diluted again in 100 ml.
of distilled water. 100 pX, of the final concentration was
calculated to contain approx, 20,000 c.p.m, (= 5 0 ’ pg cortisol).
100 ^ al, of Labelled cortisol was added to two plastic 
scintillation vials as controls and these were air dried in a water 
bath at 55° 0,
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The same volume of H cortisol was added to each of ten glass 
extraction tubes and was air dried at the same temperature, 1 ml, 
of horse plasma and 1 ml, distilled water was added to each tube.
The tubes were mixed thoroughly for 30 seconds and left at room 
temperature for 30 minutes,
■;0 ml, of the extraction agent Dichloromethane were added to 
each tube a\'d the tubes were shaken on a rotamix:-
i) four tubes for l5 minutes
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ii) three tubes fcr 20 minutes
iii) three tubes for 30 minutes
The plasma layer was aspirated off, 1 ml. of 0.1N sodium 
hydroxide was added to each tube and they were shaken on the rotamix 
for a further 5 minutes. Tiie aqueous layer was again asperated off 
and 2 ml. of the dichloromethane extract added to plastic 
scintillation vials. These were air dried at 55*^  C and 1 ml. 
distilled water and 10 ml, scintillation fluid added to each vial. 
All the vials were counted on a liquid scintillation spectro­
meter and the recovered activity compared with that found in the 
vials to which labelled cortisol had been added directly.
Results
Recoveries obtained using different extraction times are shown 
in Table 2,q,
There appeared to be little benefit in continuing extraction 
for longer than 15 min.
Table 2,1). Recovery of cortisol added to equine plasma and 
taken throu^ the Mattingly (1^62) extraction 
procedure using different extraction times, compared
3
with an equal amount of H cortisol counted directly
~ T T % Recovery 
Mean values 
(Range)
min rotating
20 min rotating
30 min rotating
^ number of tubes included
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2.2.6 Practicability
Modification of the glass extr^ntion tubes to incorporate a 
fluorometric cuvette reduced the time required for each individual 
sample and allowed twenty-six tubes to be assayed at one time.
This,together with the fact that only 1 ml. of plasma was required 
for each estimation, meant that the assay- could be carried out 
frequently and easily.
The fluorometric method was considerably cheaper than either 
the Porter - Silber colourometric assay or the Competitive Protein 
Binding (C.P.B.) assay.
Application of the Method
Table 2.5 shows the results obtained by several authors for 
corticosteroid levels in horse plasma using different methods of 
corticosteroid assay.
Levels of 11-OHOS in resting animals recorded by the Mattingly 
(1962) method in this laboratory ranged from 70 - i|26 n mol/litre 
and were slightly above the range of results recorded by other 
authors using similar methods.
Table 2,^ | Plasma Cortisol Values (n mol/litre) recorded in 
Eorses at Rest by Various Authors using Different 
Methods
Species Assay Method. Resting values 
cortisol 
n mol/l
j Horse j Colourometric i i).99 - 720
Horse C.P.D,
Horse
Horse
L
Horse
Horse
C.P.B.
PTuorometric
Pluorometric
Fluorometric
15 - 76
299 - 352
83 - 360
70 - i*26
Author
Zolovick et 
al, 1966
Bottoms at 
al, 1972
Hoffsis et
1970
Flisinska- 
Bojanowska 
et al. 197Ai­
dâmes et
al, 1970
This
Study
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2.2*7 Discussion
Estimates of corticesoeroid levels use methods involving either 
urine or plasma.
Using urine to estimate corticosteroid production however can 
result in numerous difficulties. There are problems associated with 
the varictbledilutiori effects in urine and standardising these with 
reference to the amounts of creatinine present would not have been 
possible in some of our studies e.g. exercise tests. There is also 
a lag between the production of the urine and collection, such that 
the levels of corticosteroids measured would be the mean values over 
a period.
The various methods for measuring corticosteroids in plasma have 
been compared by numerous authors (Pirke and otainm, 1972; Bruton 
et al, 1973; Gore and Lester, 1979* Crowley e_t al, 1979). The 
Porter - Silber procedure has difficulties in that a number of 
interfering chromogens in the extract may produce elevated results 
(Lorraine and Bell, 1971). It is however reproducible (Bruton 
et al, 1973) and is still used in some laboratories.
The fluorometric method of Mattingly (1962) has compared 
favourably with the more recent Competitive Protein Binding (C.P.B.) 
Assay described by Baum et (I97I4). Gore and Lester (l979) 
quoted a coefficient of correlation between the two of + O.92,
Crowley et al (1979) of + O.9U and Bour et al (1974) of + 0.974»
Bruton at al (1973) on the other hand reported a poor 
correlation between the fluorometric teclinique of Clark and Rubin
36
(1969) and the Competitive Protein Binding Method of Murphy,
Engelberg and Patti (19^3). Tliey attributed this difference to the 
fact that the former measured only the corticosteroids with an-, 
attached lT-hydroxyl group whereas tbo latter estimates all 
corticosteroids. The C.P.B, method of Murphy (19^7) however was 
further modified by Baum et al (l97h) and with this assay the 
correlation between the two tecijj-iiques was better.
An important factor in determining which assay would be most 
practical and efficient for our purposes was the fact that many 
substances will interfere with both the fluorometric and C.P.B. assays 
producing falsely high results. Be Moor _et al (1960) and Mattingly 
(1962) added various substances inclu'^^.ng dexamethasone, prednisolone 
and betamethasone to plasma samples mid assayed them using the 
fluorometric method. They concluded that whereas prednisolone 
produced a slight degree of fluorescence, dexamethasone did not, 
Crowley et al (1979) found similar abnormally high results following 
prednisolone treatment using both the fluorometric and the C.P.B, 
technique,
Gore et ^  (1974) and Crowley at al (1979) also reported that 
spironolactone, a drug used in the treatment of hypertension -an.d 
structurally similar to aldosterone, caused fluoroescence in plasma 
which lasted for several days following treatment.
It was important that drugs such as dexamethasone should not 
interfere with our assay specificity, since in the course of these 
studies a number of drugs of this type were to be administered to 
the horses.
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Mattingly (1962) also reported that timing was critical in 
measuring the fluorescence after addition of the H^SOj^/ethano]. 
mixture. Fluoroescence due to non-specific agents increases vuth 
time, and the maximal point of 11-OHCS fluorescence occurs between 
ten and twenty minutes after addition of the fluorescent agent. 
Mattingly measured the fluorescence of his samples 13 minutes after 
adding H^SOi^/ethanol mixture and could assay only a limited number 
of samples because of the time involved in transferring them from 
glass tubes into cuvettes. Use of the combined glass tube/cuvette 
eliminated this step and enabled more samples to be read in the same 
time.
All three techniques, (colourometric, fluorometric and C.P.B.) 
were developed using human plasma but have been employed by 
different workers to estimate plasma corticosteroid levels in horses. 
As shown in Table 2,9 however the different methods do produce 
variable results in the horse. The high levels recorded by Zolovick 
et cl (1966) using a colourometric technique may be explained by the 
fact that this assay is known to be subject to interference from many 
other substances.
The sensitivity as described for this technique was taken as the 
limit of detection of the -assay. The smallest single result 
distinguishable from zero as reported by Mattingly (I962) was 64 
n mol/litre and our result of 28 n mol/litre is considerably below 
this although levels of 19 n mol/litre have been recorded by Bottoms 
ejb al (1972). The limit of detection in this assay however was 
estimated using- hydrocortisone standards made up not in plasma but in
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ethanol and distilled water. li is possible that interference 
from other fluorescing- substances in plasma would increase the 
limit of detection such that these results using distilled water 
might not truly reflect the sensitivity of normal assay conditions.
Fox this reason we decided to take the limit of detection as 96 
n mol/llrre and in 9»a.tx3equant experiments, any plasma 11--0HGS 
concentration below this level- was considered to be 'blank* 
plasma. Subsequent results suggest that the amount of interfering 
fluorescence in plasma cannot be high since in samples obtained 
when dexamethasone was employed to suppress adrenocortical function, 
many of the results obtained had levels below the linrlt of detection 
(96 a niul/litre).
Be Moor _et al (196O) and Mattingly (1962) have shown that the 
method is not completely specific for 11 -OIlUS with several other 
steroids producing fluorescence. However, the fluorescence produced 
by 11-OHCS (on a weight basis) with the sulphuric acid/ethanol 
mixture is considerably greater than with other steroids. Of the 
11-OHCS present in human plasma, the greatest fluorescence is 
produced by corticosterone followed by cortisol (Mattingly, I962).
In the horse the latter is by far the more important (Zolovick ejk al, 
1966; James at al, 1970) and therefore fluorescence due to 
corticosterone should be minimal.
The green discolouration present in the quality control samples 
appeared to be the cause of the over esidmaLion of the results 
obtained since removal of the colour successfully reduced the recorded 
levels.
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Silber and Porter (1954) a::d Silber and Busch (1996) used 0.1N 
sodium hydroxide to remove some steroidal and other phenolic and 
acidic compounds which interfered in their colourometric assays, 
Mattingly (I962) also records the successful reduction in interfering 
fluorescence by certain synthetic steroids by incorporation a 0.1N 
sodium hydroxide wash in the extraction procedure. This step is 
often included in urinary assays as a further method of purification 
(Glenn and Nelson, 1993; Nor^nnberski, Stubbs and West, 1993).
When a known amount of cortisol was added to blank plasma 
(plasma from an animal whose adrenal had been suppressed by 
administration of dexamethasone and whose basal plasma 11-OHCS level 
twelve Lours later was below the limit of detection of the assay) 
and taken through the assay procedure, a linear relationship was 
found between the known amounts of added cortisol and the measured 
amounts (Pig. 2.9). These results of accuracv are similar to those 
reported by Mattingly (1962),
Precision was calculated over a large number of assays and can 
be taken to mean reproducibility as the assays were performed by the 
same person every time. The standard deviations recorded for both 
high and low Wellcomtrol samples are lower than those reported by 
Mattingly (1962) for the original method and using a similar number 
of results. It is probable that the improvement in chemical reagents 
combined with our assay technique avoiding trauisfer of the extract 
from tubes to cuvettes would be the re?ecn for this improvement in 
precision.
The recovery of tritium labelled coruisol added to,equine plasma 
was within the range of 87 - 97^ with a mean of 92^ (Table 2.4) and
AO
there was no significant difference in recovery with the length, of 
time allowed for extraction. These results are similar to the 
recoveries reported in man by Mattingly (1962), but slightly lower 
than the ones reported by De Moor _et al (1960), No corrections were 
made in subsequent assays for recovery.
3. DETERMINATION OF PLASMA CORTICOSTEROID
LEVELS IN THE HORSE
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3•1 Introduction
A number of preliminary experiments were neccesspry prior to 
the use of corticosteroid estimations as a means of assessing stress 
in the horse. These studies were as follows
i) estimation of the plasma half-life of cortisol in the horse 
since on a number of occasions repeated 11-OHCS measu-^ements had to 
be taken over short periods of time.
ii) assessment of the effect of venepuncture on plasma 11-OHCS 
levels. The majority of blood samples throughout this study were 
taken by this means and it was importarit to determine whether this 
sampling technique per se constituted a stress.
iii) basal levels of plasma 11-OHCS levels were recorded in all 
the experimental animals. Blood s.amples were collected throughout • 
this study at varying times of day and it was essential to establish 
whether a circadian rhythm of 11-OEGS and ACTE secretion as reported 
by other workers in horses, existed in our animals.
iv) suppression of adrenocortical function by dexamethasone.
v) assessment of the sensitivity of the adrenal cortex to small 
physiological doses of synthetic ACTH.
Both these latter tests are used in man to assess adrenocortical 
function and would possibly be a guide to the adrenal responses in 
our animals.
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3.2 CAlGUIiATION OF THE BIOLOGICAL HALF-LIFE OF
CORTISOL IN THE HORSE
This experiment was designed to calculate the half-life of 
tx'itium labelled cortisol in one pony.
Animals
Pony No, 3 was used in this study.
Materials
3
0.1 ml. of an aqueous solution of H labelled cortisol 
containing 0.1 m Ci was calculated to give a sufficiently high count
n
per ml. of plasma (i.e. 4.4 x 10 c.p.m.) and was diluted in 9 ml.
of saline for injection.
Blood samples were centrifuged at 4*^ and 1-g ml. plasma removed 
and added to plastic scintillation vials. 10 ml. Instage1 was put 
into each vial which was shaken thoroughly before being counted in 
the scintillation counter.
Experimental Procedure
■Ihe left jugular vein of pony No. 3 was cannulated, as described 
previously, 2 hours before the start of the experiment.
The 9 ml. saline containing the 0.,1m Ci of labelled cortisol 
was injected via the cannula. Blood samples (7 ml.) were taken at
43
10 ULin intervals over a period of 2 hours and every 30 min for a 
further 4~5 hours.
Results (Fig. 3.1)
Counts per minute recorded were plotted against time on semi­
log graph paper and sirce this revealed a mono-exponential pattern 
the equation of the line was calculated:-
y = 361.2 - 1.4 X
The half-life of cortisol calculated between 90 and 290 min was 
103 min.
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3.3 M E C T S  0? THE METHOD OF BLOOD 8.4KPLING ON
OF 11-OHO 5 Am  ACTE IK PLASM
Tliis experiment was designed to assess the effects of blood 
sampling b;v ■^ e^nepm'ict'ure on plasma 11-OHGS and ACl'H levels.
Animals
Two ponies were used in this study (îïos. 1 and 3).
Materials
Cannula ; intravenous nylon cannula set with 16C needle, l/h I.COrnm.
Length 30 cms. Portex limited
Experimental Procedure
Cannulae (30 cms) were inserted through a 16 gauge needle into 
the left jugular veins of both ponies and the animals left to stand 
quietly for 2 hours. 25 ml. of blood was taken into plastic 
heparinised tubes - 15 ml. for ACTS and 10 ml for 11-OHCS estimation 
(Cl). All blood was stored as previously described until and during 
centrifugation. Plasma was removed and stored at -15° 0 until assay 
for 11-OHCS and ACTS.
Five minutes later a blood sample was taken from the right 
jugular vein by venepuncture (V1 ) and 1 minute later a second samp] e 
was withdrawn via the cannula (C2). Finally, 2 minutes after 02
45
a third sample was withdra,wn via the cannula (03).
Results
The plasma levels of 11-OHCS and ACTH before and after 
venepuncture are shown in Table 3.1.
Plasma 11-0H03 values did not increase after venepunctuie as 
compared to resting (C1) samples. Plasma ACTH levels increased 
at each successive sampling time reaching their highest levels at 
3 min post venepuncture in both ponies (C3).
There was no significant correlation (p ^  0.05) between
plasma ACTH and 11-0ÏÏCS levels in either animal.
Table 3.1 Levels of plasma 1'i-OHOS and ACTH before and after 
Venepuncture in two ponies
I"
Fcny Sample
roasma 11-OHCS 
levels (n mol/l)
Plasma ACTE 
levels (ng/l)
“
277 . 188
1
25U 20U
"2 277 222
252 2k0
2)47 120
L 168 1622
2<1 173
°3
250 200
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3.II. LEVELS OP PLASMA 11-OHCS ANH ACTH HORSES AMD PONIES A'’
REST ANH VARIATION IN THESE HHHING ONE HOTJH AND 
TWEN.PY-POHH HOUH CYCLES
Before considering alterations in either plasma 11-OHCS or 
ACTH levels due to stressful situations, it was essential to estimate 
the range of these levels in clinically iiorm.al animals at rest and 
to determine any changes in these levels over short and long periods 
of time.
Animals
All seven horses and three ponies were used in this study. 
Experimental Procedure
Blood samples for plasma 11-OHCS estimation were taken from the 
group of horses routinely over a period of 6 months. All samples 
were taken between 9 a.m. and 10 a.m. from animals which had been 
stabled overnight and had access to both hay and water.
A separate group of samples was talcen from 20 thoroughbred 
race horses (2-7 years) before and during a training programme over 
a twelve month period. These samples were always taken from the 
animals at rest between 7 a.m. and 9 a.m.
In order to ascertain fluctuations in plasma 11-OHCS and AO'TH 
levels over a short period of time, nylon cannulae were inserted intD 
the left jugular veins of 2 ponies (Nos. 1 and 3) and blood samples
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taken at 10 minute intervals over a period of 1 hour. As with 
all the experiments where cannulae were used, they were inserted more 
than 1 hour- before blood sampling was due to start.
Diurnal variation in plasma 11-OHCS levels was studied by taking 
samples from alternate jugular veins in all 10 animals over a period 
of i|8 hours. During this period, the animals were fed and watered 
as normal but were not exercised. Care was taken to ensure that 
samples, especially those taken during the night, were obtained with 
the minimum of interference and lighting. Samples were taken from 
7 of the 10 animals at 8 a.m. and 10 p.m. for plasma ACTH 
estimation.
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Kg suits
The mean levels of plasma 11-OHCS in all of the 10 animals at 
rest were below 230 n mol/l, range 70 - 426 n mol/l (Table 3.2).
There were no significant differences (p O.I) between mares and 
geldings, thoroughbreds and heavy hunters or ponies and horses end 
there was a large degree of variation within the levels of each 
animal.
The plasma concentrations of 11-OHCS in the group of thorough­
bred horses in training are shown in Table 3»3* The levels fell 
within the range 155 - 465 n mol/litre for the group of 20 horses.
This lb a slightly higher range than was recorded in the previous 
experiment where heavy hunters and ponies were also included but 
the difference between the two groups was not significant (p 0,1 ). 
Training also resulted in an increase in resting plasma 11-OHCS levels 
which were significantly above pre-training values (p 0.05) after 
3 ar.'d 9 months training.
Alterations in plasma 11-OHCS and ACTH levels over a 60 minute 
period in ponies No. 2 and 3 are shown in Table 3»4»
11-OHCS and ACTH values varied throughout the 60 minutes in both 
animalsc The mean values of I63 and 220 n mol/litre of 11-OHGS are 
within the range of values found in the previous experiment for 
normal resting animals (Table 3*3). It is interesting to note that 
planma. ACTE levels in pony No. 3 were consistently higher than those 
in pony No. 2 although the 11-OHCS levels were not. Tliroughout the 
60 minutes there was no significant correlation in either pony
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Table 3*3 Plasma 11-OHCS levels (n mol/l) in a group of twenty 
thoroughbreds before and during training
Horse Ho. Sex Occasions Sampled
Pre
Training-
3 months 
Training
...
6 months 
Training
9 months 
Training
1 o 211 327 272
r
338
2 P 222. 338 155 393
3 S 21 1 379 216 299
4 S 278 355 449
5 8 211 li43 188 249
6 8 222 244 216 155
7 S 288 255 216 255
8 S 2W 4 244 305 438
5 P 316 2l|4 216 388
10 F 172 327 260
11 8 343 241^ 255
12 8 271 410 338 155
13 8 377 465 388
14 8 277 343 399 465
lb 8 2Uh 343 244 410
16 8 316 305 260 410
17 G 244 272 244 • 188
18 B 211 343 205 343
19 8 272 410 282 294
20 8 172 255 227 260
Mean ~ s.e 243 - 10.2 327 - 13.5 270 i 19.7 312 4 21.6
S - Stallion 
G - Gelding 
P - Pilly
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between 11-OïïOS and ACTH levels (r = 0.2835, p 0.1 : r ^ 0.5078,
p ^  0.1 respectively).
Pig, 3*2 shows the pattern of plasma 11-OHCS levels over 2U 
hours in all 7 horses sampled. The lowest mean 11-OHCS level 
occurred at &  p.m. (l^J n mol/litre) anc* the highest a t a . m .
(266 n mol/litre). This difference was significant in all 7 horses 
combined (p ^  0.001),
Pig. 3‘3 shows the pattern of plasma 11-OHCS levels over a 
twenby-four hour period in the three ponies. In this case the 
lowest mean values occurred at 12 a.m. and the highest at 10 p.m.
There were no significant differences in 11-OHGS values at 
similar times between the mares and geldings or the horses and 
ponies. The differences between highest and lowest levels 
recorded are significant in each individual group (mares p 0.05, 
geldings p 4  G.05, ponies p 0.05).
However there is great individual variation within the groups - 
standard deviation in some cases being as high as IO8 n mol/litre.
There was also a large variation in the plasma ACTH levels 
between animals (range 26 - I4I1.I ng/litre) and no significant 
correlation between these and the corresponding plasma 11-OHCS 
values fr = 0.2516, p O.I). In 3 of the 5 horses the lower
ACTH levels occurred a,t 8 a.m. and a similar trend was noticed in 
all 3 ponies (Table 3*5)* Tiiere was no significant difference 
between .'^ CTH levels at 8 a.m. and 10 p.m. in the group of animals 
(p /  0.1).
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3 • ? EFFECT hf SUPPEESSION OF TEE ADKBNAL C O R M  BY DEXAMETHASOCTS
0?? THE T.EVELC OF 11-0HC8 AFP ACTH IN PLASMA
The initial object of this experiment was to ascertain whether 
or not dexamethasone wonld suppress adrenal function and thus 
produce a fall in circulating plasma 11-OECS levels. If it could 
be sho'i-m. that dexamethasone successfully suppress adrenocortical 
function producing low levels of plasma 11-OHGS, it would then be 
possible to extend the in-'/estigation and measure the adrenal response 
bo physiological doses of ACTH.
Animali
Three ponies (Nos. 1, 2 and 3) and one thoroughbred mare (No. $) 
were used.
Drugs
Dexamethasone ; Dexadreson (2 mg/ml). Intervet.
Exrei'imental .Procedure
Dexamethasone was administered intramuscularly at dose rates 
(on a weight basis) similar to those producing suppression of adreno­
cortical function in humans.
11^ mg. dexamethasone (equivalent to approx. 0,06 mg/kg) was 
administered to each pony and 30mg. (equivalent to approx. 0.06
51
mg/kg) to the thoroughbred mare.
Plasma samples for 11-OHCS estimation were collected before 
injec+ion and at 12, 2I4., 36 and 48 hours post-injection. In 2 
of the ponies (Nos. I and 2) samples for 11-OHCS measurement were 
taken a,t 60, 72, 9^t 120, II44 and 168 hours, to ascertain the duration 
of adrenocortical suppression.
Results
In all the animals given dexamethasone there was a marked 
reduction in plasma 11-OHCS levels (Table 3*^)«
Iwelve hours after dexamethasone administration circulating 
plasma 11-OHCS values were below the limit of detection for the 
assay in all 4 animals and in ponies No. 1 and 2 they remained 
below the limit of detection (i.e. ^6 n mol/l) for the first Ij.8 
hours. In horse No. 5 and pony No. 3; levels had almost returned 
to resting (pre-injection) values by i|8 houTs.
Duration of suppression achieved following this dose of 
dexamethasone was 36 hours, in ponies Nos. 1 and 2. By this time 
plasma 11-OHCS levels had returned to resting (pre-injection) values.
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3.>6 HÆSITIVITY 0? Ti’E ABMALTOPHY^IOLOGICAL LOSES OF
SYNTHETIC ACTH
Having: established in the previous experiment that 
adnn.nistratJon of dexamethasone results in decreased levels of 
plasma IV-OHCS over a period of at least 2l|. hours, the response of 
the adrenal to physiological doses of ACTH was investigated in the 
7 hour period beginning 12 hours after dexamethasone injection.
Animals
One pony (No. 2) and two Tliorough or e ds (Nos. 1 and 3) were used 
in this study.
Synacthen : synthetic Adrenocorticorrophic hormone (0.2^ mg/ml)
Ciba
ACTH is a single chain peptide and the terminal 2l|. amino acids 
are identical in all species studied to date. Since this terminal 
portion of ACTH is the only part necessary for biological activity 
it has been possible to synthesise an identical peptide to the 2l\. 
amino acids of the natural hormone «nd this is Synacthen (James and 
Landon, 1976).
Experimental Procedure
Synthetic ACTH (Synacthen) was diluted to the required
53
concentrations in acidified saline (pH2) •- it has been si own 
(Landon, James, Wharton and Friedman, 196?) that this procedma 
reduces adsorption losses onto the glass bottles used.
Dexamethasone at the appropriate dose rate was administered 
at 10 p.m. after a blood sample had been barken for 11-OHCF! 
estimation. At 8 a.m. the following morning a cannula was 
inserted into the left jugular vein and at 9*30 a.m. a blood sample 
taken.
At 10 a.m. (l2 hours after dexamethasone administration) the 
following dosing and sampling regime was commenced. Injections 
were given through the cannula at 60 minute intervals and blood 
samples taken after each injection (10, 1p, 20, 30 and 60 minuLes'. 
Immediately the 60 minutes sample had >)een taken, the next injection 
was administered and the procedure repeated.
A control injection of 1 ml. acidic saline was given to'eacn 
animal at 9 a.m. before treatment with increasing doses of Synacthen 
from 2^ to 1000 lig. was commenced at 10 a.m.
Blood samples, taken before and 11 hours after dexamethasone 
administration, were assayed rapidly for plasma 11-OHCS levels to 
confirm that a reduction in values had occurred.
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Results
The responses of all 3 animals to this procedure are shown 
in Tables 3*7 and 3-8.
Plasma 11-0ÏÏCS levels decreased in all the animals to a level 
below that of the assay sensitivity 12 hours after dexamethasone 
administration. Injection of acidic saline appeared to produce 
no effect in any of the animals on circulating plasma 11-OHCS levels, 
neither did administration of 2^ and. 50 ng. Synacthen. In both 
horses Nos. 1 and 3 injection of 100 ng. Synacthen produced an 
increase in plasma 11-OHCS levels which at its maximum was 160% 
and 6^% respectively above the levels immediately prior to thab 
injection. Increasing doses of 2^0 and 500 ng. produced little 
change in horse No, 1 but after administration of 1000 ng. plasma 
11-OHCS levels increased to almost resting (pre-dexamethasone) values
Horse No. 3 on the other hand responded to increasing doses of 
Synacthen with gradually increasing levels of plasma 11-OHCS and 
following 1000 ng. these values were at 30 min post injection 39% 
higher than resting (pre-dexamethasone) levels.
Pony No. 2 did not respond to the increasing doses of Synacthen 
until the 250. ng, dose was administered. The maximum 11-OHCS level 
produced by that injection was 3^9% above the value immediately 
prior to it. Following the 500 and 1000 ng. doses the circulafclug 
plasma 11-OHGS levels increased by and 93% respectively above 
resting (pre-dexamethasone) values.
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3*7 Mscussion
Half-Life
The plasma, half-life of cortisol recorded in this study (103 
min) is slightly above the values of 60-90 min reported in man 
(Sawin, 19^9; Heilman et ad, 1970; Few, 1974; James and Landon, 
197^) and also higher than the half-life of 80 min recorded by James 
et al (1970) in horses.
The half-life represents the rate at which cortisol is cleared 
from the plasma mainly due to its being metabolised in the liver 
and it has been shown in man that exercise will decrease and liver 
disease increase the half-life of cortisol (Few, 1974; James and 
Landon, 197^)* The difference in our results compared to those of 
James et ad (l970) could be due to a number of factors.
Firstly, although the pattern on the graph appeared to be mono- 
exponential there is a suggestion that there might be two phases of 
breakdown - the initial one being the more rapid of the two.
Secondly there was a difference in the methodology employed in this 
experiment compared to that carried out by James at ad (l970).
These authors employed chromatographic separation before estimating 
plasma cortisol levels by a fluorometric method and they measuz'ed 
the half-life of cortisol by studying its rate of clearance from 
the blood after one intravenous injection. The method used in 
this study on the other hand does not differentiate between corrisol 
and its labelled metabolites and would therefore always tend to lead
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to overesti.ii'.abion.
In this study there also appeared to ho some variation in 
individual points around the line and this could be due in part to 
the low results obtained in these cases and the relatively high 
counting error (10%), Because of all these differences it would 
be of more interest to repeat this experiment in a greater number of 
animals in order to establish any patterns of individual variation. 
Venepuncture
It was important to establish xhe effect of venepuncture on 
plasma ACTH and 11-OHCS concentrations because in many of the 
expteriments carried out in this study it was not practicable to use 
a cannula..
The fact that no alterations in plasma 11-OHCS levels were 
found within 3 Diin of venepuncture agrees with the results of James 
et al (1970,)* In both our ponies however pla.sma ACTH levels had 
'increased quite markedly by the time of the last sample suggesting 
that had blood sampling been continued over a longer period a 
similar rise in 11-OHCS values might have occurred.
During routine blood sampling from the animals at rest it was 
always possible to obtain blood within 3 min and therefore increases 
occurring after this time would not influence the results. On 
several occasions however sampling vas continued at 10 or 19 min 
intervals and in these cases a oanrul.i.  ^.a.s inserted in order to 
minimise the 'effect of repeated stresses.
Plasma 11-0H08 and ACTH levels were never estimated immediately
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following oannulation and having determined that Ti for cortisol 
was in the region of 103 min in one of onr ponies, a period of at 
least 1-g- hours was always allowed efter oannulation hefore 
coimnencing each experiment. Posting (pre-experiment) blood samples 
were taken before cannulation of the v^in and compared with a second 
resting sample taken immediately prior to the experiment for 
comparison.
Normal resting levels
The range of plasma 11-OHCS levels recorded in both groups of 
horses (Tables 3»3 and 3»h) are similar to those reported by other 
workers (James et 1970; Hoffsis, Murdick, Tharp and Ault, 19'0; 
Flisinska-Bojanowska, Skwarlo, LuJcaszeu^ska, Bobilewicz, Wilk and 
Gill; 1974; Snow and Munro, 1975) but lower than those quoted by 
Zolovick _et aJ (1966). This discrepancy could be due to the fact 
that latter authors used the colourometric technique of Porter 
and Silber (1950) for cortisol estimations and as has been discussed 
previously this method can over estimate corticosteroid levels due 
to interference from other substances.
No significant differences in 11-OHCS levels were apparent 
between animals of d i f fe r e n t  sex. This confirms the results of 
earlier authors (Hoffsis e_t ad, 1970; Flisinska-Bojanowska et ad, 
•197^)« In man, the levels of plasma corticosteroids are thought 
to decrease with age (Bliss, Sandberg, Nelson and Eik-Ness ,1953) bii: 
no age related findings were obvious in this study nor in the work 
carried out by Hoffsis at ad (l970).
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The range of plasma 11-OHCS levels recorded in the thoroughbred 
horses throughout a training programme was slightly higher than that 
in our ten experimental animals. The increases in values of 
individual horses (Table 3■5-) were spasmodic and apparently unrelated 
to specific animals or to the stage of training. There was however 
a significant difference between the mean resting levels of the 
untrained horses and the same animais after three and nine months of 
training. These results agree with those of Frenlcl and Csalay (1970) 
and Buick and Tharp (1971) who reported an increase in resting plasma 
11-OHCS levels in rats half way through a training period of six 
weeks.
Variations in plasma 11-OHCS and AGTH levels
Circadian variation in plasma 11-CHCS levels have been 
demonstrated in many species including man (Orth, Island and Biddle, 
1967; Weitman, Fukushima, Hogeire, Hoffwarg, Gallagher and Heljmari, 
1971) rats (Krieger, 197U)» dogs (Halliwell, Schwartzman, Hopkins 
and McEvoy, 1971» Campbell and Watts, 1973), cattle (McAdam and 
Eberhast, 1972), pigs (Whipp, Wood and Lyon, 1970) and horses
(Zolovick _et ad, I966; Hoffsis _et ad, 1970; Bottoms, Roesl, Rausch
End Akins 1972; Snow and Munro, 1975)*
This pattern of 11-OHCS secretion, has been reported to coincide 
with similar changes in plasma ACTH levels (Krieger ad, 1971) 
and five to ten bursts of episodic secretion have been shown in irrx
to occur throughout the 2Ji hour period (Heilman et ad, 1970).
The initial experiment in this study was carried out to
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recognise not only circadian rnytjLus of 11-OHCS secretion but also 
patterns of shorter periodicity i.e. 60 mir. Prom these results 
it would appear that plasma 11-01108 levels do alter over short 
periods of time and this would agree with the studies of Heilman 
_et ad (1970) who demonstrated secretory bursts of 11-OHCS production 
in man occurring every 20 min throughout a 2l|_ hour cycle.
Plasma ACTH levels do not show a similar pattern, there being 
no significant correlation between the two sets of results in either 
pony. There was a coefficient of variation of 20% in the assay 
method used to estimate ACTH levels however (Cray, personal 
communication) which means that the values recorded may not truly 
reflect any rhythm of ACTH secretion. In man, Kr-ieger et ad (1971) 
have shown that at the great majority of times throughout the 2i| 
hour period, a given ACTH peak preceded or occurred at the same 
time as an elevation in plasma 11-OHCS levels. As ACTH values have 
never been recorded previously in horses it is probable that a 
similar picture would emerge in this species if more work were 
carried out.
Combining the results from all ten experimental animals of 
11-OHCS levels a definite pattern of circadian secretion emerges 
similar to that reported by other workers. Highest values were 
recorded in early morning and lowest in early evening. The exact 
mechanism controlling the periodiciby of 11-0JÏC3 secretion is 
unknown but a number of suggestions nav= been put forward. In man, 
the sleep-waking cycle is closely related to changes in plasma 
11-OHCS levels and experimental alteration of this schedule over a
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period of 7 days did r in chajiges in tho nattom of 11-OHCS
secretion (Orth et sd., 1957; Perkoff, Eik-Nes, Fred, Himer, Rush, 
Saiuue“'s and Tyler, 1959i bellman _et al, 197S; Weltaman et al,
1971)' Association with light-dark cycles has also been reported 
in rats (Pisko and Leenan, 195b; Cheifetz, Gaffud and Dingman,
1955  ^ although in monkeys hatelson, Holaday, Meyerhoff and. Stokes 
(1975) reported no correlation between illumination and cortisol 
secretion. In man, also Perkoff _et ad^  (l958) reported that total 
blindness had no effect on the oiroacian rhythn of 11-OHCS secretion. 
Krieger (l97b) recorded that hy restricting food and water intake 
in rats to a certain limited time a 12 hour shift in the time of 
peak plasma 11-OHCS levels occurred. This change was linked however 
to alterations in the animals sleep-wake pattern due to a need to 
obtain adequate food aiid driirk.
The h^qjothalamus releases cortiootrophin-releasing-factor to 
stimulate ACTE secretion and a cir'cadian rhythm iîi this pituitary 
stimulatory activity of the hypothalamus has been described in mice 
(Ungar, 195b). Disease of the central nervous system has correspond­
ingly been shown to alter the circadraa pattern of patients especially 
those suffering from disease of the temporal lobe or hypothalamus 
(Krieger and Krieger, 1956) and experimental destruction of the 
anterior areas of the hypothalam.u8 also inhibited the normal 5 p.m. 
rise in rats (Slusher, 196b). In both these cases however, normal 
corticosteroid responses to stressful st_i..mu1 i such as noise were not 
abolished, suggesting that two distinct areas are involved in these 
aspects of ACTH release.
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Circadian changes in plasr.a 11-OHCS levels can alsc be abolished 
hy the actions of several drugs. Atropine, adird.nisfcered just 
prior to the time of expectea elevations in '11-OHCS levels blocks 
this increase suggesting that cholinergic mechanisms arc involved 
in ACTH release (Krieger and Krieger, I966; Krieger ejc al, I968). 
Atropine however did not block the adrenal response to administered 
ACTH, or insulin-induced hypoglycaemi.a suggesting that several CHS 
mechanisms or structures are responiscle for the regulation of 
circadian preiodicity as opposed to stress induced adrenal cortical 
responses.
Betamethasone on the other hand, when injected into rats 
suppressed both circadian and stress-induced changes in plasma 
corticosterone (Hodges and Mitchely, 197'C). These observations 
agree with the suggestion that the mechanisms controlling circa 11 an 
ACTH rhytlrm and stress-induced ACTH release are dissociated.
The circadian pattern recorded in our horses could be related 
to sleep-wake cycles although this is difficult to say since al'L the 
samples taken through the night involved wakening the animals.
For this reason blood samples were taken at 2 hour intervals over a 
b8 hour period in the hope of reducing the interference caused, 
as much as possible. It was noticed that when considering the 
group of horses compared to the ponies, the latter did not show 
such an obvious circadian pattern. All the horses (Thoroughbreds 
and heavy hunters) were kept in loose boxes and had been over a 
number of years, the ponies were usually allowed to graze.outside in 
a field and were only brought in for experiments. The peak plasma
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11-OHCS levels occurred in the horses between 6 and 10 a.m. - 
stable routine involved work starling around 8.30 a.m. and .feeding 
was always carried out around 9 - 9.30 a-m. Hy 6 p.m. when 
11-OHCS levels were at their lowest, all the work was over for the 
day and the grooms had left. It is possible therefore that the 
pattern of corticosteroid secretion was, as well as being controlled 
by a sleep-wake cycle affected in some way by the day-to-day routine 
in the stables. A similar pattern has been demonstrated in dairy 
cattle (MacAdam and Eberhapt, 197?) subject to a strict daily 
schedule except that their peax levels occured earlier at b«30 a.m. 
Dexamethasone suppression
Dexamethasone is the steroid most commonly used in man because 
at the doses required to produce suppression neither it, nor its 
metabolites influence plasma steroid levels as determined by the 
fluorometrio method (James and Landon, 1976).
The effects of dexamethasone on circulating levels of plasma 
11-OHCS have been recorded in horses by various workers. Hoffsis 
et al (1970) gave an intramuscular dose of dexamethasone and recorded 
maximal adrenal suppression occurring at between 12-2b hours and a 
gradual return to pre-treatment levels by 72 hours. James et ad 
(1970) administered 0,0b mg/kg. dexamethasone intravenously and 
recorded depression of plasma 11-OHCS levels 2b hours later.
The results reported in these expe_:iments therefore agree with 
those published elsewhere. Hie two ponies (Nos. 1 and 2) in which 
duration of suppression was recorded both showed complete depression
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of 1 l-OHCS levels for hS hours after dexamethasone treatment. This 
is slightly longer than was reported hy Eoffsis et ad (1970) hut the 
latter gave no details for the dose of dexamethasone used.
There was a considerable degree of Individual variation between 
the animals in that 2 of the h animals showed suppression lasting 
only between 12 and 2b hours. This variation could be due to 
different levels of threshold sensitivity i.e. certain animals mjght 
need higher levels of circulating corticosteroids before the 
negative feedback mechanism is triggered. It would be advisable 
therefore to confirm total suppression of the adrenal by estimating 
plasma 11-OHCS levels before commencing any further tests dependent 
on low basal corticosteroid values.
Adrenal sensitivity to physiological doses of ACTH
The low baseline levels which resulted from dexamethasone 
injection made the small changes in circulating corticosteroid levels 
in response to administered ACTH much more apparent. Also 
dexamethasone in doses sufficient to suppress endogenous 11-OHCS 
secretion did not appear to impair adrenocortical function. A 
procedure based on determining plasma 11-OHCS values immediately 
before and after nanogram -amounts of synthetic ACTH has been used 
in man as a test of adrenal sensitivity (Landon _et al, I967).
In those studies both horses showed a greater degree of adrenal 
sensitivity to ACTH than did the pony. This may be a feature of 
fit Thoroughbred animals since training has been shovm in rats to 
produce adreUcul hypexp)lasia (Tharp, 1975).
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It was surprising thax in Horse No. 5 the peak level produced 
following the 100 ng. dose of Synacthen was higher than that 
recorded after either the 2^0 or $00 ng, dose a,lthough the maximum 
'I1-0HG3 levels were recorded following the iina]. 1000 ng, dose of 
Synacthen,
Summaag'-
From these studies it would appear that the modified 
flucrometric method of Mattingly (1962) is sufficiently sensitive 
to assay peripheral plasma 11-OHCS levels in horses.
The noimal range of plasma 11-OHOS levels in horses at rest 
has been established and those correspond to those reported by other 
workers. It was also established that a circadian variation occurs 
in Thoroughbred horses but this could not be demonstrated as clearly 
in ponies. The response of the equine adrenal in a number of 
situations is similar to that of man and other animals.
b. THE EFFECTS OF V^RZOHS STRESS SITUATIONS
ON THE ADRENAJ; CORTEX AND ON THE
SWATHETIC NERVOUS SYSTEM
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i|. 1 Introduction
The adrenal cortex responds to a wide variety of stressful 
situations by increasing the rate of production and re]ease of 
11-OHCS. This response depends upon intact neural and hormonal 
pathways between the central nervous system; hypothalamus, pituitary 
and adrenal cortex.
It is possible to artificially s+imulate either the entire 
hypothalamic-pituitary-adrenal (H.P,A.) axis or the adrenal cortex 
alone using a number of substances e.g. synthetic ACTH or insulrn 
(James and Landon, 1976; Kehlet, Llichert-Toft, Lindholm and 
Rasmussen, 1976). By using such methods of artificial stimulation, 
the integrity of the H.P.A. axis can be assessed. These tests are 
used frequently in man and have also been carried out on horses 
(James et al, 1970).
Changes in plasma 11-OHGS levels are also associated with 
natural conditions such as physical exercise (Wasserman, Van Kessel 
and Burton, 1967; Wasserman and V/hipp, 1975) and surgical trauma 
(Clarke, Johnston and Sheridan, 1970). These alterations have been 
extensively investigated in man but there is a paucity of similar 
results in the horse.
The following experiments were undertaken to compare the effects 
of various stressors, on heart rates, packed cell volumes, pla.smo 
11-OHCS levels and a number of associated parameters.
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k.2 EXPERxME-NTAL STIMULATION OF THE H.P.A. AXIS BY INSULIN 
and INOREASING doses OF SYNTHETIC ACTH
b.2,1 Effects of insulin-induced hypoglycaemla on circulating 
plasma 11-OHCS, ACTH and glucose levels
Insulin-induced hypoglycaemia is used in man to test the 
integrity of the hypothalamic-pituitary-adrenal system (Landon, Vyn 
and James, 1963; Greenwood, Landon and Stamp, 1966; Stauh,
Jenkins, Ratcliffe and Landon, 1973) and has been used in horses as 
a means of maximally stimulating glucocorticosteroid release (James 
et.al, 1970).
Insulin administration produces an increase in the uptake of 
glucose into muscle and an increase in the conversion of glucose to 
glycogen in the liver and in fat tissue. The net result is a fall 
in blood glucose levels (Goodman and Gilman, 1975). In order to 
increase the supply of glucose again many changes occur including 
increased gluconeogenesis and glycolysis. These changes are brought 
about by a number of hormones but mainly by the catecholamines, the 
glucocorticcsteroids and glucagon. Glucagon end the catecholamines 
increase glycolysis in the liver and in muscle and the latter 
inhibit further insulin release. Together with the glucocortico- 
steroids, all three hormones stimulate gluconeogenesis in the liver 
and kid,iey^ and also lipolysis in the adipose tissue (Williams, 1968).
Tiie response recorded following insulin-induced hypoglycaemia 
should dspand therefore on the fall in blood glucose produced (Landon 
^  al, 19&3/. The purpose of this experiment was to assess the
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ofieots of varying doses cf insulin on blood gluovse levels in ponies 
and to compare the adreno-cortical responses to insulin-ind.uced 
hypoglycaemia with those resulting from maximal stimulation by ACTH.
Materials
Insulin. EP (IqO units/ml) , 
Technicon Autoanalyser II,
Duncan, Plockhart and Co. Ltd., 
London.
Technicon Corp., Incorp., Tarry town, 
Lew York.
Animals
Three ponies (Nos, 1, 2 and l) were used. All were housed in
loose boxes and allowed hay and water ad lib, Pood was withdrawn
throughout the experimental pericc.
Methods
Plasma 11-OHCS levels were measured as described previously. 
Plasma ACTH levels were measured by radio.immianoassay.
Blood (approximately 3 ml) was added to tubes containing 20 mg, 
sodium fluoride/sodium oxalate mixhrre and the plasma removed
for blood glucose estimation. This was ceiried out on a Technicon 
Autoanalyser II using the method AV 11 -- 2- (Neocupr^ine 
Hydrochloride).
Heart rates were measured by a,uKcuI'':-:.tion in experiment 1.
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Experimental Procedure
0annulation of the jugular vein was carried out 2 hours before 
j.nsulin injection described previously). A control blood 
sample for pl3,sma 11-OHOS, ACTH and glucose estimation was taken 
1 hour L$ mill later.
Plasma 11-OHGS and glucose levels were measured 15» 30, b5? 60, 
75j 90 min after insulin administration in both experiments.
Plasma ACTH levels were estimated in one pony in each 
experiment at 15, 30, 60 ana 75 after insulin.
EXPEHIMENT 1
0.1 units/kg. of soluble insulin were administered intravenously 
to all three ponies.
EXPEHBISPT 2
0,2 units/kg. of soluble insulj.n were administered intravenously 
to ponies No, 2 and 3-
All times quoted are times after insulin injection.
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b.2.2 . Results
EXPER1MÜNT 1 : 0.1 UNITS INSDl IN/KG.
Pony No. 1
BEHAVIOURAL SIGNS
Between 30 and 60 min this pony showed mild sweating and 
restlessness.
HEART RATE (TABLE b-1 )
Heart rate altered slightly between b5 and 60 min.
BLOOD GLUCOSE (PIG. b*1)
A marked hypoglycaemia was apparent, blood glucose levels 
falling t o '92 nr\mol/litre within 60 min. By 2.5 hours the levels 
returned towards resting (pre-insulin) values,
P LASM 11-01108 AND ACTH (PIG. b. 1 )
Alterations in plasma ACTH and 11-OHCS levels occurred at the 
same time as the fall in blood glucose values. Maximum ACTH levels 
(b90 ng/litre) occurred at b5 min and maximum 11-OHCS levels (7b8 
n mol/litre) at 60 min,
ACTH levels had fallen towards resting values by 75 min but 
plasma 11-OHCS values remained elevated 2.5 hours after insulin 
injection at which time blood glucose levels had returned almost to 
resting values.
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Ponies No. ^ and 3
SEMYIOP-ML SICmS
No abnormaj. behavioua’al signs were apparent.
HEAiiT RAVN (T/JîLE ^.l)
Heart rates remained unchanged throughout the 2.5 hour period. 
BLOOD GLTJCO'JE (PIGS, k.2 AND U.S)
Blood glucose levels fell in both animals but not to values as 
low as those recorded in pony No. i and 2-28 mmol/litre
respectively). The response was also much slower, lowest levels 
being recorded between 60 and 75 min. By 2.5 hours the levels had 
returned almost to resting vaNues,
PLASKA 11-OHCS (PlGS. k,2 AND 1|.3)
Changes in plasma 11-OHCS levels were less marked than those 
in pony No, 1. One of the ponies (No, 2) showed an increase in 
11-OHCS valaes above pre-treatment levels - the peak occurring at 
75 min. In pony No. 3 no definite pattern was apparent.
EXPERIIIBNT 2 : 0.2 HNITS INSULIN/KG.
Ponies No. 2 and 3
BEHAVIOURAL SIGNS
Pony No. 2 began to sweat and L-ocm u restless between 60 and $0 
min Pony No. 3 showed no behaviouraj changes.
BLOOD GLHCOSE (EIGS. k-k -AND U.5)
Blood glucose levels in these arm male fell further than in the
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previous experiment reaching 1O0 and 1*28 mmol/litre respectively 
between 60 and 90 min. In pony No. 2 the levels were still below 
2-00 rnmol/litre, 2.$ hours after insulin but in pony No. 3 they 
had returned almost to pre-treatment values by this time.
PL/ISMA 11-OHCS AND AOTH. (PIGS. U.i; ANN i|.5)
Plasma a CIH levels in pony No. 2 showed a similar pattern to
those recorded in pony No. 1 following the lower dose of insulin
although the response was much smaller. The peak level occurred 
at min and was followed by the increase in 11-OHCS values.
Plasma 11-OHGS levels in these animals increased to values of
6I4O and 728 n mol/litre respectively between 60 and 75 min post- 
injection - times corresponding to the lowest levels of blood 
glucose. Hy 2.5 hours in both animals 11-OHCS levels had returned 
to resting (pre-treatment) values.
I
I
-cf
- c t
ui
CN
I
PLASMA ACTH ngji
ü)
y
0
1 8
3IDa0
3
Cû
w
1
c
&
L U
S
)—
o Q■oS
ijioui m SHHAST aSOOmO aOGHS
U2
CQ E-l
O H
O
b
Ü!
OJ
S O
F-S
CQ SU
W qo
1 A
V“ p
p-j
a o
1 A
A
o
I
BLOOD GLUCOSE mmoî/l
O
3
I
r—I c:
U J
K
|/|0UJ u SDJ-lO -ll V W SVld
72
i|.3 EFFECTS OF ST1TTÜLATIQN n? THE EQ.UIiIS ADEENAL [iLW  INCPÆLSING
DOSES 0? RYFTHETIC ACTH
0?he mode of action of ACO;H and tlie control of its n^odnction 
and secretion have been discussed in detail in an earlier section.
The doses of ACTII used in this experiment were much greater 
than the normal physiological range and were used in order to find 
the dose of ACTH which would produce maximal adreno-cortlcal stim­
ulation in these animals. A simila.r method has been employed in 
man (landon and James, 197^) and has been used in horses (James 
et al, I97O; Snow and Munro, 1975)-
It was intended that the response of any stress in an animal 
might be q^uantitated by comparison of the plasma 11-OHCS levels 
produced with those produced maximally by this procedure.
Animals
Three ponies (Nos. 1, 2 and 3) were used.
Experimental Procedure
Three doses of synthetic ACTH (Synacthen) were administered - 
50, 100 and 200 iu. Each dose was given intramuscularly to 2 of 
the 3 ponies on separate occasions. On each occasion, one pcpy 
acted as a control and was given an injection of sterile water. 
Blood samples for plasma 11-OHCS estimation were taken 30, 60, 120, 
2l|.0, 3&0, ^80 and in some cases 720 min after ACTE injection.
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The ponies were restrained throughout the 8 hour period hut 
were allowed access to hay and water. No pony was used more than 
once as a control animal and at least 10 days were allowed between 
experiments.
Results (Fig. h.6)
50 ID SYNACTHEN - PONIES NO. 1 AI7D 2
The maximum response to this dose of ACTH was seen between 2 
and U- hours post injection when the plasma 11-OHCS levels rose by 
136%  and 222% respectively above pre-experiment values. A diphasic 
response was noted in both ponies. In both animals the levels hc.d 
returned to pre-injection values by i;80 min.
The plasma 11-OHCS levels of the control animal (No. 3) 
fluctuated over the 8 hour period but never exceeded 3^0 n mol/litre.
100 ID SYNACTHEN - PONIES NO. 1 AND 3
The maximum response was recorded at h hours post injection, 
n/lien the plasma 11-OHCS levels increased by and 1^ 2% respectively 
above pre-experiment values. Again the response appeared to be 
diphasic with two maxima at 60 and 2l|0 min„ Levels had returned 
to pre-injection values by J4.8O min post injection.
The plasma 11-OHCS levels in the control animal (No. 2) did 
not exceed n mol/litre.
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200 IU SYNACTHEN ~ PONIES NO. 2 AND 3
The maximum response following this dose of ACTH was seen much 
earlier. In pony No. 2 plasma 11-OHCS levels increased by 225% 
above control values at 3C min post injection and in pony No, 3 5, 
790% increase occurred at 60 min post injection.
There did not appear to be a diphasic response following this 
dose. Levels fell quickly however and had returned to pre-injection 
values by 720 min.
11-OHCS values in the control animal (No. l) were always below 
220 n mol/litre.
FIG, It. 6 ALTERATIONS IN PLASM^n 11-OHOS LEVELS 
IN THREE PONIES EOLLOVjNG 50, 100
AND 200 iu SYNACTHEN 
ADMINISTERED INTEAMDSCULARLY
800 50iu
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l|.i4 Discussion
Experimental stimulation of the adrenal and the H.P.A. axis 
resulted in increases in plasma 11~0HCS levels. The maximal 
increases in each pony produced by injection of synthetic ACTH 
(Synacthen) were taken bo be the levels of ma^zimal adrenal 
production.
The doses of Synacthen used in this study produced circulating 
plasma ACTH levels greatoD? than those occurring naturally in any of 
our* animals (Chapter 3*U) and should therefore ensure that maximal 
adrenal stimulation was occurring. Peak levels of plasma 11-0ÏÏ03 
were recorded in two of the three ponies (Nos, 1 and 2) following 
the lower doses of Synacthen suggesting that at this point the 
adrenals of these animals had reached maximum production. In pony 
No, 3 en the other hand the greatest increase in 11-OHCS levels was 
recorded after the 200 iu dose of Synacthen,
James et _al (1970) and Hoff sis _et al (1970) injected similar 
doses of Synacthen to those used in this study into horses and 
recorded little difference in the peak levels achieved following 
each dose. In these studies the range of maximum levels (Table U*2) 
appeared to be within a narrow range, the only differences between 
ponies bein^ in their sensitivity to the administered doses of ACTH.
This .'individual variation between animals was demonstrated in 
earli.cn, experiments involving dexamethasone suppression and adrenal 
sensitivity to low doses of Synacthen. It would appear that this 
large individual variation is a constant feature of equine animals 
as it i.*^ of man and other species and suggests that experimental
r—I
i
}>î
I
frf
S(D
-P
CQ
H
ooOCM
CM
CM
CT\
MO
ens
s
CM
d
Io
c/3
<
aen
P
p
CM
A
(D
«
EH
76
data should be collected fiom as large a group of animals as 
possible before drav/ing any conclusions on adreno-cortical function 
in horses.
The peak levels in our ponies were higher than any of those 
recorded by James et pd_ Hoffsis et ^  (1970) or Snow and
Mun.ro at similar times post-injection but were wiLhin the
range of levels reported in man following thé 5 hour Synacthen test 
(James and Landon, 1976).
The rate of onset of the adrenal response in our animals was 
slowest following the 50 ii^. dose of Synacthen and most rapid after 
200 iu. This is similar to the results of Eoffsis e_t ai (1970) and 
Snow and Munro (1975)* The increase :n the plasma 11-0ÏÏCS levels 
in all our animals was as rapid, as that reported by Eoffsis et ai 
(1970) following intravenous administration of Synacthen and more 
rapid than that reported by Snow and >îunro (1975) following a 100 
iu dose ad.ministered intramuscularly.
This rapid increase could be due to variation in experimental 
animals - both previous workers were using horses of Thoroughbred 
and Standardbred types whereas ponies were used in this study. It 
also appears to be common practice in such procedures in man and 
animals that Synacthen doses are not calculated on a weight basis. 
If this were taken into account then the ponies used here would be 
receiving considerably higher doses than the horses in the other 
studies and this would explain the more elevated plasma 11-0EC8 
levels and the more rapid onset of action found in our animals.
The duration of corticosteroid responses in this study was
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also similar %o that reported hy James et al (19?0) and Hoffsis ^  
al (1970)' Both groups of workers noted that the length of time 
over which the plasma corticosteroid levels was increased was 
related to the dose of Synacthen administered and to the route of 
administration. Intramuscular injection of 100 iu (Hoffsis ^  al, 
1970) produced elevated 11-OHGS levels during 8 hour period after 
injection and the same period of elevated 11-OECS levels is visible 
in OUT' results (especially pony No, 3).
The biphasic response recorded in these ponies following the 
50 and 100 iu doses has not been reported previously in horses or 
man. It could be due to the normal carcadian pattern of 11- 
corticosxeroid secretion being superimposed on the increases produced 
by the injected Synacthen. If the circadian rhythm in 11-OECS levels 
is mediated via ACTH it would be probable that the doses of Synacthen 
used would dominate any small changes in ACTH and therefore it seems 
un]ikely that the biphasic pattern seen is due to this reason.
, The mechanism by which hypoglycaemia produces an increase in 
plasma ACTH levels has been studied in man. It has been shown that 
the response is due entirely to the hypoglycaemia and not to any 
direct action of the insulin since administration of both insulin 
and glucose simultaneously produces no alteration in corticosteroid 
production (Hendon ejt al, I963).
The ro&ponse to hypoglycaemia is mediated via the hypothalamus 
which io juiovn to be an important regulatory centre for food uptake 
and to contain numerous receptors sensitive to glucose levels in the 
blood (xxo'-cr, 1953; Donovan, 1970)* Stimulation of these centres 
leads to the release of catecholamines, glucagon and ACTH (which in
7G
turn produces increases in glucocorticosteroid levels). All these 
hormones by oheir num.erous actions increase blood glucose levels 
and tend to minimise the hypoglycaemic effects of the insulin.
Previous workers in man and in horses have used soluble insulin 
in dose rates ranging from 0.1 - 0.3 units/kg. in the human 
(Greenwood et al, ^^ 66; Landon, Greenwood, Stamp and Wyn, 1966; 
Gtaub _et al, 1973) to 0.^ and 0.8 units/kg. in horses (James ej; oJ., 
1970)' Argenzio and Hintz (1971) used zinc insulin in ponies which 
is more slowly absorbed at dose rates of 0.2 units/kg. but in this 
study the soluble type was more suitable as a rapid effect was 
required.
The dose of insulin used in experiment 1 was similar to that 
given to man and was selected in order that the sensitivity of the 
adrenal cortex to this degree of hypoglycaemia in the two species 
could be compared. The doses administered by James et al (1970) 
were higher but were chosen to produce maximal stimulation and their 
experiment was not intended as a means of assessing the adrenal 
sensitivity to varying degrees of hypoglycaemia.
Injection of the low dose of insulin (Chapter i|.2.l) produced 
8, hypoglycaemia with blood glucose levels below 220 n>mol/litre in 
two of the three ponies studied. In both these animals an 
accompanying rise in plasma 11~0HCS levels occurred but this 
elevation v/as most marked in pony No. 1 whose blood glucose levels 
fell to the greatest extent. Slight sigis of hypoglycaemia 
(restlessness and sweating) were also visible in this animal and 
there appeax’ed to be a small increase in heart rate ~ occurring at
the time of most marked hypoglycaemia.
The increased sensitivity of this pony to the low dose of 
insni.in could perhaps have been due to its low resting blood glucose 
level as compared with those of the other two animals. It is 
probable that the response to insulin-induced hypoglycaemia depends 
to some extent upon the normal resting glucose values of individuals.
Landon £ t a l  (1963) concluded that in man the adrenal response 
to insu] hv-induced hypoglycaemia depended on the degree and duration 
of the hypoglycaemia and that there was no response in subjects 
whose blood glucose levels did not fall below 200 nymol/litre.
James et si (19?G) however reported that in horses changes in plasma 
11-OIlCS levels were only achieved when blood glucose values fell 
below 1*00 mmol/litre.
From these results it would appear that the latter is the case 
in ponies but that the elevations ±n plasma 11-0HC8 levels produced 
were not dependent on the hypoglycaemia below the 2^0 m m o l  glucose/ 
litre level. This is especially apparent following administration 
of the larger doses of insulin in experiment 2. In pony No. 2, 
blood glucose levels fell as low as those recorded in pony No. 1 after 
0.1 units/kg. and yet the plasma 1'i-0H0S levels remained lower than 
in the latter. Similarly with pony No. 3 - the peak plasma 11-OHCS 
values were higher than those recorded in pony No. 2 but the fall in 
blood glucose less.
The increases in plasma 11-0'HCS 'laveIs recorded in all three 
ponies in these experiments were within the ranges reported in man 
during similar studies (Landon et al. "963? Greenwood et al, I966;
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Staub et_ al_, 1973) but h.i.gtier than those quoted by James at al 
(1970). This is interesting since the corresponding blood glucose 
levels reported by James e_t were considerably below 1*10 mmol/ 
litre. The latter authors estimated corticosteroid levels however 
by a semi-automated fiuoroine trie method after chromâtogj?aphic 
separation and this could have resulted in some losses. In general, 
the majority of their results are well below those found in this 
study.
Plasma ACTH levels recorded in ponies No, 1 and 2 showed a 
pattern similar to that reported in man by Staub et ai (1973) 
following insulin administration. These authors found that although 
peak ACTH levels occurred consistently at I4.5 min post insulin 
injection, peak plasma 11-0HC8 Jevels occurred at 60 min. They 
also reported that the plasma 11-OHCS levels achieved correlated 
very poorly with the ACTH values and a similar pattern is apparent 
in this study.
The maximum 11-OHCS levels in ponies No. 1 and 2 were above 
600 n mol/litre but the corresponding maximum ACTH values differed 
by 300 ng/litre. This could be due tu different levels of adrenal 
sensitivity between the two animals or that the suppressive effect 
of rising 11-OHCS levels on further ACTH release may be greater in 
one than in the other. The feedback effect may also explain why 
the ACTH levels reached their peak before the 11-OHCS and why they 
fell off rapidly while 11-OHCS levels vrex-e still increasing (Staub 
et al, 1973).
It has been suggested that insulin-induced hypoglycaemia will 
result in maximal stimulation of the adrenal (landon _et al, 19&3)
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and that injection of ACTH at the time of peak response will result 
in no further increase in 11-OHCS levels. Comparing peak 11-OHCS 
levels in our ponies following ACTH and insulin-induced hypoglycaemia 
however (Table h»3) pony No. 1 appeared not to have been stimulated 
maximally by the large doses of Synacthen. The results further 
suggest that the degree of insulin-induced hypoglycaemia in ponies 
No. 2 and 3 was not sufficient to produce maximal 11- hydroxycort- 
icosteroid secretion. Because the degree of hypoglycaemia recorded 
in all 3 ponies was similar this could mean that the H.P.A. axes 
of ponies No, 2 and 3 were less sensitive to this stress.
Summary
Prom these studies, it would appear that adrenal stimulation 
by (l) large, non-physiological doses of ACTH and (2) insulin-induced 
hypoglycaemia with blood glucose levels below 2'20 ni mol/litre 
both resulted in elevated plasma 11-GHCS levels. If increases in 
plasma 11-OHCS concentrations are taken to indicate stress, it 
would also appear that the widely variable responses in adrenal 
function from animal to animal would make quantitative comparison 
of stress using this parameter very difficult.
The I'dcenal response in the horse to insulin-induced 
Hypoglyco,e7iiia is similar to that produced by Synacthen stimulation 
ard both are within the range of responses recorded in man under the 
seme conditions. This would suggest that the same controlling 
meohanijms ?re present in both species and that the hypothalamus 
plays a similar role in respect of this aspect of body function
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in both species.
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5. THE EEEECTS OE A ÎÜNOR SITRGICAL
PROCEDURE OH HEiRT RATE,
PACKED CELL VOLUME J\HD
P L ASM 11-OHCS LEVELS IE HORSES
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"i Introduction
Snxgical prooednreo have been shown in man and horses to 
prodnce increases in adreno-cortical function which are dependent 
on the degree and duration of the surgery performed (Tyler, Sclnidt, 
Eik-Nes, Drown and Samuels, Clarke, Johnston and Sheridan,
19?0; James et 197' )^*
Disturbing stimuli have also been shown to produce increases 
in heart rate in horses (Aitken and Sanford, 1972) and as has been 
suggested in previous chapters, might also be expected to produce 
elevations in P.C.V. levels.
Alterations in heart rates and plasma 11-OHCS concentrations 
in response to stress have been employed in horses and some 
laboratory animals as quantitative means of assessing the effective­
ness of tranquil} ising and antipsychotic drugs (Smith _et 19^3; 
Aitken and Sanford, 1972; Lahti and Barsuhn, 197^0»
This study was designed to assess the effects of a minor 
surgical procedure on the above parameters.
If the procedure involved produced alterations in heart rate, 
P.C.V. and 11-OHCS levels indicative of stress it was intended to 
complete the experiment by using this technique to compare the 
effectiveness of three commonly used vetez’inary tranquillisers.
The surgical procedure employed was that of percutaneous muscle 
biopsy (C.':irw and Guy, 197&). These muscle samples were being taken 
in the course of a study into the biochemical and Ultrastructural 
changes in muscle associated with training.
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3\2 .Animais
All seven horses were included in this study. Their 
temperaments are assessed in Table ^,1.
Materials
Lignocaine ï 2% Xylocaine Astra
Methods
Heart rates were recorded by radiotelemetry as described 
previously.
Blood samples for P.C.V. and plasma 1'1-OHCS determinations were 
collected and stored and the estimations carried out as described 
previously.
Operative Procedure
The procedure involved the taking of small muscle biopsies 
from six limb muscles - the long head of the triceps, deltoid, 
lateral vastus, biceps femoris, middle gluteal and semitendinosuc - 
by percutaneous needle biopsy (Snow and Guy, 197^)- 
The main steps were
i) shaving the area of skin over the biopsy site,
ii) injecting 1-2 ml. of local anaesthetic (li^ocaine)
subcutaneously along the line of the proposed incision.
Description of Horses used in study involving 
Muscle Biopsies
Horse
1
2
•i: .
Temperament
+
+
3 +++
h -H-
s •h
6 +
7 it
* 4- quiet, easy to handle
•H* moderately quiet
•H-i- nervous, highly excitable
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iii) Making an. incision about -g" in length through the skin 
and fascia.
iv) inserting the biopsy needle through the incision and 
withdrawing a muscle sample.
The experiments were carried out between 9 a.m. and 12 îioon,
all resting samples and recordings being taken before 9*30 a.m.
Tlie entire procedure was generally completed within min and
the horses were restrained in stocks throughout.
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Experimental Procedure
Heart rates were recorded continuously throughout the procedure 
and those quoted are the means of the heart rates monitored over a 
period of 'i min after commencement of each individual stage of the 
procedure.
Blood samples for P.C.V. and plasma 1'1-OIIGC estimation were 
collected from the animals at rest before commencing the procedure, 
immediately after injection of the local anaesthetic and following 
the muscle biopsies.
Under ideal conditions, when the horses allowed the procedure 
to be completed, injection of the local anaesthetic took 2~3 min 
and the biopsies 5-10 min.
5* 3 Results
BEHAVIOURAL SIGNS
In only three of the seven horses (Nos. 1, 5 and 6) was the 
entire biopsy procedure completed. All the animals showed some 
signs of discomfort viz, moving in the stocks especially after 
injection of the local anaesthetic and the four in which the biopsies 
were not taken became very violent at this stage. Failure to inject 
local anaesthetic was the reason for the procedure being abandoned 
on all four occasions.
HEART RATE (TABLE 5-2)
Increases in heart rate occurred throughout the procedure.
%Maximum levels were recorded in associatj.on with injection of the 
local anaesthetic when rates were significantly elevated above 
resting values (p This increase was most marked in the
horses in which the biopsy procedure was net completed. Incising 
the skin produced only a sliglit elevation in. heart rates whereas 
following the muscle biopsies values were again significantly 
increased above resting levels (p ^  0.05).
PACKED CELL VOLUME (TABLE 5,P)
P.C.V. levels increased after injection of the local anaesthetic 
and maximimj values were recorded on completion of the muscle 
biopsies.
PLASM 11-OHCS (TABLE 5.2)
Plasma 11-OHCS levels increased throughout the procedure and 
were significantly elevated above resting values (p 0.05) 
following injection of the local anaesthetic. On completion of all 
the biopsies, values had almost returned/to resting levels.
There was a significant correlation (r - 0.736^, p 0.05) 
between the heart rates recorded and plasma 11-OHCS levels after 
injection of the local anaesthetic.
Table 5*2 Heart Rate, Packed Cell Vo lime and Plasma 11-OHCS 
Levels (mean - s.e. ) Before an.d During Biopsy 
Procedure
1 Heart Rate j Packed 
Stage of Procedure j (beats/min) j Cell Volume
Plasma 11-0EG3 j
(n mol/l) !
. . _ __ . , . .,... -____  j
Pro (Control)
I .
>9 - 1,3 37.7 - 2.0
(7) 1 (7)
_ ___ _..........
j
270 i 41 1
(7) 1
1
Before local 
anaesthetic
After local 
anaesthetic
W  ± -J.5 
(6)
—
^2.4 - 3.5
(7)
«
•r91 - 11.0 
(7)
334 - 41 * 
(7)
Before muscle 
Biopsy
]’8 - 6.0 
(3)
— -
After muscle 
Biopsy
78 ± 9-2 
(3)
Wi.o ■- 3.7 
(3)
291 i 35
(3)
figures in parenthesis indicate nimnber of times each stage of 
the procedure successfully completed
^  P ^  0.05 (refers to difference from mean control levels) 
indicates samples not talien
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^, 1L Diseusnion
Aitken and Sanford (197^) described tachycardia in horses 
associated with various disturbing stimuli of either an awditory 
or a visual nature and concluded that these alterations could be 
used as an accurate means of assessing stress in the horse.
As discussed previously (chapter 1) heart rate is controlled by 
the vasomotor centre in the medulla (Ruslimer, 1972; Guyton, 1971/ 
and uhis in turn can be influenced by higher centres in the brain 
vis. the h^-pothalamus and cerebral cortex.
During this study elevations in heart rate occurred to the 
greatest extent following injection of the local anaesthetic but 
were also markedly increased after the biopsy procedure. Reaction 
to the injection of local anaesthetic was possibly due to the pain 
associated with this procedure.
Stimulation of the sensory nerve endings in the skin by a 
painful procedure results in reflex withdrawô^ of the part of the 
body concerned from the painful stimulus and also other psychological, 
and physiological effects (Guyton, 1971). In the brain, impulses 
related to pain are believed to stimulate the cerebral cortex and the 
hypothalamus and in the case of the latter to result in increases in 
sympathetic nervous activity (Rushmer, 1972).
In man there is great variation in individual responses to pain 
and the came is apparently true of horses. In the four most 
nervous animals it was impossible to complete the biopsy procedure 
because of the violent reactions produced by attempts to inject the
B9
local anaesthetic.
Marked elevations in heart rate were also recorded following 
the muscle biopsies suggesting that some degree of discomfort was 
present. Similar findings have been reported in man after muscle 
biopsies when feelings of dull discomfort have been described 
(Edwards, Lewis, Maunder and Pearce, 1973)* Because stimulation 
of any individual part of the sympathetic system generally results 
in the entire system being stimulated (Guyton, 1970 the changes 
recorded in P.C.V. levels in this study were to be expected. As 
described in chapter 1 the splenic capsule is rich in adrenergic 
receptorc (Davies and Withrington, 1973) and any increase in 
sympathetic activity results in contraction of the organ and 
expulsion of red cells into the circulation. The fact that the 
greatest erevation in P.C.V. levels did not occur at the same time 
as the peak heart rates could have been due to reflex responses 
involving vagal tone affecting the heart.
In the tnree quietest horses which allowed the entire procedure 
to be completed, P.C.V. levels were highest at the end of the biopsy 
procedure. As the biopsy techniques took the longest however 
(between b and 10 min) values would have had time to increase over 
this period more than during injection of the local anaesthetic 
which only took 1-2 min.
All the horses showed a significant increase in plasma 11-OHCS 
levels fet the same time as maximum heart rates were recorded 
immediately after injection of the local, Pollowing the muscle 
biopsies however 11-OHCS values had decreased whereas heart rate 
and P.Lî.'V. levels were still elevated. These results would suggest
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that increased sympathetic activity does not necessarily result in 
elevated plasma 11-OHCS levels or that it cd.n affect different 
systems to varying degrees. Siiico the metabolic half-life of 
cortisol recorded in these s'brHes war in the region of 103 min 
however it seems unlikely that 1 1-OIIOC levels would have fallen as 
rapidly as this over such a short period of time. The low levels 
recorded following the biopsy procedure could therefore be due 
either to the small number of samples assayed or to methodological 
error.
Summary
Prom these results it would appear that muscle biopsy docs 
constitute a stress as measured by elevations in heart rate, racked 
cell volume and plasma 11-OHCS levels. From, the variations in the 
results recorded however, a constant stress would appear to affect 
different systems to varying degrees. These differences may be due 
to individual variations between animals. The timing of sampling 
may also be important in using 11-0ÏÏGS and P.C.V. levels as a mearjs 
of assessing stress.
6. THE æE'JTS or EXERCISE
ADD TRAINING ON ADRENO-CORT'ICAL 
AM) SmPAT'BETIG NERVOUS ACTIVITY
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^• 1 Introduction
Exercise in the horse is accompanied by changes in both 
physiological, and biochemical parameters. These alterations are 
related to the intensity and ouration of the exercise carried out 
and also to the state of fitness of the animal (Milne, 157U; Aitken, 
Anderson, MaoKenzie and Canford, 1979; Lindliolm and 9altin, 197U? 
Milnej fkarda. Gabel, Smith and Ault, 197^).
Elevations in heart and reepiracory rates and packed cell 
volumes aiid alterations in circulating plasma 11-OHCS levels, 
blood gas concentrations and in the acid-base status of the blood 
occuc during and immediately following exercise. Many studies have 
been carried out in man and horses to monitor these effects and to 
dete mine the adaptive processes, if any, which occur in them follow­
ing a period of training (Wasserman et al, 19^7; Astrand and Rodahi. 
1970; Milne et 1976).
In these experiments the effects of exercise of varying intensity 
and duration on heart rates, packed cell volumes and. plasma 11-OHCS 
levels were recorded in order that the degree of stress produced by 
such exertion could be assessed. Alterations in blood gas 
concentrations and in the acid-base status of the blood were also 
measured.
In order to investigate the effecb of training on cardiovascular, 
respiratory and adreno-cortical ac n"''viry tw-n of the exercise tests 
were carried out before and after a ten week training programme.
Hie third test was carried out at a n'.^ erhy racecourse using four
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Tlioiüughbreds which after ten weeks training were considered to be 
fit.
All blood lactate levels included in this chapter were 
estimated by Dr. D. Snow in the process of his studies into the 
various changes occurring in blood biochemistry and muscle during 
exercise.
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6.2 THE EFFBCO?S OF mXWiJ-.L EXERCISE ON IIBAiiT. ,:\KD RESPIRATORY RATES, 
P.C.V. , PLASMA 11-OHCS LEVELS, BLOOD GA.S CONCENTRATIONS AM) 
ACID-BASE BALANCE IN HORSES BEFORE AND .tFTER A TEN VEEX
TRAINING PROCRANME
AriJ.inals
Pour Thoroughbreds (Nos, 1, 2, 3 and I*.) and two heary hunters 
(Nos. 5 and 6) were used. All were housed in loose-boxes end had 
been given only maintenance exercise consisting of limited walking 
and trotting every day except at weekends for the previous 3 months.
Diet consisted of bran, oats, horse nuts and hay fed twice 
daily in the initial stages of training. Later in the training 
programme the amount of oats given was increased, the bran decreased 
and a third mid-day meal included.
Methods
Heart rates were recorded by auscultation over 30 sec periods. 
Respiratory rates were recorded visually over 20 seconds.
Blood samples for P.C.V. and plasma 11-OHCS levels were 
collected and treated as described previously.
Blood samples (2 ml) for blood gas analysis were collected 
anaerobically into cold plastic heporinioed tubes and stored on ice. 
Blood gas and pH measurements were made at 37° C on a direct leading 
electrode system (Eel Corning l69). B:>arbonate (HC0^“ ) and base
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excess values were calculated automatically on the same machine.
Experimental Procedure
The training progrcumne lastea ten weeks and consisted of 
suhmaxiïïial work (trotting and cantering over a 10-19 distance) 
four days per week and maximal work (galloping three times over 600 
m) on a circular course two days per week. The amount of suhmaximal 
work was increased gradually from 10 to 19 Km. over the training 
period.
All the horses were tested before and after the training 
programmes. Each test was carried out in the morning after the 
animal was fasted overnight. The test exercise consisted of a 
maximal gallop over 600 m on a circular oour-se. This was repeated 
three times (referred to as G^) with a period of approximately
9 min between each gallop. Each horse was timed over the distance 
and the mean speeds before and after training calculated.
Heart and respiratory rates were recorded prior to the exercise, 
after each gallop and in some cases up to 30 min post-exercise.
Blood samples for P.C.V. and 11-CHGG estimations were collected 
from the horses at rest in the stables prior to exercise, immediately 
after each gallop and at 19, 30, 60 and 90 min after completion of 
the 3^^ gallop. Samples for blood gas determinations were collected 
at similar times up to 30 min post-exercise.
All blood tubes were stored on ice from the time of sampling 
until the plasma could be removed or the appropriate estimations 
made. When assays were not carried oat on the same day as sampling.
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the plasma was stored at -19° C until required. Plasma was never 
stored for periods of ] cnger than 6-7 days before being assayed.
2.1 Results
The changes in the various parameters recorded were similar to 
both types of horses and therefore all the results have been 
considered together.
SPEED (t a b l e 6.1)
All the horses were significantly faster after the training 
programme (p ^  0.01).
HEART R7JE (TABLE 6.2)
Heart rates before and after training increased significantly 
above resting values (p 0.09) after each gallop and were still 
elevated 30 min post-exercise. There was no significant difference 
between the hear-t rates immediately after exercise in either the 
trained or the untrained horses.
RESPIRATORY RATE (TABLE 6.2)
Respiratory rates were increased significantly above resting 
values (p 0.09) after each gallop in the trained and untrained 
animals. There was no difference in post-exercise rates between 
trained and untrained groups.
PACKED CELL YOLUMS (TABLE 6.3)
P.CoY. increased progressively immediately after each gallop in 
both trained and untrained animals reaching maximum levels after 
and Gg respectively. By 90 min post-exercise values had returned
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0?ABLE 6.3 THE EJf'EEGT OF MAXIMAL FIFJHCISB . ON
A NDÎVÎBFH OF PAEAMSTER3 IN 
6 HORSES (m e a n  - s.e.„ ;
Stage
ol
Train in ç,
Stage of Proccd;
Parameter Pre
Ex,
Post
U1
Post
02
Po.it
S3
l'osL 
I5in.i u
Post
30^in
Po J t 
6Gr lu
Pc-.t
9'l:ii.i
Plasma
11-OHCS
(n:eol/l)
Pre -33
261
-UT
31a
±15
1;01*
±27
4U>
±48
420*
±39
330*
±34
314
±20
PcGt
26g 30U
-61
36U
±79
403*
±69
3?7"
±61
297
±63
371*
±56
31 ; 
±6-
PC’/ Pre
33
-1.8
50.5*
Î2.6
52.7»
±3.7
54.9**
±2.7
45.7*
±3.5
42.9k
±2.6
37.7
±1.8
33'. 1 
±1.5
193) Post
33. G 
-2.h
51.3*
l'il. 8
5U.5*
-h:h
54.3*
±4.0
46,8*
±3.5
40.5*
±1.6
39.7
±2.2
36.4
±2 î
Blood Pre
0.8
-0.2
11.0**
±1.1
16.2**
±1.9
18.B** 
±1.9
16.8*
±2.1
14.5*
±2.5
7.4
±2,1
4.1
±^.3
Bactato 
n^ieol/l) Post
C.7
-0.2
lU.ü*
±2.1
20.7**
±1.8
22.8**
±2.7
22.1*
±3.4
14.6*
±2.6
6.0
±1.2
3.6
±0.6
V etjou.s Pre
7.336
-0.006
7.159*
±o.o]i3
7.122**
±0.0 Wi
7 .101*
±0.078
7.185*
±0,057
7 .229*
±0.064
pH Post
7 . ¥12 
-0.02^
7.209
±0.026
7.1U2*
±0.030
7 .112*
±0.041
7.192
±0,038
7.301
±0.023
/f-nouG
pCO^
Pre
¥ 1.5
10.6
U6.8
-5.7
U3.0
±5.2
33.6
±5.7
29.2*
±2,0
30.9*
±2.0
(ül-nirp,) Post
I4J4.6
i2.0
U2.5
±1.9
33.0
±2.1
29. C*
±2.7
30.3*
±2.0
34.2
± 1.7
Venons
rO
Pre
35.8
ik.5
U5-0
±2.6 ±3.6
57.4
±8.4
60.1*
±5.1
62.5*
±6.7
2
Pcst
ho, 6 
13.8
1(6.7
±2,6
54.3
±3.9
66.5*
±3.9
69.7
±12.7
56.9
±14.7
Vendus
CCû^
(oEq/l)
Pre
26.3
-%o
21.U 
Ï5.3
I3.2+*
±0.7
11.7**
±1.2
11.5**
±2.1
14.0
±2.7
Fos t
23.6
"3.3
16.U 
±0.6
12,6 * 
±0.3
9 .3*
±0.3
11.7
^ ± 1.6
16.5
±1.2
Baie Pre
1.5
-1.2
-11.2**
±2.2
-111. 7** 
±1.1
-17.2**
±2.7
-15.5*
±6.4
-6.4
±4.6
Pont
-2. il
-3.0
-11.2
-0..9
-15.7*
+
-1.1
-16.9*
-2,3
-10.5
4-
-5.5
-6.6
+
- 1 .9
Jevols siçïiiricîLntiy (p ^  
levels s.ic7.iificaiitly (p ^
.001) altered fron resting vainc: 
0 .05) altered fron; resting value;
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almost to resting levels. P«G„V4. recorded immediately after ±he 
individual gallops were higher in the 'Thoroughbreds than in the 
heavy hunters with one value of 65/c being recorded (Eoise Eo. 'i). 
■VENOUS pH (TA13LE 6.3)
Venous pH values decreased after each gallop5 reacning the 
lowest levels on completion of both pre and post-training. In
both cases the levels were still decreased 30 min after exercise.
The lowest pH value recorded was 6.8L.1 (Horse No, 1 pre-training, 
on completion of G^). The drop in venous pH after each gallop was 
less marked in the trained animals ai though the corresponding changes 
in venous lactate levels were greater,
BLOOD LACTATE (TABLE 6.3)
Blood lactate levels markedly increased after each gallcp and 
were still elevated 3C min post-exercise in both trained and, 
untrained animals. In all the trained horses blood lactate levels 
immediately after each gallop were significantly higher than iv. the 
untrained ones (p 0.0^). There was a significant negative 
linear correlation (r = -O.8316 and -0.68i|2 p 0,0^) between
blood lactate and pH levels in each group of horses before and af+er 
training.
VENOUS pOp (table 6.3)
Venous pO^ levels increased after each gallop and continued to 
rise until 30 min post exercise in the untrained animals. In the 
trained group maximum levels occurred at 15 min post exercise and by 
30 min values were decreasing towards resting levels. All pO^ 
values recorded were slightly higher in the trained animals.
97
VENOUS pCO^ (TABLE 6.3)
Venous pCO^ levels increased after and decreased after G,, 
and. G^ and up to "^ 3 min post exercise in the untrained anima.Ls.
After training the lowest levels were recorded immediately after G-^  
and in both groups values were increasing towards resting levels by 
30 min post-exercise.
pGOg levels throughout the test were slightly lower in the 
trained horses,
WNCUS BIGAKBOMTE (TABLE 6.3)
Venous HGO^'" values fell progressively after each gallop 
reaching their lowest levels immediately after G^ and 13 min post- 
exercise in the trained and untrained animals respectively. Values 
fell more markedly in the trained horses but also appeared to be 
returning towards control levels more rapidly in this group,
BASE EXCESS (TABLE 0,3)
Base excess values decreased progressively after each gallop. 
Lowest levels occurred immediately after G^ in both trained and 
untrained animals,
PLASMA. -il-C-HCS (TABLE 6.3)
Plasma 11-OHCS levels increased steadily after each gallop 
both pre and. post-training. In the former they continued.to rise 
reaching ma:J.mum levels 30 min post-exercise whereas in the latter 
maximum levels occurred immediately after G^. By 90 min post- 
exerciso both groups values had returned almost to resting 
levels.
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6.3 the EFHEGTS OE SlHl-MJiXIiyEAl EXERCISE ON HEART AND RESPIMTO'RY 
RATES. P.O.Vo, PLASi^ IA 11-OHCS LEVELS, RLOOL GAS CONCENTRATIONS 
A m  AiCID-BASE BAi-ANCB iN HORSES EEEORE AND AFTER A TEN WEEK
TRAINING PROGRAMME
Animal
The same six horses (Table 6.1) were used in this study.
Feeding and exercise regimes were as described previously.
Methods
Heart rates were recorded by auscultation as described 
previously in all 6 horses before training. In four of the horses 
post training heart rates were recorded by radiotelemetry.
Respiratory rates, P.CfV., plasma 11-OHCC levels, blood gas 
and acid-base determinations were carried out as described earlier. 
Rectal temperatures after exercise were recorded in several 
horses and increases from resting values of 38.0 - 0.1 to 39*7 - 
0.2 after 11.2 km. and 39*3 *- 0,1 after 22.1+ km, were obtained both 
before and after training. Blood pH, pCC^, pO^, HCO^” and base 
excess values were all corrected to post-exercise temperatures using 
a blood gas calculator (Radiometer)
Experimental Procedure
The training programme was the samo as for the previous
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experiment and the exercise tests were carried out before and after
a ten week training period,
Tho tests V703:e all carried out in the morning, the horses having
been fasted overnight,
The norses were ccmtered a,t a steady pace around the perimeter
of a large field. The l\. Thoroughbreds were exercised over a total
distance of 22.[|. km, and the 2 heavy hunters VI.2 km.
Heart and respiratory rates were recorded and blood samples for
P.C.V., 11-OHGS and blood gas analysis collected from the animals at
rest prior to the exercise (in the stables) after S.6, 11.2, 16.8
and 22,14 km, and at 1^ and 30 rain post exercise.
It has been suggested that pro' onged exercise results in
exhaustion of the adrenals and a reduction in cIrculating plasma
11-OHCS levels (Chin and Evonuk, 1971). In order to investigate
30 iTiin after exercise 
this possibility, 1 mg (lOO iu) Sviiacthcn was injected^intramuscularly
into all six horses before training and five horses after training.
Blood samples were then collected at 30 and 60 min post-injection.
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6.3.1 .Results
SPEED (TABLE 6.I4)
Before and after training the Tliorouglibreds were cantered at 
a speed of approximately 7 metres/s and the heavy himters at 6 
metres/s.
All six horses (except No. I) maintained approximately the same 
speeds throughout the test on both occasions.
HEART RATE (TABLE 6.5)
Heart rates were increased at each intermediate distance, 
maximum levels in the trained and untrained animals occurring on 
completion of the longer distances (16.8 and 22.Ij. Ion. respective!
In both cases rates had returned towards resting values by 30 m.in 
post-exercise.
The rates recorded by radiotelemetry post-exercise in the 
trained animals were all higher than those recorded by auscultation 
in the same animals before training.
There was no significant correlation between the individual, 
heart rates recorded inimediately after each intermediate distance 
and the mean speed (metres/second) over the same distance either 
before or after training (r = 0.2^32, p ^  0,1),
RESPIRATORY RATE (TABLE 6,5)
Respiratory rates increased after each 5.6 km. distance in loth 
trained and untrained animals. Maximum values being recorded on. 
completion of 22.^ km. in the untrained horses and after 11.2 Inn. 
in the trained ones.
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TABLE 6.5 THE EFFECT OF STJBMAXmAL EXERCISE 
ON A NUMBER OF PARAMETERS IN 
6 HORSES (MEAN - s.e.)
Stage
of
Trailing
Stage of ■Procedure
i’a.'/ameter
Pre Ex. 5 .6 Km. 11 .2 Km. 16.8 Km. 22.4 Kin.
Post 
15fflin
Post
30min
Heart
Rp.te
Pre 48
±1.8
1 1 4*
±7.0
112 * 
±2.0
119 * 
±3.0
123 *
±7 .0
51
±4.0
42
±7 .0
(beato/
LLin)
Post 42
±1.5
in6 *
±3.0
158 * 
±11.0
167 * 
±12.0
165 * 
±11.0
58
±4.0
54
±2 .0
Respir­
atory
Rate
(Respira­
tions/m j a)
Pro 12
±1 .0
79 * 
±9.0
89 * 
±9.0
82 * 
±16.0
91 » 
±20.0
Post 10
±1.0
77 * 
±11.0
80 * 
±9.0
79 * 
±10.0
70 * 
±9.0
PCV Pre 34
±2.0
43.8*
±6.5
41.5* 
— 0
41.3*
±1.7
41.8
±5.9
36.2
± 1.0
37.5
±1.6
(%) Post 30.7
±1.1
45.7*
±2.1 ±2.5
46.8
±4.6
46.8
±3.1
42.8*
±1.7
40.2* , 
±1.7
Blood
Laf'tate
Pre 0 .9
±0 .3
1 .6
±0 .6
1.5
±0.5
1.1
±0 .2
1.3
±0 .2
1 .2
±0 .2
1.1
±0 .2
(nmol/l)
Post 0 .6
±0.1
1 .7
±0.3
2.5
±0 .5
2.1
±0 .6
2 .3
±0 .6
2.0
±0 .6
2.1
±0 .8
VencuB Pre 7.433
±0.027
7.444
±0.014
V 456
±0.014
7.463
±0.014
Î. 46o
±0.005
7.431
±0.007
7.462 
—O.OI4
pH Post 7.378
±0 .013
7.397
±0.007
7.415"
±0.010
7.427*
±0.009
7.425
±0 .0 i1
7.413*
±0.005
7.426
±0.014
Venous
pCOg
(mmHg)
Pre 46 .2
±2.7
42.1
±1 .4
39.4*
±1.1
38.9*
±0 .6
40.3*
±0 .6
43.2
±0 .8
43.4
±1.0
Post 54 .2
±2 .0
47.6*
±1.5
43 7* 
-1.9
44.3*
±2.9
47.0*
±1.9
46.9*
±1.8
47.2 
■ ±2 .0
Venous
pOg
Pre 40 .8
±1.5
49.7*
±1.9
50.0*
±2.0
50.2*
±2.5
50.0*
±2.1
44.1
±2.3
39.9
±2.5
(imnHg)
Post 47.7
±9 .2
59.6
±2.2
50.0
±2.0
57.9*
±2 ,2
. * 
50.0
±2.1
53.9*
±9.7
42.9
±1.5
Venous
HCO^“
(mEq/l)
Pre 34.4
±1.5
28.3
±1 .4
27.7
±0.6
“
28 1 
±1.6
28,9
±0 .8
28.1
±1 .3
31.0
±1.8
Post 31.5
±1.5
29.6
±1.3
29. t
±1.7
29.7
±%c
31.2
±0 .6
30.9
±1.4
29.9
±1.2
Base
Excess
Pre 5 .6
±1.7
3.7
±1 .2
3.9
±0.
4.4
"■1.5
4 .7
±0.5
5.5
±1.3
6.6
±1 .0
(mEq/l) Post 4.7
±1.3
3.9
±1.1
2.8
Î1 3
4 9 5 .7
±0.4
5.2
±1.1
4.0
±0.9
* = levels signiricantly (p O.c;) altered Trou restiiig values
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PACKED CELL VOLIXME (TABLE 6.5)
P.C.V. values were elevated throughout the test in both trained 
and untrained animals, ï'îaximum levels occurred pre-training on 
completion of the first ^.6 km. and post-training after l6,8 and 
22,If. km. By 30 min post-exercise P.C.V. levels were stil] increased 
above resting values.
The magnitude of increase recorded appeared to be greater in the 
trained animals but this difference was not significant (p ^  0.1). 
VENOUS pH (TABLE 6.5)
Venous pH levels increased progressively after each 5-6 km. 
distance, maximum levels in both trained and untrained animals 
occurring after 16,8 Inn. The increases in venous pH were less 
marked in the trained horses althougn as in the previous study^ fche 
changes in venous lactate levels were greater in this group. By 
30 min post-exercise pH levels were still above resting values,
BLOOD LACTATE (TABLE 6.5)
Blood lactate levels were only slightly elevated throughout the 
test before and after the training programme. These increases were 
greater in the trained than in the untrained animals and in both 
groups levels were still elevated 30 min post-exercise.
VENOUS pOg (TABLE 6.5)
Venous pO^ levels were elevated by varying degrees after each 
5.6 km. in both trained and untrained animals but to the greates r 
extent in the former.
By 30 min post-exercise in both groups levels had fallen to 
below resting (pre-experiment) values.
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TOOus pGO (t a b l e 6.5)
Venous pCO^ levels fell during the test in both groups of 
animals. The magnitude of the decreases varied considerably but 
were greatest in the untrained group. Values were skill below 
resting levels at 30 min post-exercise.
VEH0U8 BIGAEBONATE (TABLE 6.5)
HOOJ' levels decreased during the test in both groups of 
animals but lowest levels were recorded pre-training after 11,2 km.
30 min post-exercise pre-training lev^^ls were still decreased when 
post-training values had almost returned to restin levels.
BASS EXCESS (TABLE 6.5)
Base excess values decreased dviring exercise in the untrained 
animals but increased half way through the test (I6.8 1cm. ) in the 
trained ones. 30 min post-exercisa pre-training levels were 
slightly above and post-training levels slightly below resting 
values.
PLASMA 11-OHCS (PIG. 6.1)
Plasma 11-OHCS level increased throughout the exercise in both 
trained and untrained animals, reaching maozlmum levels on completion 
of the 22.li- km. The values appeared to be slightly higher in the 
trained animals. 30 min after exercise the levels in both groups 
were returning towards resting values, tho decrease being more rapid 
in the trained horses.
30 min after injection of 100 iu Syr.acthen there was a marked 
elevation in 11-OHCS levels in both, trained and untrained animals 
(the increase appearing greater in th,- trained horses). By 60 min 
post-injection the 11-OHCS values were returning towards resting levels.
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6 Jj TEE EF.?7^ ]CTS 0? lECHEAOING L7.&’J.'MCES 0? MXIMiil. EXEECISS OE 
P.Q.V. , PX.ASMA 11~0HGS, BLOOP GAS CONCENTRATIONS AiiP ACID-BASE 
BALAIJCE IN HORSES AEONjR A TEN WSEK TRAINING PROGRAmE
Hie fo'ar ThoroiJ.ghbredd incladed in the two previoas e^cperiments 
were used..
Tills study was carried out at her the 10 week training programme 
immediately following the maximal aid sub-maximal exercise tests, 
ïîxercise and feeding regimes have been described previously.
Methods
All determinations were carried out as described previously. 
Experimental Procedure
The tests were carried out at a race course 30 miles from the 
stables. The horses were transported by horse-box on a number of 
separate occasions ranging over a 3 week period. The tests were 
sometimes carried out on consecutive days but never on Mondays.
Each horse (except No. 3) was tested once over 2, 3> 5» 8, 12 and 
16 furlongs (No. 3 was tested over 3, 8, 12 and 16 furlongs).
V/hen possible, the horses were galloped ever each distance in groups 
of three but when riders were not available the horses were galloped 
singly or in groups of two.
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All the tests were carried vuc between 10 a.m. and 12 noon.
Each horse was timed separately over each distance.
Blood samples were collected for ?.C*V., 11-OHCS and blood 
gas estimation from the horses before transportation, on arrival at 
the race-oourse, immediately after each gallop and at 13, 30, 60 and 
90 min post exercise.
All blood tubes were stored on ice until such time s,s the 
appropriate assessments could be carried out (this was always within 
3-ii- hours of sampling).
6.1|,.1 Results
SPEED (t a b l e 6.6)
The speeds of each horse varied considerably over the different 
distances. Horse No. 2 proved fastest over all except the 8 furlong
distance and horse No. 1 although fast over the 2 and 3 furlong
gallops was much slower over the longer distances.
PACKED CELL VOLUME (TABLE 6.?)
Packed cell volume increased si,giA.ficantly (p 41^  0.01 ) on all 
occasions by the time the horses arrived at the race course (Table 
6.l3). Following the gallops the levels became markedly elevated. 
All values falling within the range of 61-63TÛ
After exercise, the levels returned slowly towards resting
values but a>t 90 min were still slignt'ij increased.
BLOOD pH (TABLE 6.8)
A slight increase in pH values acp'^ored to occur after transport
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of the horses to the race course (Table u.l5). Immediately 
following- each gallop pH values were markedly reduced; the lowest 
level (6.760) being recorded in horce No, 1 following the 1.8 
furlong distance. There was a sigij.ificant correlation between 
pH and blood lactate levels (p <' 0-.05). on all occasions. Hy
30 ird.n post exarci.se pH levels were still below resting values.
BLOOD LACTATTl (TABTjE 6.9)
Blood lactate levels were markedly increased immediately after 
each gallop. Highest lactate levels were recorded after the 5t 8 
and 18 furlong distances. By 30 min post exercise values were 
still above resting levels.
TENOUS pOg (table 6.IO)
Venous pOg levels increased after each gallop but most ma.rkedly 
following the 5 and 8 furlong distances. After 2, 3s 12 and 16 
furlongs venous pOg values were at or below resting values.
15 min after exercise the highest values (post 5 and 8 furlongs) 
had decreased whereas those following the 2, 3s 12 and 18 furlorigs 
had increased. By 30 min post exercise all except the 5 furlong 
levels were falling towards resting values.
VENOUS pCOg (TABLE 6.11)
Maximum venous pCOg levels occurred following the two shortest 
and two longest gallops. Values immediately after the 5 snd 8 
furlong distances were below resting levels.
15 and 30 min post exercise all levels were below resting 
values.
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VSNGuS BICARBONATE (TABLE 6.12)
HGO^ levels fell markedly after each gallop the greatest 
differences being recorded after 2, 3» aTid 12 furlongs. By 30 min 
pose exercise values were increasing slowly towards resting levels. 
BASE EXCESS (TABIE 6.13)
Base excess was reduced after each gallop, lowest levels being 
recorded following 5»  ^ and 18 furlongs. Following a,ll but the 
2 furlong gallop, levels wore still markedly decreased 30 min post 
exercise.
PLASMA 11-OHCS (TABLE 6,11+)
Plasma 11-0ÏÏCS levels were increased on all occasions by 
transportation of the horses to the race course (Table 6.15). 
Immediately after each gallop levels were further elevated but 
following all except the 2 and 12 furlong distances maximum levels 
occurred between 15 and 60 min post exercise.
Following the longer distances (8, 12 and 18 furlongs) the 
levels, although beginning to decrease by 90 min post exercise, were 
markedly higher than the corresponding resting values.
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Table 6.13' Alterriions in various parameters (Mean ~ s.e.)
before and after transportation to the race-course
Parameter Before After
Transportation Transportation
P.G.V.
(%)
38.8
-0.6
42.4*
±0.8
7.400 7.408
pH -0.010 ±0.010
Venous
1.1
^0.1
1.2
±0.1
lactafce 
(m mol/l)
Venous
f  2 „ V
(ram Hg)
34.6
-'.3
33.4
±0.9
Venous
PGO
(mrafEg)
4t'. 8 
-0.7
44.2
±1.0
Venous
HGOq"
(m iq/l)
28.1
^0.6
27.7
±0.6
Base 
Excess 
1 (m Eq/^1)
3.6 
±0,6 .
3.2
±1.0
11-OHCS 
(n raol/l)
)_ ___ __________
333^
±36
429*
±3Ï^
 ^ levels significantly (p ^  Or03) above pre­
transportation values
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6,p Discussion
1. Physiological Changes
As sxpected; exercise resulted in marked increases in heart and 
respiratory rates in horses similar* to those shown by other workers 
(Krv.ywanek et al, 1970; Aitken, Sanford and MacKenzie, 1973; Hall 
et _al, 1976). These elevations are the result of increased 
anticipai cry mental activity and also increased metabolic demands 
(Guyton, 1971; Vasserman and Wliipp, 1975)*
During this exercise stud/ it was intended to record heart 
rates using radiotelemetry but due to a number of factors (discussed 
in chapter 1 of this thesis) this was not always possible.
Consequently the heart rates recorded by auscultation are much 
lower than those reported by other authors in simi..lar types of 
horses and following similar types of exercise.
Rates reported using radiotel ometry range for 200-240 beats/min 
in Thoroughbreds immediately after racing (kr-zywanek _et ad, 1970;
Hall et _ad, 1976) and Standardbred horses trotting at maximal speed 
(Persson, 196?; Marsiand, I968; Asheim, Kbudsen, Dindholm, Rulcker 
and Saltin, 1970; Dindholm and Salxin, 1974)» Heart rates of 
160-200 beats/min have also been recorded in Standardbred horses 
trotting at speeds of 4-7 metres/second (Persson, 1967; Asheim 
_et 1970). On several occasion^ however, not connected directly 
with this study, heart rates have been successfully recorded by 
radiotelemetry in our experimental horses during and immediately after 
maximal exercise of short duration (Pig. '’.I). In these instances,
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rates of over 200 beats/min have been measm:ed which agree with the 
results published previously.
The difference in recidiîigs measured by radiotelemetry and 
auscultation is the result of two factors. Firstly, it usually 
■ takes a short time for the heart rates measured by auscultation 
to be recorded i.e. for the operator to approach the horse and locate 
the heart beat and secondly, the heart rate is a mean over a period 
of 30 seconds during a time when the heart rate is almost certainly 
decreasing rapidly (Aitken ad, 1973; Hall _et ad, 1976).
Radiobeleraetry on the other hand, allows an instantaneous heart rate 
to be obtained.
Respiratory rates also increased after exercise but the levels 
recorded in these experiments were markedly lower than those 
reported by Aitken et ad.(l973) who monitored rates of up to 118 
respirations/min in Thoroughbreds and 12^ respirations/min in heavy 
hunters after cantering a distance of 5*6 km. The length of time 
between the end of exercise and the time when the recordings were 
made will also influence the values reported however since respiratory 
rates fall more rapidly than heart rates post exercise (Aitken ^  al,
1973)* This difference could also be due to the times at which 
recordings were taken post exercise from these horses. Heart 
rate recordings were always made immediately the animal stopped and, 
after these had been completed, respiratory rates were measured. 
Consequently it was always three or four minutes after exercise that 
respirations were recorded
2. Me r, ab d i e  Change s
Increases in P.C.V. following exercise of varying intensity have
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been previously reported ir. horses (Persson, 1967; ÎE.lne, 1974).
In this species, as in others such as sheep, cattle and dogs, the 
spleen has been shown to be the main reservoir of erythrocytes and 
to be able to regulate the oxygen-carrying capacity of the blood 
wheîiever required (Persson, 1967; Torten and Schalm, 1964; Turner 
and Hodgetts, 1959; Gartner, Ryley and Beattie, 1965; Slenes,
Ewald and Crosby, 1964). This anility to increase the ox^rgen- 
carrying capacity of the blood is very important in the horse 
expeoialiy during exercise.
The control of splenic contraction has been discussed previously 
(chapter 1 ) and increases in P.C.l?, have been noted in horses 
following excitement and adrenalins infusion as well as exercise.
(Irvine, 1958» Turner and HodgetTs, 1959; Persson, 1967; Sreter,
1959; Kj.-zj/wanek, 1973).
Following maximal exercise Milne (1974) reported greater 
increases in P.C.V, than following submaximal work and in these 
studies a sird.lar pattern is apparent. Highest levels occurred 
immediately after the exercise tests at the racecourse and all the 
values fell between definite limits suggesting that in these horses 
60-63^ was the maximum levels possible, Similar maximal levels 
have been reported by Persson (1967) following injection of adrenaline 
intravenously at dose rates of up to 1,0 mg/kg.
That P.C.V. values were highe'^t afrer the maximum exercise tests 
is to be expected since the oxygon rcqcjrement during acute 
strenuous activity will be higher than for prolonged submaximal 
effort. The high P.C.V, levels aftrr xhe gallops also reflect 
a high degree of .splenic contraction wn:ch will be due to increased
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sympathetic activity at maximal work loads. Bloom, Johnson. Park, 
Rennie and Hulaiman (1976) and Rowley (1976) reported increased 
levels of circulating catecholamines in man following exercise of 
high intensity and similar alterations have been recorded in horses 
(Snow and Summers, 1977). Smaller increases in sympatnetic activity 
during submaximal exercise (Snow, personal communication) would also 
explain why P.C.V. values were lower after this less strenuous 
effort.
During the tests carried out at the racecourse, an increase 
in P.C.V. was also apparent after transportation from the stables 
suggesting that the horses all became slightly excited or 
apprehensive during the journey.
Blood gas levels and the acid-base status of the blood also 
altered to varying degrees during the different exercise prograj-Qines. 
Throughout exercise, increased cardiovascular and respiratory function 
is required in order to increase the supply of oxygen to the 
exercising muscles and also the removal of carbon dioxide from the 
circulation. These processes are closely linked to the amount of 
work being performed and the energy requirements of the working 
muscle. At low levels of work intensity (i.e. below half of the 
maximum oxygen uptake) all the energy required can be supplied 
aerobically because adequate oxygen is available. Above this 
level however, at higher work intensities sufficient oxygen is not 
available and anaerobic pathways of metabolism have to be utilised*
The end product of anaerobic metabolism is lactic acid and blood 
lactate levels begin to increase only after a threshold level
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(approx. of maximal oxygen uptake) bas been reached
(Vasserman and J^hipp, 1975)* The result of an increase in blood 
lactate values is a metabolic acidosis and fall in blood pH and 
bicarbonate levels, as was apparent in these studios following the 
maximal exercise tests.
Changes in the blood gas status and acid-base balance were
monitored on all occasions on samples of venous blood. This is by-
no means the ideal situation but practical difficulties in obtaining 
ai:-terial blood quickly made venous sampling the method of choice. 
Levels of pH, HOO^ and pCO^ in arterial and venous blood have 
been compared at various stages of exercise and recovery, and it 
has been shown that venous values consistently mirrored the changes 
in arterial ones (Milne, 1974).
Metabolic acidosis as a result of maximal exercise in the horse 
has been reported previously (krzywanek, 1974; Milne, 1974; Persson 
and Ullberg, 1974; Asheim et al, 1970; Krzywanek, Milne, Gabel and
Smi-f]L, 1976) and extremely low levels of blood pH can be attained
during this t'i'pe of activity as is shown by the decrease in pH to 
6,780 in Horse Ho. 1 following the I8 furlong gallop. At low levels 
of pH and consequently high blood lactate concentrations, exercise 
cannot be successfully continued for any length of time (Astrand and 
Rodalil, 1970). It is interesting to note that Horse No. 1 although 
proving fastest over the 2 furlong gallop became progressively 
slower over the longer distances as his blood pH level dropped lower 
than in any of the other horses. The ether three horses were perhaps 
therefore more able to continue utilising aerobic pathways of 
metabolism before having to switch to anaerobic ones and were
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capable of maintaining their speeds over the longer gallops.
The decreases in pH recorded can be attributed mainly to 
elevations in blood lactate levels as shown by the high inverse 
linear correlation between the two reported in experiment 6.2. 
However changes in venous pCCd levels will also affect pH values 
(Vasserman and ^Vhipp, 1975). Excess CO^ is produced from the 
buffering action of bicarbonate on the increased lactate levels 
and by 'olowing off' this excess COp the animal may be able to 
partially compensate for the metabolic acidosis by shifting the 
equilibrium
GOg + HgO gth H^OO^ ^  + HCO^“
to the left and thus raising the pH
This respiratory compensation might explain the elevation in 
blood pH 15 min after the 3 ^ 600 metre gallops when lactate levels 
in most of the horses were still increasing and also the smaller 
decreases in pH with given lactate levels following training in the 
same experiment.
It would also explain why the decreases in blood pH following 
the 5 and 8 furlong gallops were less than, the others when in fact 
levels of blood lactate were highest after bhese two distances.
In both cases venous pOO^ values were only slightly above or (as in 
the 8 furlong test) below pre-exercise lerels suggesting that during 
this exercise the horses were able g o  blow off 00^ and compensate 
in part for the acidosis.
Hyperventilation will also occur in response to increased body 
temperature in the horse and it has beSi .suggested (Milne, 1974)
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that this temperature--controlling mechanism could be the cause of 
lowered pCO^ and elevated pH values within a few minutes of exercise 
ceasing. Body temperature has been shovai in men to be regulated 
at a higher level during work than at rest (Nielson and Hi elscx.i, 
1962; Saltin and Hermanssen, I966). As elevations in body 
temperature of 2- 3^  were recorded after the submaximal test it is 
most likely that similar or greater elevations would occur after 
maxi.mal exercise and would be inducing a greater degree of 
hyperventilation increasing the effects on pCO^ and pH aireadv 
apparent.
Unlike the marked decreases in pH recorded after all the 
maximal exercises, submaximal effort produced a slight increase in 
blood pH values. It would appear rherefore that under these 
conditions the animals were all able to maintain aerobic metabolism 
throughout the tests since only very slight elevations of blood 
lactate levels also occurred. The alterations in blood pH could 
have been due therefore to a respiratory alkalosis caused by 
hyperventilation and demonstrated by a reduction in venous pCO^ 
and bicarbonate values (Milne, 1974).
Venous pO^ and pCOg levels following the two types of exercise 
also differed. Measurement of venous pO^ levels has been reported 
as not being a true estimation of the oxygen content of the blood 
(ihLlne, 1974). However Krzywanek _et ad, (I976) found that although 
venous pO^ values were lower than arterial ones, they did provide an 
overall picture of any alterations which might occur.
Venous pO^ values increased to a greater extent after maximal
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exercise and in some cases did not reach peak levels until 15 or 
30 min after the exercise had ceased. This elevation had been 
attributed to the inability of the tissues to fully remove the 
elevated concentrations of arterial oxygen stii.l being suppil ed 
to them (Milne, 1974) and also to the fact that the cardiovascular 
system does not respond immediately after exorcise to the working 
muscles shutting down their high levels of oxidative metabolism 
(Krzywanek et ad, 1976).
The more elevated levels of venous pO^ recorded after the 5 
ancl 8 furlong gallops at the racecourse occurred simultaneously 
with lower levels of pOO^ and higher pH values than were recorded 
over .my of the other distances. The combination of these three 
effects further suggests that by hyperventilating^ the animals in 
this case were able to partially compensate for the metabolic 
acidosis.
The more rapid return to resting values in both trained and 
untrained animals following submaximal exercise and in the trained 
group after maxj.mal exercise suggests that in the former the 
oxygcii-dobb, which is due largely to lactate production (Knuttgen, 
1962), is very small and that in the latter training might improve 
the capacity to overcome this oxygen-debt. This would also be 
borne out by rhe more rapid return to resting lactate levels which 
alee occurred post-training in this group of animals,
Venoiu pCOg levels in horses after a single bout of strenuous 
exercise have been found to increase (bergsten, 1974; Milne £t ad, 
1976; Hivywanek et 1976) and then during recovery to decrease 
slightly below resting levels due to hyperventilation.
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COg during exercise is produced from two sources - the 
increased rate of metabolism in the working muscles end, as 
discussed previously, at high work loads from the buffering of 
lactic acid by bicarbonate (Wasserm-an and Whipp, 1975)»
During and after the 3 % 600 metre gai ].op tests pCO^ ] eve Is 
decreased. This reduction could have been partially due to the 
fact that no corrections on account of body temperature were made 
in this study. As has been discussed previously elevations in 
temperature of 2-3^ can be expected after exercise and had all 
blood gas estimations been corrected accordingly the alterations in 
pCOg values would have been less marked although still apparent,
A decrease in pGO^ levels was also noted during the submaxima] 
exercise test and in both tests this was probably a result of 
respiratory compensation for the decreased HCO^"” levels and 
hyperventilation occurring in order to help control body tempera.tore, 
The lower pCO^ levels recorded after the 10 week training 
programme in the 3 % 600 metre gallop test could be due to an 
increase in pulmonary ventilation (i.e. tidal volume) or in the 
alveolar diffusing capacity of the lungs (Vasserman and Vhipp,
1975) since no apparent alterations in respiratory rates were noted 
before and after the training programme.
In the individual gallops pCO^ values increased markedly afver 
exercise except following the 5 and 8 furlong gallops. These 
elevations are similar to the results reported by Milne et ^  (1376) 
and Krzywanek et ^  (19?6) and are attributed to increased metabolic 
rate during exercise.
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The fact that pCO^ values were lower after the 5 and. 8 
furlong gallops has been discussed previously and it has been 
suggested lhat this could be due to hyper^/entilation as a result 
of the decreased bicarbonate levels and possibly increases in body 
temperature.
The alterations in venous bicarbonate, as discussed previously, 
and in ba,se excess levels recorded after maximal exercise are 
a further indication of the degree of metabolic acidosis produced* 
(Vasserman et ai, I967; Osnes and Hermans sen, 1972; Krzywanek, 
1974; Milne, 1974). Base excess is a direct measurement of the 
excess or deficit of non-volatile acid in the circulation (Sigaard- 
Anders ui, I963) and changes in base excess reflect either an 
increase in non-volatile acids in the blood or a removal of base.
It has been suggested that base excess measurements provide a more 
accurate estimation of metabolic acidosis than do blood pH 
estimations since the latter is affected by respiratory compensatory 
mechanisms (Osnes and Hermansen, 1972), These authors however also 
reported that decreases in base excess levels were higher than the 
corresponding increases in blood lactate concentrations and that 
this overestimation of acidosis could be due to the increase of 
other acids such as pyruvic acid in the blood after exercise. In 
these studj os following maximal exercise, base excess values 
underestimated the degree of metabolic acidosis as indicated by 
blood lactate levels. This difference could possibly be due to 
the facv +hat no corrections were made in base excess values for 
increases in body temperature during these tests.
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Following submaximal exercise both base excess and blood 
lactate levels altered only slightly indicating that a small 
degree of matabolic acidosis was present. The decrease in 
bicarbonate levels and venous pCO^ however along with the fact 
that pH values increased slightly suggest that respiratory 
compensation had occurred and that in fact a slight respiratory 
alkalosis had ensued.
3* Hormonal Changes
Coiif lie ting' data exists on the effects of exercise of varying 
intensity on plasma 11-OHCS levels. It is generally considered 
(Thrap, 1975) that light to moderate exercise may produce increases, 
decreases or no chang-e in circulating plasma 11-OHCS levels in man, 
rats and dogs (Oornil, De Coster, Copinsohi and Franckson, 1965; 
Suzuki, Otsuka, Matsui, Ohukuzi, Sakai and Harada, 1967; Davies and 
Few, 1973) Few, 1974; Foss, Barnard and Tipton, 1971; Rose, 
Friedman, Beering and Cooper, 1970).
Moderate to exliaustive prolonged exercise on the other hand 
nearly always produces increases in 11-OHCS levels in man, rats, 
dogs and horses (Hartley, Mason, Hogan, Jones, Kotchen, Mougey, 
V/herrj’-, Pennington, and Ricketts, 1972; Davies and Few, 1973; 
Sutton, Young, Lazarus, Hickie and Maksuytis, 1969; Chin and 
Evonuk, 197': ; Foss at 1971; Snow and Munro, 1975; Flisinska- 
Bojanowska ab ad, 1974)*
The di/erslty in all these results has been suggested to be due 
to variation in the duration and intensity of the exercise employed 
as well, ,0k differing methodology of 11-OHCS estimation (Foss et ad,
1971).
118
The range of plaeme 11--0HG8 levels recorded from this gronp of 
fonr 'fhoroughhreds before transportation to the race course falls 
within that reported earlier (che.pter 3) for a series of twenty 
Thoroughbreds before and during a training programme. There wa.s 
however a significant increase In the corticosteroid levels after 
transportation in the horse bor which could have been due to 
excitement apprehension or the physical effort of maii/taining balance 
in the box while travelling.
The maximum plasma 11-OHCS levels recorded in this study 
following all three exercise tests vis. maximal, sub-maximal and 
maximal over varying distances are recorded in Table 6.16 and are 
also expressed in this table as percentage increases above the levels 
recorded immediately prior to exercise in each case (those samples 
collected at the race course i.e. Pre 2 were considered to be pre- 
exercise values for this test). Ai.though the results in this 
study demonstrated that the greatest increase in 11-OHCS concentrat­
ions occurred up to 60 min after the gallops over distances varying 
from three to eighteen furlongs and immediately following the 
prolonged sub-maximal test when percentage increases above resting 
(pre-exercise) values are considered, this is not the case. Tlie 
greatest percentage increase of plasma 11-OHCS levels occur.’red follow­
ing prolonged sub-maximal exercise but when changes in corticosteroid 
values per unit time were considered the greater alterations were 
associated with maximal effort. These results therefore agree with 
those of Foss _et al and Davies and Few (1973) who demonstrated
a linear relationship between plasma 1l-CIIOS values and work
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intensity in dogs and man,
'Hie increase in plasma 11-OHCS levels for a length of time 
after the completion of exercise has been recorded by other workers 
in dogs ( F o s c  et al, 1971) and could be due to a decrease in the 
rate of metabolic clearance of these steroids from the blood,
Davies and Dew (1973) reported that during exercise the rate of 
metaboiic breakdown of cortisol is increased. Few (l97U) also 
demonstrated that the rate of removal of labelled cortisol from 
the circulation immediately after exercise falls markedly whereas 
corticosteroid production continues for a short time,
Cynacthen was administered to the horses after submaximal 
exercise because it has been suggested by several authors that 
11-0EC3 levels decline following prolonged exercise due to adrenal 
exhaustion (Frenkl and Csalay, 1970; Chin and Rvonuk, 1971). 
Injection of 100 iu Synacthen produced elevations in plasma 11-OHCS 
values much lower than those reported in previous chapters in ponies, 
but similar to those recorded by Snow and Munro (1979)' In neither 
group of animals were the elevations in 11-OHCS values as high as 
those immediately after exercise suggesting either that stores of 
corticosteroids had become slightly depleted or that because of 
the still high resting plasma 11-CHG3 levels the negative feedback 
mechanism was functioning and that basal plasma ACTH values were 
low.
The duration of response was al «o i:u.ch shorter in these horses 
compared to the results of Cnow and Munro (1979) and to those 
recorded earlier in this study. Thi^ o:^ld be due to uptalee of
120
Syjiacthen from the site of injection being more rapid in those 
horses as a result of increased blood flow to the muscles immediately 
following exercise.
There was no apparent change in pre-exercise 11-OHCS levels 
recorded in either of these exercise tests after the ten week 
training programme although such alterations have been previously 
reported in rats (Frenl;l and Csalay, 1970; Buick and Tharp, 1971) 
and were noted in earlier studies (chapter 3*U) in a group of 
twenty Thoroughbreds during a twelve month training programme.
It would appear from these results however that training does 
cause an elevation in plasma 11-0EC8 levels immediately after 
exercise and similar findings have been reported in both animals 
and man by other workers (Frehkl, Csalay, Csalcvary and Zelles, 1^o8i 
Foss et ad, 1971; White, Ismail and Bottoms, 197&)« Tliis increase 
could be due to adr-enal hyperplasia caused by continued ACTH 
stimulation (Tharp, 1979) to some adaptive process in the CHS 
resulting in more ACTH being secreted, or to an increased sensitivity 
of the adrenad to the same amount of ACTH. In these studies, the 
results indicate that adrenal hyperplasia and/or increased adrenal 
sensitivity to the same degree of stimulation are responsible for 
the training effects since administration of Synacthen to the trained 
horses caused slightly greater elevations in 11-OHCS levels.
Summary
i) Maximal and submaximal exercise in the horse result in elevationj
ir lieart and respiratory rates, P.C.V, and plasma 11-OHCS
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values. Alterations in the acid-base status of the blood 
also occurred.
ii) maximal exercise produced the greatest increases in P.C.V. 
levels end also the greatest degree of metabolic acidosis. 
Gha'iges in plasma 11-DECS ■\'-alues on the other hand appeared
■ to be influenced by the duration of the exercise as well as the
speed.
iii) 0?rsining produced less marked reductions in venous pH for 
given blood lactate levels ar.d this effect could have been 
the result of more efficient respiratory compensation for 
the metabolic acidosis in the trained animals.
iv) Training appeared to result :î n increased levels of plasma 
11-C’HC3 levels after exercise and this together with the 
greater adrenal response to Synacthen post-training suggests 
that some degree of adrenal hyp»erplasia haa occurred.
7. THE USE OP CENTRAL DEPRESSANT
DRUGS TO ALLEVIATE STRESS
1 22
( • ' Intreduction
A tranquilliser is a drug which, produces central nervous 
depression without at the same time causing drowsiness, analgesia 
or snaesthesia, A sedative on the other hand is a drag which can 
produce sleep and which at high doses c<m be used as an anaesthetic
(Soma^  1971),
The distinction between tranquilliser and sedative in 
veterinary medicine is not always made and the two terms are used 
by some authors synonymously. However, the distinction between 
tranquillisation and sedation can still be made in that with the 
former at the same degree of centra], depression there is much less 
motor involvement than with the latter.
Tranquillisers are widely used in all domestic animals as 
chemical restraining agents in order to faci3itate handling for 
both routine work and for minor surgical procedures. They are 
also used widely as premedicants for general anaesthesia.
Prior to I96O the sedatives chloral hydrate and pentobarbitone 
were widely used for animal restraint (Arthur, Vaughan and Yeats, 
1993; Wright, 1998) but with the advene of tranquillisers, 
principally the phenothiazine group, these compounds have been 
largely superceded for this purpose although they are still used 
currently to a small extent,
For the last decade the most coim.aon''y used tranquillisers in 
horses have been the phenothiazine derivatives promazine and 
acepromazine (Carey and Sanford, 19&3; .t^ Jgh, l9^Uî Jones, 1972),
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The general structure of the phenothiazine group :i s shown in Fig.
7.1 end the characteristic actions of these drugs are governed "by 
the nature of the side-chain substituted at position on the 
nucleus. The development of useful derivatives has occurred in. three 
separate groups I) those compouads with a dimethylaminopropyl side- 
chain produce tranquillisation with marled sedation, 2) those 
compounds with a piperazinopropyl side-chain have very potent 
tranquillising properties hut little sedative effect. They also 
possess a high incidence of extrapyramidal effects. 3) those 
compounds with a methylpiperidyl group have very low potency.
Further variations are possible within each group by substitut­
ion on ohe site and tranquillisiug ability has been shown to 
increase .in order from unsubstituted to trifJuoromethyl (Carey and 
Sanford, I963). Promazine and acepromazine both belong to the 
first group of phenothiazines.
A newer group of tranquillisers Introduced were the 
butyrophenones (Marsh00m, 1971)* Their general structure is also 
shown in Fig. 7.1 and highest neuroleptic potency is associated with 
the presence of a fluorine substituent in the R^ position,
Azaperone (I4* fluoro-U (l4-(2-pyridyl )-1-piperazinyl-butyrophenone) 
is one of this class of drugs which has been used extensively and 
successfully in pig practice (Mitchell, I966; Marsboom and Symoens, 
1968). It has been used in horses to produce tranquilllisation 
(Roztocil, Hemecek and Pavlica, 1971; fatten and Sanford, 1972;
Lees and Serrano, 197^; Serrano emd Lees, 197&) and in combination 
with metomidate, a short acting indueuf-n agent to produce
riG, 7.1 THE GENERAL STRUCTURE OF THE PHENOTHIAZENES,
THE BUTYROPHENONES M B  XYLAZINE
12
r  \
5
N
-NH
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an.aesth.esia (Roztocil, hemecek, Ravlica, Boada and Misic% 197^> 
Hillidge, Lees and Serrano, 197o)«
The third of the most commonly used drugs is the 'crarqu: lliser 
xylazine (2(2,6-dimethylphenylamino)-^E-^,6 dihydro-1,3-thiazine 
hydrochloride). Its general structure is shown l.n Rig. 7 .^ .
Xylazine has teen shown to he extremely suer-essful as a tranquilliser 
in horses (Clark and Hall, 19^9; Ressi, 1970) and a number of 
workers (McCashen and Gabel, 1971; Kerr, Jones, Holbert and Huggins, 
1972? Hoffman, 197U) have concluded that it is a superior 
tranquilliser to acepromazine and the other phenothiazines for 
minor surgical operations in terms of speed of onset, shortness of 
action and analgesic properties. A disadvantage of xylazine for 
routine use however is its high cost compared to phenothiaaines- 
Tranquillisers and sedatives lower the stress response to 
various stimuli and therefore measurement of this stress can be used 
as a quantitative means of assessing the efficacy of various 
tranquillisers (Greenblatt and Shader, 1973)» As stress in this 
study is being measured by changes in the adrenal-cortical system 
and in sympathetic nervous activity, the ability of these drugs to 
reduce stress can be estimated from the changes, if any, which 
occur in these parameters during physical or pharmacological 
stimulation. Aitken and Sanford (1972) compared the effects of 
acepromazine, azaperone and xylazine on the changes in heart ratu 
produced by various disturbing stimuli on horses and Smith et al. 
(1963) and Lahti and Barsuhn, (197U) evaluated the effectiveness of 
several tranquillising and antipsychotic drugs in rats by measuring
125
increases in plasma corticosteroid levels.
As well as reducing stress by their effects on the central, 
nervous system however, these drugs can alter heart rate, blood 
pressure, respiratory rate and numerous biochemical parameters by 
direct pharmacological actions.
The oarCOtic analgesic etorphine is estimated to cause stress 
when this is assessed by both subjective and objective means and is 
normally administered in combination with a tranquilliser to reduce 
thin stress. The two drugs are normally given simultaneously but 
it is probable that the maximal central depressant effect of the 
tranquilliser does net occur at the time of greatest stress produced 
by tha etorphine. In addition the peripheral cd - adrenergic 
blocking actions of the tranquillisers may play a major part in 
their value in this particular usage.
The following experiments were designed to clarify these points
1 26
IHTRA'VMOTTSIjY AITO IHTMigSCULMlLY OH HEART AlID R'^SPIRATORY BATES 
AM) OF ACHPRQMAZIHE ADMIHIGTERED H T R ^ E O U S L Y  OH HEART RATE A m  
ARTERIAL BLOOD PRESSURE IF POHIES
The initial experiments in this study involving the effects of 
intravenous and intramuscular administration of acepromazine, 
azaperone and xylazine on heart and respiratory rates i?i ponies were 
carried out concurrently with the studies on ihe actions of etorphine 
and 'ImmoLilon' in the same ajiiraals i.e. ponies Nos. 1 and 3 (see 
chapter 9).
The investigation into the effects of acepromazine on arterial 
blood pressure was undertaken at a, later date, J^ ll three ponies 
were included in this and further studies on the actions of etorphine 
and *Immobilon*.
Animals
All three ponies were used in these experiments.
Before monitoring arterial blood pressures all three animals 
were anaesthetised and the right carotid arrery was transposed 
subcutaneously 1.9 inches dorsal of the jugular furrow. This 
raising of the carotid artery facilitated the measurement of 
arterial blood pressure in the animals, The surgical procedure 
used was that of Taverner (1969)-
A period of 12 weeks was allowed aft^r surgery before the
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animals were used experimentally.
Methods
Clinical observations were made following administration ox 
each drug on onset of action , depth and duration of tranquillisation 
(assessed by the physical appearance of the animal, reluctance i;o 
move, reaction to handling), Other actions were also noted.
Heart rates were recorded by radiotelemetry as described 
previously and respiratory rates were measured visually over a 
period of 30 seconds. Blood pressure was monitored in the
relocated right carotid artery, A 30 cm. (nylon) cannulac was 
inserted into the artery through a 16 gauge 1.9 inch needle and was 
kept patenb by injection of small volumes of heparinised saline.
The caamula was attached to a Bell and Howell Type h-i|22-000l 
pressure transducer (previously calibrated to the height of the 
animal) and the blood pressure readings recorded on a Devices (M I9) 
pen-recorder.
Blood pressures quoted are mean blood pressures (diastolic 
blood pressure plus one third of pulse pressure).
Drugs
Acepromazine : Acetylpromazine IO mg/ml. C-Vet Limited 
Azaperone : Sxiicalm l^ o w/v. Grown Chemical Company Limited
Xylazine î Hompun 90 mg/ml. Bayer UK Limited
The drugs were administered at the following dose rates,
acepromazine 0.2 mg/kg intramuscularly
0.1 mg/kg intravenously
i) azaperone O.U mg/kg intramuscularly
0.2 mg/kg intravenously
ill) xylazine 3,0 mg/kg intremuscularly
0,9 nig/kg intravenously
The doses of all three drugs were similar to those used by
previous workers in horses (Aitken and Sanford, 1972; Pugh, I96I1;
Serrano and Lees, 1976; Clarke and Hall, I969; Hoffmaxi, 197U)»
The dose of acepromazine used in. the second experiment was
also 0.1 mg/kg administered intravenously. This dose is
equivalent to that included i.n the recommended dose of 'Immobilon'
(0,9 ml/90 kg) which was employed in later experiments (Chapter 9)
with these same ponies.
Experimental Procedure
EXPERIMENT 1
Heart and respiratory rates were recorded from the animals 
before tranquillisation with, all 3 drugs and at 10, 20, 30j ^0, 90 
and 60 min after drug injection.
A period of at least U days was allowed between doses.
EXPERIMENT 2
Heart rate and arterial blood pressure were recorded from all 
three ponies prior to tranquillisation with acepromazine and at 1, 9» 
10, 20, 30j U9 and 60 min after injection-
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7.2.1 Results
K'tPBRZvlGNT 1
Intravenous administration of tranquil1isore
BEHAVIOURAL SIGNS
All three drugs produced penile relaxation and di^ooping of the 
head, acepromazine and azaperone produced slight sweating in the 
groin and axillae,
Azaperone and xylazine produced signs of sedation within 9 
min of injection which lasted hetween Li.0 and 90 min following each 
drug. Acepromazine produced signs of sedation within 10 min wr'ich 
lasted for 2.9-3 hours,
HEART RATE (TABLE 7.1 )
Acepromazine and azaperone increased heart rate by 2^ /o and 
91 % respectively during the first 20 min of sedation. Thereafter 
the rate fell gradually reaching pre-injection values I4O min later. 
Xylazine caused a 29% reduction in heart rate within 10 min of 
injection and the rate was still below resting values 90 min labor. 
Dropped beats were seen during the first 3 min following xylazine 
admini s tration.
RESPIRATORY RATE (TABLE 7.2)
Acepromazine appeared to produce a slight decrease in 
respiratory rate over the 60 min period whereas azaperone and 
xylazine produced no obvious effect.
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InTramusCU.1 ar administration of tranquillisers
BET1AVI0URAL SIGNS
The clinical signs seen were similar to those recorded after 
intravenous administration. The onset oi action of all the dr^ igs 
was much slower following injection by this route. Azaperone 
produced signs of tranquillisation at 10-19 min, xylazine at 10-19 
min and acepromazine at 90-60 min. The effects were still visible 
1.9 hours after xylazine and 2.9 hours after acepromazine and 
azaperone.
HEART HATS (TABLE 7.1 )
Acepromazine and azaperone produced increases in heart rate of 
149% and 38% 20 and ju min post-injection respectively, Xylazine 
on the other hand produced a 20% fall in heart rate 30 min post- 
injection. Ho dropped beats were recorded.
Aid heart 3/ates had returned to pre-injection values by 60
min.
RESPIRATORY RATE (TABLE 7.2)
Acepromazine appeared to produce a slight decrease in 
respiratory rates over the 60 min period. Following azaperone and 
xylazine administration the rates appeared to increase but this 
effect was ylight,
EXPERIMENT 2
BEHAVIOURAL SIGNS
The clinical signs observed were the same as those described
131
previously,
HEART :RATE (TABLE 7.3)
Heart rate increased to a maximum 9 min post-injection (v9'39n 
above resting values) but Had returned to pre-injection values within 
60 min,
ABTERIAI. BLOOD JPEESSHRE (TABLE 7.3)
Blood pressure decreased slowly over the first 30 min reaching 
its lowest level between 20 and 30 min post-injection. By the end 
of the 60 min period however it had returned almost to resting 
values.
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7.3 t h e EFïECTS o f ACEPR0MA21FR AZAPEROKE AND XYLAZINE ON ÎIEYDT
RATE, PACKED CELL VOLTOIE AND PLASMA 11-OECS MÜVI-jLS IN HORSES
This eKperiment was carried or.t concurrently with bhe work 
described previously on the effects of imsole biopsy. This 
surgical procedure was repeated in t.ranquillised animals, the doses 
of drugs used being higher than those employed in the preceding 
study.
However before administration of acepromazine, azaperone ar^ d 
xylazine prior to muscle biopsy, each drug was administered to 
three horses without carrying out the operative procedure. The 
effects of the drugs on heart rate, packed cell volume and plasma 
11-OHCS levels were measured over a 60 min period as it had been 
shown in the previous study that the muscle biopsies could be 
completed within this time.
Animals
All seven horses were used in this study. Their temperaments 
are assessed in Table ^.1.
Methods
Clinical observations were made following administration of 
each drug as described in the preceding experiment.
Heart rates were recorded by radiotelemetry as described
13;
previously.
Blood, sairip1.es for P.C«V. and plasma 11-OIIOS levels were 
collected and treated as described previously.
Dru,
All three drugs were administered intramuscularly at the 
following dose rates,
i) acepromazine . 0.5 mg/kg
ii) azaperone 0,7 mg/kg
iii) xylazine 2.0 mg/kg
The dose of acepromazine was five times that recommended by 
the manufacturers for horses and the maximum required to produce 
obvious signs of sedation in all horses (Hall, 1971) also Aitken 
and Sanford (1972) have shown that doses of 0.2 mg/kg acepromazine 
administered intramuscularly produced very little tranquillising 
effect on the responses to disturbi.ng visual stimuli and for this 
reason also it was decided to use the 0.5 mg/kg dose.
The doses of azaperone and x^^^’lazine were within the ranges 
employed by other workers (Hillidge et ad, 1975; Lees and Serrano, 
I97&; Aitken and Sanford, 1972; Clauke and Hall, 19&9; Hoffman,
1974).
The schedule of drug administration is shown in Table 7.7h 
Experimental Procedure
All the experiments were carried out between the hours of 9
Table 7«U Drugs administered in Control experiment
Horse Drug
1
....
AGP Î X
2 AZ
3 X : AGP 
AZk
5 X
6 AGP
7 AZ
AGP " Acepromazine 
AZ = Azaperone 
X = Xylazine
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ajid 12 noon.
Heart rate recordings and hload samples for P.C.Y. and 11-OHGS 
estimation were taken from the animals at rest prior t^ 
tranquillisation and at 30 and 60 min post-injectron.
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7 .J .1  R esu lts
BüEAYIOURi^L SIGNS
Azaperone aiid xylazine produced vi&ible signs of 
tranquillisation by 20 min post-injection compared with between 30 
and I4O min following acepromazine. All throe drugs produced penile 
relaxation and drooping of the head and ears and both aceproraazine 
and aaaperone produced varying degrees of sweating especially around, 
the axillae and groin. Excess salivation wras seen in the same three 
horses each time azaperone or xylazine was administered.
Twenby-four hours after acepromazine and azaperone injection 
the horses still showed sligh.t signs of tranquillisation in that 
they were reluctant to exercise and when ridden showed slight 
incoordination of movement. Following xylazine the effects had 
worn off within ^ hours.
Horse No. 4 became hyper excitable between 20 and 1^ 0 min 
following azaperone injection. This reaction was accompanied by 
severe sweating, trembling and restlessness.
HEART RATE (TABLE ?.$)
Acepromazine and azaperone both appeared to produce a slight 
elevation in heart rate 60 min after injection when levels were 
increased by and 2U% respectively above resting values,
Xylazine on the other hand produced little change in heart 
rate bub caused occasional dropped beats especially within the 
initial 10-20 min.
CO
o
WC;
V"
%~
(d
0M
CCÎ
rH
pH
S
,
o
pH
0
-P
CD
pH
H
CD
0
M
o
0
.3
p
cD
nd
Jh0
0
FI
OU0
&cd w
N
td +  1
fj0 (d1 P
P
cd
Ü 0o o
P 0
pH A0 o
Ü W
0
-O
«H
O M'H
w
-p 0
Ü . 40 /t'.
(H S
44 "J
pa
\A
0 
I—t
EH
CM 00 
C\J +1
M3 -Cj- 
’„0 CM 
CM + 1m  + 1
CO CMcn +1 CvJ + 1
CM 
+  1
CO (M 
C^  +1
VO
VO
V O  4-1
OV CM 
CM 4-1o
CM CO
CM CO 
^  4-1 C O  4-1
I—I
8
N 'H
0
iI
I
iH
H
ch
•H
r4
•H
§
-P■H
i
«H
O
•HM
0
I
•S
I
-Cf-
0m
H
S
w
I
136
PACÏCED CELL VOLUME (iLVBLE ? .3')
Both acepromazine and azaperone administration produced 
decreases in P.C/V. levels at 60 min post-injecbion which were 1^% 
and 20^ helow resting values. Xylazine appeared to cause little 
alteration in P*C.V,
PLASMA 11-OHCS (TABLE 7.3)
Daily variations in plasma 11-OHCS levels occurred in all the 
horses Lut these values always fell within the ranges quoted in 
earlier studies (chapter 3)« Acepromazine caused a slight 
increase J.n 11-OHCS values in all 3 horses, Azaperone also 
produced increases in 11-0ÏÏCS levels, the most marked occurring in 
horse Ho, )4 which exhibited a mild hyperexcitability reaction. 
Xylazine on the other hand, produced little change in two of the 
horses and a decrease in 11-OHCS levels in the third.
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7.1- REDUCTION OF THE STRESS OF SURGICAL PROCEDURE 11" FREMEJECATION
WITH TRANQUILLISERS
This study was carried ou+ at the same time as the experiment
described previously on the effects oi muscle biopsy on heart rate,
P.C.V, and plasma 11-OHCS levels.
Premedication with acepromazine, azaperone and xylazine wa.s
emploved, to enable the biopsy procedure to be carried out in all 
including those 
the horsesy^in which this had previously proved impossible.
Animals
All 7 horses used in previous studies were included in thic 
experiment.
Methods
Heart rates were recorded by radiotelemetry as described 
previously.
Blood samples for P.C.V. and plasma 11-OHCS estimation were 
collected and treated as described previously.
Acepromazine, azaperone and xylazine were administered 
intramuscularly at the dose rates used in the previous experiment
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in section 7»3» The iiitramuscular route was chosen in preference 
to intravenous because the duration of tranquillisation following 
the former route was greater and was sufficient to allow completion 
of the biopsy procedure.
A higher dose of azaperone (0,9 mg/kg) was administered on one 
occasion to horse No. 3 which was the most nervous of all the animals,
Operative Procedure
The biopsy procedure was the same as described previously 
(chapter 3).
Exppr.-.meiital Procedure
All the experiments were carried out between 9 a.m. and 12 
noon the resting samples and values always being recorded before 
9.30 a,m. The entire procedure (drug injection to last biopsy) 
was always completed within 1.3 hours.
All the drugs were administered at least once to each of the 
7 horses before the operative procedure and azaperone was used on 
13 occasions. The order in which the drugs were given is shown
in Table 7.$. There was an interval of at least 3 weeks between
drug administrations to each horse except on the occasions when 
inad;,qual:e restraint resulted and on these occasions another drug 
wa.s 1,8 hour's later.
Heart rates were monitored continuously throughout the 
procedure. Blood samples for P.C.V. and 11-OHCS estimation were
Table 7.6 Schedule of drugs administered prior to Muscle 
Biopsy
Horse Drugs 
AZ : AZ ; X : AGP
2 AZ ; AZ : X : a GP
3 AZ : AZ : AGP ; X 5 AZ
h : AGP : AZ : X : AZ
AZ ; AGP ; X
6 AZ : AZ : X : AGP
7 AZ : AGP ; AZ : X ; AZ
* = order in whi.ch drugs were given 
AGP Acepromazine 
AZ Azaperone
X Xylazine
139
taken after drug administration, injection of local anaesthetic 
and on completion of all the biopsies.
The results recorded when the procedure was attempted without 
tranquillisation are included in this study as a control group.
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7»Ù*1 Results
BimVIOURAL SIGNS
13.1 the drugs produced the same effects on behaviour end 
■posture an described previously.
In o:ie of the horses (No. 1+) acepromazine produced a 
hyperexcitable reaction between 20 and 60 min after injection.
Severe sweating; staggering and trembling occurred and the operative 
procedure was abandoned. On subsequent occasions when this animal 
was given azaperone (described in the previous section) a similar 
but milder reaction occurred,
-Although all three drugs produced similar signs of central 
nervous depression in the horses, they did not produce similar 
degrees of tranquillisation. This was only regarded as adequate 
if the animals allowed completion of the operative procedure without 
showing signs of distress (indicated by excitability, apprehension 
and attempts to resist injection of local anaesthetic and biopsying) 
As with the control studies when no tranquillisers were used, 
injection of the local anaesthetic produced most agitation and 
failure to .inject the local anaesthetic into all the biopsy sites 
was the normal reason for the procedure not being completed.
Only azaperone was effective in all 7 horses on each occasion 
although in horse No. 3 a higher dose (0.9 mg/kg) was necessary, 
Iceprrmiaz.i.T^ e was effective in five horses (Nos. 1, 2, 3> 3 and 6) 
and xylazine in only four (Nos, 1, 2, 3 and 6). In three of the 
animals (hns. 1, 3 and 6) however it was possible to complete the
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procedure with no tranquillisation,
HEART RATE (TABLE 7,7)
Following premedication; as when no drugs were used, the 
biopsy procedure produced an increase in heart rate associated 
especially with injection of the local anaesthetic. This increase 
was most marked in those animals which did not allow completion of 
the procedure,
Prcmedication reduced the heart rate increases below those of 
the control group following injection of the local anaesthetic 
(p ^  O.C3) but not following the biopsies.
The dropped beats recorded following xylazine disappeared as 
the heart rate increased.
PACKET' CtBL VOLUME (TABLE 7.8)
No increases in P.C.V* were recorded following premedication 
at any time during the operative procedure. Contrary to the 
elevations in P.C.V. recorded after injection of local anaesthetic 
and after the biopsies when no tranquillisers were used, acepromazine 
and azaperone both decreased P.C.V, below resting values. Xylazine 
produced no effect on P.C.V.
PLASMA 11-OHCS (TABLE 7.9)
Following acepromazine premedication there appeared to be a 
slight increase in plasma 11-OHCS levels which was higher following 
the biopsies than the local anaesthetic. Tn the azaperone treated 
animals the 11-OHCS levels were marine,dry iiigher following the 
biopsy procedure than after injection of the local anaesthetic even 
though this group of horses showed leuct evidence of distress and
Table 7*7 Effects of Biopsy Procedure on Heart Rate
(beats/min Mean - s.e.)
Stage of Procedure
1
Control (Ho 
Tranquillisers)
Acep:
Pre Experiment 39 i  1.8 
(7)+
ho
Before local 
Anaesthetic
ho -  2.3 
(7)
37
After local 
Anaesthetic
4- •X-
91 Î  11.0  
(7)
6i+
Before Biopsy 46 6 .0  
(3)
3h
After Biopsy 78 i  9.2* 
( 3>
66
(7)
(6)
i  I 
(6)
+ ,
(5)
 ~ 11|,0 
(5)
Aaaperone Xylazine j
h2 -  1.0
(U)
± l.il 
(14)
38 ± 1.5
(7)
34 -  2.0 
(7)
58 t  5.6 [ 53 -  9.Ù 
(15) i (7)
42 -  1.4 
(15)
61 -  6 .0
(15)
35 “  1
(4)
5
62 7.2
(4)
* _
figures in parenthesis indicates number of times each stage of 
procedure successfully completed
p 0.03 (refers to difference from mean pre-tranquillising 
levels)
Table 7.8 Effect s of Biopsy Procedure on Packed Cell Volume
(Mean t ^- s.e.;
Stage of Procedure Control (No 
Iranqnillls er)
Acepromazine Azaperone Xylazine
Pre Experiment 37.7-2.0
(7)
35.2-1.0
(7)
38.5io.8
(15)
37.6^1.3
(7)
After local 
Anaesthetic
U2. G 3.5
(7)
28 .o i l . 6 
(6)
J. *
29 . l i l .0
(15)
36.0-2.8
(7;
After Biopsy 44. o h . 7 
(3)
+ .* 
29,010.3
(3)
29 . 0- 0 .6
(15)
* = p O.Op (refers to difference from mean pre-tranquilliser 
levels)
Figures in parenthesis indicates number of times each stage 
of the procedure successfully completed
Table 7«9 Effects of Biopsy Procedure on Plasma 11-OHCS
Levels (n mol/l Mean - s.e.)
Stage of Procedure Control (No 
Tran quilliser)
Acepromazine Azaperone Xylazine
Pre Experiment 270 i VI 
(7)
269 ~ 25 
(7)
208 i 17 
(15)
1
196 ± 26 
(7)
After L(/Oal 
Anaesthetic
334 i 41*
(7)
380 i 59
(É)
304 i 33*
(15)
+ ^ 
271 - 42
(7)
After Biopsy
. . r
291 ± 55 
(3)
' - -- "
395 - 24 
(5)
l'Oi i 46 '
(15)
174 - 30 
(4)
. - P ^  0,03 (refers to difference frcjm mean pre-tranquilliser 
level s)
Figures in parenthesis indicate number of times each stage 
of the procedure successfully completed
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agitation. Xylazine premedication, in accordance with the 
observations made on behaviour and heart rate, produced more 
elevated 11-OHCS levels after injection of the local anaesthetic 
than after the biopsies.
1 1 levels at the end of the operative procedure wore 
higher following acepromazine and azeperone premedicaticn than in 
the control studies when no tranquillisers were used.
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7•3 Discusdion
The phenothiazines and the hutyrophenones share many 
pharmacological properties amongst them depression of the brain 
stem reticular system and vasomotor reflexes and an ability to 
block the dopamine receptors and thus the transmission of nervous 
impulses in various areas of the brain. These areas include the 
hypo thaï, anus, basal ganglia, limbic system, and chemoreceptor trigger 
zone aiid this action of the two groups of drugs explains many of 
their psychological and anti-emetic effects (Marsboom, 1971;
Goodman and Gilman, 1973) •
CLIjMIOAr, SIGNS
The clinical signs, onset and duration of tranquillisation 
recorded in this study following acepromazine and xylazine 
administration have also been reported previously by workers using 
similar doses of both drugs (Carey and Sanford, 19^3; Aitken and 
Santord, 197%; McCashin and Gabel, 1971; B u m s  and McMullan, 1972; 
Hoffman, 197U; Tronicke and Yoke, 1970)« Lees and Serrano (197&) 
reported similar clinical signs and onset of tranquillisation in 
ponies following azaperone (0.I4 and 0.8 rag/kg intramuscularly) as 
have been described in this study but they recorded a duration of 
action of between I4 and 6 hours whereas signs of sedation were still 
apparent in our horses hours post-injection. This difference 
could be due to the fact that all the horses concerned were riding 
animals and the effects noted after 2)4 hours were visible only as 
reluctance to exercise and sli^it hesitation of gait. This
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prolonged duration of action of azaperone not recorded in any 
of our ponies which world support the suggestion that the effect 
might not be apparent in restrained animals.
Tile increased doses of acepromazine and azaperone employed 
prior to the biopsy procedure (Sections 7*3 and 7*U) did not 
increase the degree of tranquillisation as assessed by visual 
signs buo lengthened the period of tranquillisation. The fact 
that azaperone proved to be a more successful tranquilliser than 
acepromazine in reducing the stress of muscle biopsy (even when 
acepromazine was administered at five times the recommended equine 
dose) is similar to the findings of Marsboom and Symoens (I968), 
and Aitken and Sanford (1972). The former authors reported that 
azaperone was a more effective tranquilliser than oropionylpromazine 
in the pig and the latter authors that it was more effective than 
acepromazine in the horse. The iow success rate following xylazine 
premedication is surprising considering the reports of previous 
workers (Tronicke and Vocke, 1970; Hoffman, 197Uj Kerr et al, 1972; 
McCashin and Gabel, 1971; Clarke and Hall, I969). The lack of
adequate sedative effect in our horses coul.d have been due to 
inadequate dosage via the intramuscular route but this seems unlikely 
since the dose rates used were those recommended by the manufacturers 
and found by other workers to produce excellent tranquillisation 
(Aitken and Sanford, 1972; B u m s  and HcMiAllan, 1972).
Xylazine has been reported, howeve.c- as being more effective 
in docile animals (Hoffman, 197^0 and also to exert greater 
analgesic properties when administered intravenously than
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intramuscularly. Both these offsets could explain the lack cf 
success with this drug during the muscle 'biopsy procedure. The 
animals in wfilch it was impossible to complete the biopsy technique 
under xylazine were the more nervous of the seven horses and t'he use 
of xylazine intramuscularly might have produced insufficient 
analgesia for the injection of the local anaesthetic.
The salivation recorded in three of oar horses (7<>3) has also 
been recorded previously in cattle by the manufacturers of xylazine 
and in pigs and horses following azaperone by Marsboom and Bymoens, 
(1968) and Lees and Serrano (19?6). The reason for this effect is 
not known.
The hyperexcitability reaction reported in Horse No. .3 
following administration of acepromazine (7*3) has also been 
recorded by other workers using phenothiazinesin horses (Carey and 
Sanford, I963; Jones, I963). The exact cause of this reaction is 
unknown. Hall (I960) attempted to discover whether this excitement 
might be due to the hypotension produced by chlorpromazine and Carey 
and Sanford (I963) also considered this. Neither, however, could 
demonstrate a reduction in blood pressure coinciding with any 
excitement phase. Owen and Neal (193?) suggested on the other b,and 
that muscle weakness due to the tranquillising effect of the drug 
might cause a panic reaction but again there is no evidence of this.
Carey and Sanford (I963) concluded that the phenothiazines 
might exert some fundamentally different action in certain 
individual horses but could not suggest what this action might be. 
If, however, it is some central effect of the drug, since both
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aoepromaaine and azaperone act in similar ways, it is possible that 
this could explain why the same horse reacted similarly to both 
agents.
Acepromazine and azaperone produced slight sweating in all the 
animals. Sweating in the horse is considered to be iznder the 
control of the sympathetic nervous system (lioEwan-J'enkinson, 1973) 
and recent work by Andersen and Aitken (1977) suggests that 
receptors rather than oi. receptors are concerned. More detailed 
investigations by Snow (1977) have also demonstrated that ^  ^ 
rather than^  '.j receptors are involved.
Acepromazine has been reported by Aitken and Sanford (1972) 
to potentiateithep^" receptor actions of adrenaline on the heart as 
described by Nebster (I966) and Sutherland (1970)«
Several ot- - adrenergic receptor blocking drugs have been 
shown to increase noradrenaline release from nerve endings (Enero, 
Lar.<ger, Kothlin and Stefano, 1972; Cubeddu, Langer and Weiner,
I97a; and some phenothiazines have been reported to reduce the 
uptake of catecholamines into tissues (Hertting, Axelrod and V/hitby, 
1961). Azaperozie also possesses - adrenergic blocking activity 
(Marsboom, 1.971; Lees, Tavemor and Hillidge, 1971 ) und another 
of the butyrophenone group, droperidol, has been demonstrated to 
increase circulnting noradrenaline levels in cats by stimulation of 
post-ganglionic sympathetic nerve endings and inhibition of 
noradrenaline re-uptake (Herbaczynska and Staszewska, 1971). By 
eitner of +nese two mechanisms the end result would be''*the same as 
prolonged sympathetic activity. However, because of the oC-
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adrenergic blocking activities of uhese two tranqnillisore, the net 
result would be that greatest potentiation wi11 occur on ^ - receptors 
thus producing increased sweating.
CARDJOYASCUT^R EFFECiTS
The mild tachycardia recorded in both sections 7^2 and 7*3 
following administration of acepromazine and azaperone has also 
been reported previously (Gabel, Harilin,and Smith, I964; Kerr _et ai, 
1972; Lees and Serrano, 197&) end. is thou^t to be a reflex 
response to the decrease in blood pressure produced by these drugs. 
This increase in heart rate occurs in response to signals from the 
cardi.oregul.atory centre in the brain via the sympathetic system 
(Rushû'ior, 1972), Stretch receptors in the aortic arch and 
carotid sinus are very sensitive to alterations in blood pressure 
and relay information accordingly be the brain which in turn 
regulates the heart rate via the parasympathetic (inhibitory) and 
sympathetic (stimulatory) systems.
In section 7.1 when heart rate and blood pressure were recorded 
following acepromazine administration tachycardia did occur during 
the period of hypotension, suggesting that reflex control of the 
heart was responsible for the changes recorded in these studies. 
During the muscle biopsy procedure it was interesting to note that 
tachycardia was not recorded betwef=n stages of the operative 
technique following acepromazine and az-,rercne premedication.
Xylazine produced bradycardia when administered either 
intravenously or intramuscularly, the effect occurring more rapidly
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following administration by the intravenous route. This action of 
xylazine has been recorded previously (Hoffman, 197U? Kerr et al, 
1972; Garner, Amend and Hosborcugh, 1971; Clarke and HalL, I969) 
and is suggested by the manufa.cturers to be due to a direct action 
of the drug on the myocardium. Kerr et al (1972) however claim 
that the bradycardia may result from p. reflex response to the 
hypertension they recorded immediately following zqylazine 
administrabion. This hypertension wap present for less than 10 
min, the blood pressure thereafter decreasing slowly to levels below 
resting values, whereas the bradycardia lasted for 60 min. A 
similar pattern of alteration in heart rate was recorded in t}iese 
studies suggesting that some direct action of xylazine on bhe 
heart or, as described by Schmitt, foumadjiev and Schmitt (l97f’)j 
some centrally produced reduction in sympathetic tone might be the 
cause of the bradycardia.
Pretreatment with all three drugs reduced the changes in heart 
rate produced by the different stages of the biopsy procedure as 
compared to the increases recorded in the control studies without 
premedication. This effect may be due to some central action of 
these drugs on the hypothalamus involving suppression or blockage 
of nerve impulses to the pain centres (Guyton, I9?l) or as described 
previously in the case of xylazine to some direct central effect on 
the heart rate.
Arterial blood pressure was recorded only following 
administration of acepromazine intravenously (Section 7.2). A 
fall in blood pressure was recorded similar to that reported by
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other workers in dogs (Taverner, 1962; Popovic, Mudlane and Thap, 
1972) and in horses (Gahcl ejb ad, l96Ji; Kerr et al, 1972; Glen,
1972).
The hy%)otensive effect of acepromazine is attributed to its 
. oC - adrenergic blocking action causing a reduction of sympathetic 
vasoconstriction. Most of the phenothiazines possess cd. - receptor 
blocking activity although their potency varies (Bhargava and 
Chandra, I96U) and acepromazine has been shown to actively 
antagonise bhe pressor effect of adrenaline (Serrano and Lees, I976).
The effects of the three drugs on respiratory rates were 
monitored only in section 7.2. Acepromazine produced a slight 
decrease in respiratory rates over a 60 min period and similar 
results have been recorded in horses by Kerr et al, (1972) and Muir 
and Hamlin (1973)* They attributed this effect to the depressant 
action of acepromazine, most central nervous depressants producing 
some degree of respiratory depression, and. xylazine produced no 
changes in respiratory rates, agreeing with the results of Hoztocil 
^  al; (1971) and Gamer et al, (1971). Lees and Serran.o (1976) 
on the other hand reported significantly increased respiratory rates 
following 0,8 mg/kg azaperone in ponies and suggested that this 
could be due to the hypotensive effect of the drug producing 
stagnant hyro^ûa causing stimulation of chemoreceptors in the aortic 
and carotid bodies. Several authors (Clarke and Hall, I969; 
McCasnln end Gabel, 1971; Hoffman, 197U) also have reported a 
decrease in respiratory rate following xylazine administration to 
horses > The reason for the difference between these results could
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be that the animals used iji this study were less disturbed during 
the experiment since Gamer et (1971) and Hoffman (19?L)
Êïnggested that animals with higher than normal respiratory rates 
were affected to a greater degree by xylazJne administration.
The effects of acepromazine and azaperone on packed cell 
volumes recorded in experiment 7,3' have also been reported 
previously and will be discussed in detail in the following chapter 
of tills study. Briefly, however, both drugs produced a fall in 
packed cell volume. The effects of phenothiazine tranquillisers 
on packed cell volume in sheen have been recorded by Turner and 
Hodgeits (1960) and in dogs by Collette and Meriwether (1965)
Both groups reported that chlorpromazine lowered venous haematocrit 
and the latter authors that spleni.c enlargement also occurred. 
Aronson, Magera and London (1970) reported that droperidol (one of 
the butyrophenone group) produced a small decrease in venous 
haematocrit in humans and Roztocil et ad (1971) and Lees and 
Serrano (1976) demonstrated a similar reduction in horses following 
azaperone.
This fall in packed cell volume has been attributed to the 
central depressant effects of the drugs (Turner and Hodgetts, I960), 
causing splenic relaxation and an accumulation of red cells in the 
spleen, or to the oC - adrenergic blocking action causing relaxation 
of the splenic capsule and an uptake of rod cells from the 
circulation (Lees and Serrano, I976), Heil and Chidsey (I968) 
found that in man sympatholytic agents produce a haemodilution due 
to an alteration in pre/post capillary resistance resulting in
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changes in plasma protein concentrations. Such changes were noted 
in these studies (see next chapter) hut were not recorded by Lees 
and Serrano (1976) following azaperone administration to ponies.
It would appear therefore that the fall in packed cell volume seen 
following acepromazine and azaperone may be due both to an 
accumulation of erthrocytes in t3ie spleen ar.d to a lesser extent 
to haemodilution.
ENDOCRINE EFFECTS
The presence of a circadian variation rn plasma 11-OECS jsvel.s 
as recorded in our horses and by others (Bottoms et al, 1972) makes 
evaluation of the results in sections 7*3 and 7*U difficult. By 
carrying out the procedures at the same times each day and within as 
short a time as possible it was hoped that these effects would, be 
minimised.
The results in section 7*3 indicate that in the horse, azaperone 
and possibly acepromazine per se produce an .increase in plasma 11- 
OHOS levels. Reports on the effect of phenothiazines on the 
secretion of 11-OHCS are contradictory. Mahfouz and Ezz (1938) 
suggest that chlorpromazine decreases the output of ACTE in 
response to stressful stimuli Holzbaur and Vogt (193L), Smith et al 
(1963) and de Wied (I967), however, carried out studies which 
indicate that chlorpromazine increases 11-OHCS secretion and 
furthermore that this increase is due to AGTH hypersecretion.
Smith et al (I963) also demonstrated that the increases in plasma, 
11-OHCS levels in rats was directly proportional to the degree of
152
central activity of the phenothiazines. If this is the case it 
might explain why azaperone caused higher increases :n plasma 11-OHCS 
levels than acepromazine. The mode of action of both drugu is 
very similar (Goodman and Gilman, 1975) and they might both affect 
AGTH secretion in the same manner. This effect of azaperone on 
ACTII secretion would also help to explain why 11-OHCS levels were 
greatest when the biopsy in section 7*U was carried out following 
azaperone premedication, even although the horses were most 
tractable during this time.
Xylazine appeared to have no effect on plasma 11 OHCS levels 
when administered alone ( Table 7•5)* During the biopsy procedure 
however it did successfully reduce 11-OECS values, below those 
recorded following either acepromazine or azaperone premedication.
If corticosteroid secretion is in some way influenced by 
increased sympathetic activity then the central action of xylazine 
decreasing sympathetic tone as described by Sclmiitt et ad, (1970) 
might result in a decrease in adreno cortical activity. This central 
effect might also be most obvious under conditions of increased 
sympathetic stimulation such as was seen to occui? after injection 
of the local anaesthetic and the muscle biopsies.
Summary
Acepromazine and azaperone reduced the stress of a minor 
surgical procedure (muscle biopsy) as assessed by changes in heart
153
rate and packed cell volujiie, compared to the control experiments 
when no tranquilliser was used. The effect on heart rate was 
probably due to the central depressant actions of the drugs 
reducing the anxiety, apprehension and possibly pain associated 
with the various procedures whereas the effect on PoC.V. was due to 
a direct, pharmacological action of both drugs. This effect on P.C.Y, 
is investigated in more detail in the following study.
Both these drugs apparently produced, elevations in plasma 
11-OHCS levels per se suggesting that in this instance measuxcment 
of 11-OHCS values is not a useful means of assessing the efficacy 
of certain tranquillisers.
Xylazine reduced heart rate, bjth in resting animals and 
during the biopsy procedure. This effect was possibly due to a 
central depressant effect of the drug on sympathetic tone. No 
changes in P.C.V. were recorded following xylazine but a reduction 
in plasma '11-OHCS levels was apparent during uhe biopsy.
Of the three drugs used, azaperone proved to be most effective 
in allowing completion of the surgical procedure in horses of all 
temperaments.
M  INVESTIGATION IF.'Vj THE ACTIONS OE CEÎ^ TE./J,
DEPRESSANT DRUGS ON CIRCULATING RACKED CELL VOI.-UMES
IN HORSES .AND DOGS
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8.1 Int,3:odiic tion
The splenic capsule is rich in oC - adrenoreceptors and 
contraction of the splenic capsule occurs in response to increased 
Fjympathetic stimulation (Davies and Withrington, 1973)*
In the quiet resting animal the splenic capsule is always in a.
state of partial contraction and the organ functions as a reservoir
for red blood cells* In certain species e.g. horses, dogs and 
sheep this reservoir capacity is large (Schalm _et al, 19750* The 
fall in circulating packed cell volume as recorded following 
premedication with acepromazine and azaperone in the previous studies 
could have been due to either;-
i) local blockade of normal sympathetic activity at the
oC - adronoreceptors in the splenic capsule 
tij a general decrease in sympathetic activity due to 
central nervous depressant effects of these drugs 
iii) .an increase in plasma volume
Several phenothiazine tranquillisers possess - adrenoreceptor 
blocking actions (Courvoisier, Foumel, Ducrot, Kolsky and Koetschet, 
1953) and a number of the butyrophenones have also been shown to 
exert this effect (Marsboom, 1971; Lees and Serrano, 197&)*
A fa3-l in circulating packed cell volume levels in horses has 
been 'f'ecorded following injection of chlorpromazine (Martin and Beck, 
1956) end ct propionylpromazine/promethazine mixture (De Moor and Van 
den Honde, 1968). Turner and Hodgetts (I960) reported similar 
findings .Ui sheep following chlorpromazine administration and
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suggested that the fall in circulating red blood cells wan due not 
to the local o( - adrenoreceptor blocking actions of this drug on 
the splenic capsule, but to its central depressant actions.
In this study the effects of acepromazine and. azaperone on 
packed cell volume and total plasma protein concentrations in horses 
were monitored. Total plasma protein concentrations alter as a 
result of either increased or decreased plasma volume and the former 
has been reported to occur following administration of certain 
tranquillising dnigs including aceprcmazine and chlorpromazine 
(Gartner, Ryley and Beattie, 1965; Dalton, 1972). This change in 
plasma volume has been attributed to the ol. - adrenoreceptor blocking 
actions of these drugs causing a fall in capillary pressure and a 
transfer of protein free filtrate from the interstitial spaces into 
the vascular system.
To try and elucidate the relative importance of the three 
factors in reducing packed cell volume the following studies w-re 
carried oub, Aceprcmazine and azaperone were administered to cogs 
before and after splenectomy and on one occasion to rabbits (animals 
known to possess a very small spleen with little or no reservoir 
capacity (Schalm et al, 1975)»
Binaily, a number of drugs known to possess central nervous 
depressant actions similar to aceprcmazine and azaperone and a 
specific adrenoreceptor blocking agent (phenoxybenzamine) wvre
administered to dogs in order to establish whether or not packed 
cell volume was affected by the central rather than the local actions 
of these drugs.
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8.2 THEEFBFGT.S OB VMIIMG DOSES OB ACEPROMAZINE AND .AZAPIRONE 
ON THE PACICED CELL VOLUMES J\ND TOTAL PI.ASMA PROTEIN 
CONCENTRATIONS IN PONIES
Animals
All three ponies v^re used (Nos. 1, 2 and 3).
Methods
Packed cell volumes were measured as described previously. 
Dlood (5 ml) was taken into a heparinised plastic tube and 
1 mi. plasma removed for total plasma protein estimation. Thesn 
measurements wore made on a Technicon Autoanalyser using the 
standard AAII - iq method, which is based on the Biuret technique. 
Signs of tranquillisation were assessed as before.
The Coefficient of Variation of this assay was 5%*
Drugs
Aoapromazine at dose rates of 0.5, 0.25, 0.12 and 0.06 mg/kg 
and azaperone at dose rates of 0.7, 0.35, 0.18 and 0.09 :ng/kg were 
injected intramuscularly into the three ponies on separate 
occasions.
Expert meni: : 1 Procedure
Blood samples for P.C.V. and plasma total protein estimation
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ware taken before the experiment and at 15, 30, 60, 90 and 120 min 
after drug injection.
Onset and degree of centrFii depression produced were assessed 
visually in each animal.
A period of at least 5 days was allowed between experiments.
Results
BEHAVIOURAL SIGNS
Both drugs produced similar clinical signs which included 
drooping of the head, closing of the eyes, relaxation of the penis 
and reluctance to move at all but the lowest doss rates (0.06 mg/kg 
aceprcmazine and 0.09 nig/kg azaperone). The signs of central 
depression were apparent within 1+0 rain following azaperone injection 
and between 1;5 - 60 min following acopromazine injection and were 
still visible after both drugs at the end of the 2 hour period, 
PACKED CEIL VOLUME (TABLES 8.1 ANu 8.2)
All four doses of each drug produced a decrease in P.C.V. 
within 15 rain of injection. The greatest changes in all cases 
occurred between 60 and 120 min after administration of the 
tranquilliser when levels on one occasion decreased by 2li% below 
control (pre-injection) values. Decreasing doses of both drugs 
did not alter the effects on P.C.V, levels.
TOTAL PLASMA PROTEIN (TABLE 8.1 ANB 8.2)
The responses to both drugs were varied but a slight decrease 
in total plasma protein (T.P.P.) was recorded especially between 60
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and 120 min after injection. There was no marked difference eetween 
the 2 drugs except following the highest dose of azaperone (0.7 
mg/kg) when a, 1ij^  ^drop in T.P.P. was recorded. In all oases levels 
were still decreased at the en8 of the 2 hour period.
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8.3 TEE EFl'DCT OF ACEPHOMAZINE M L AZAPERONE ON PACKED CEIL 
■'DJLDMB: and total PLASMA PR0TEE3 LEVEilLS IN DOGS
Animais
Four male .greyhounds were used in this experiment. All the 
dogs weighed between 20 and 30 kg.
Methods
Dlood samples for packed cell volume and total plasma protein 
estimation were taken by venepuncture from right and left cephalic 
^eins alternately into heparinised tubes.
P.C.V, and total plasma proteins were estimated as described 
previously.
Tranquillisation was assessed visually using a scoring 
system
animal on feet throughout 2 hour period 
-H- animal recumbent between blood samples but on feet 
when disturbed
animal recumbent • throughout 2 hour period and 
undisturbed by blood sampling
Dctn d]Tugs were administered intravenously, acepromazine a.t
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close rates of 0.2^ and 0.5 nig/kg and azaperone at 0,5 mg/kg. 
Experimental Procedure
Before commencing the experiment, the dogs were allowed to 
rest quietly for 1-2 hours in order to ensure that P.C.V, levels 
recorded were those of nonexcited animals.
Aceprcmazine was administered to all four dogs on two separate 
occasions once at a dose rate of 0.25 mg/kg and once at 0.5 mg/kg. 
The effects of both dose rates on rake of onset of effect, degree of 
central nervous depression and P-O.V. were recorded.
A.saperone was administered to the same four dogs and similar 
recordings made. Blood samples were always taken from the dogs at 
rest prior to drug administration and 15, 30, 60, 90 and 120 min 
later.
A period of at least 3 days \.'as allowed between experiments and 
longer if resting P.C.V, levels had not returned to within the range 
of original contro]. values.
Results
1. Acepromaz.ine administration (0.25 and 0.5 mg/kg intravenously)
BEHAVIOURAL SIGNS (TABLE 8.3)
The onset of action of both doses cf aceprcmazine 00cured 5-10 
min after injection and the effects lasted throughout the 2 hour 
period.
Table 8.3 Degree of Central depression produced by administration 
cf various drugs in dogs
Drug Degree of Central Depression I
Acepromazine
Azaperone "HU-
Xylazins +++■
Diazepam
Chloral Hydrate +++
i
Phenoxyb enz amine ++
+ animal on feet throu^out 2 hour period
-H- animal lying down between blood samples but 
on feet when disturbed
*hH- animal lying down all the time and undisturbed 
by blood sampling
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PACKED CELL VOLTU'ÎE (TABTiE 8.1|.)
There was no apparent difference between the effects of the 
two dose rates on P.C.V. levels. In both cases, values were 
significantly below pre-injection levels by 15 min (p / 0.02/ 
an.d by 120 win were even more depressed (p 0.001).
TOTAL PLASiYLl PROTEIN (TABLE 8.5)
Total plasma protein levels were significantly bolow resting 
(pre-injection) values by JO min (p k 0.05) and remained low 
throughout the remainder of the 2 hour period,
2. Azaperone administration (0.5 mg/kg intravenously)
BEHAVIOURAL SIGNS
The onset of action following azaperone was similar to that 
recorded after acepromazine. By 10 min post-injection the dogs 
were recumbent and remained thus throughout the 2 hour period, 
PACKED CELL VOLUME (TABLE 8.6)
P.C.V. levels were significantly decreased (p ^ 0.05) 
throughout the 2 hour period. Percentage decreases were slightly 
greater than following the same dose (0«5 mg/kg) of acepromazine 
(Table 8.?).
TOTAL PLASMA PROTEIN (TABLE 8.6)
Total plasma protein levels were also decreased throughout the 
2 hour period and were significantly below pre-injection values 
between 60 and 120 min post drug administration. Percentage 
decreases were slightly greater in this case than those recorded
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following acepromazine injection (Table 8.?).
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8J. TEE EFFECT OF EPLFilECTOlW,: ON THE ACTION OF ACEPHOHAZINE 
ON PACKED CELL A^ 'OHDEES AND TOTüL PLASMA. PHOTEIN 
LEVELS IN DOGS
Anlnals
The four greyhoxinds used, in experiment 2 were inplnded in this 
study.
Methods
Packed cell volumes and total wlaoma protein levels were 
estimated in a.ll blood samples as described previously.
Drugs
Aceprcmazine was administered intravenously at dose rates of 
0,2^ mg/kg since previous work had shown no apparent difference 
between the effects on P.C.V, of this and O.b mg/kg dose. 
Experimental Procedure
Blood samples for P.C.V. and T.P.P. estimation were collected 
from all the dogs at rest prior to aceprcmazine injection and at 1$, 
30, h$f 60, 90 and 120 min internals following this.
The dogs were splenectomised under halothane anaesthesia and 
were allowed 3 weeks to recover before t>o same procedure was
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repeated. Resting P.C.V, levels were slightly lower in all the 
splenectomised dogs.
Results
1, Pre Splenectomy
BEHAVIOITRAL SIGNS
O'h.e onset and signs of tranquillisation were as described ii' 
the pT'evious experiment.
PACKED CELL VOLUME (TABLE 8,8)
After tranquillisation levels fell significantly (p 0.02) 
below resting vadues and remained decreased throughout the 120 min 
period.
TOTAL PLAEKA PROTEIN (TABLE 8.8)
T.P.P. levels fell gradually after tranquillisation and by 
min post-injection were significantly (p 0.0$) below resting 
values. They remained decreased throughout the remainder of the 2 
hour period.
2. Post S'plenectomy
BEITAvIOURAL SIGNS
The OiiSeb and signs of tranquillisation similar to those 
described before splenectomy.
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PACKED CELL YOLIME (TABLE Ü.8)
P.C.V. levels remained constant throughout the 120 min.
'I'OITE, PLASMA PEOTEIE (TABLE 8.6)
Plasma protein levels had fallen by Q% 60 min after aoeproma%ine 
injection bu.t had returned to almost resting values by the end of the 
2 hour period.
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8,6 THE EFFECTS OF ACEPROBLE/.IEE M L  AEAPEROHE ADMIFISTRATIOH 
ON PACKED CELL VOLUME A T^L TOTAL PLASMA PROTEIN 
LKVE.LS IN RABBITS
Animals
A white male rabbit weighing 3*5 kg was used in this study. 
Methods
P.C.V. and T.P.P. values were determined as described 
previously.
Drugs
Acepromazine and azaperone were administered intramuscularly 
at dose rates similar to those used previously in dogs i.e. 0.6 
mg/kg.
Experimental Procedure
Blood samples for P.C.V. and T.P.P. estimations were collected 
from the ear vein prior to drug administration and 15? 30, 60, 90 
and 120 min later.
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Results
PACKED CEI.L VCLmiE (TABLE 8.5)
Following both drugs there was a slight decrease in FtC.V. 
levels, lowest values being recorded between 30 and 50 min pose- 
injection (-8% in both cases below resting values).
TOTAL PLASMA PROTEIN (TABLE 8.9)
T.P.P, levels fell markedly following both drugs throughout 
the 2 hour period. Lowest vaines were recorded between 60 and 120 
rain (-17% following acepromazine and --34% following azaperone below 
resting values).
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Tffiü EFFECTS ON PACIŒD CELi, YOLIFIES IN TOCS OF SSrETL/iL
8.6 THE EFFECTS ON PACKET CELj, VOgFES IN TOCS OF SErETL/iL 
CENTRAL TEPKESSi'JIT TRCCS ANT OF A SPECIFIC 
- ATRFNORECjSFTOR TLOŒCINC TRUC.
Animals
A separate group of four male gre^/honnds, all weighing between 
20 and 30 kg* were used in this study.
Methods
Packed cell volrjues and total pl.asma protein concentrations 
were measured as described previously.
Degree of tranquillisation where relevant v/as assessed using 
the visual score as in sections 8.3 and 8.1|_.
Xylazine (lO^) Bayer Agrochemical Ltd,
Chloral Hydrate {^ C^P/o : w/v) May and Baker Ltd,
Valium : diazepam (3 mg/ml) Roche
Phenoxybenzamine hydrochloride Smith, Kline and 3?i?ench Ltd.
The drug (300 mg) was dissolved in absolute alcohol (11.9 ml), 
propylene glycol (l3.6 ml) and N'/1 hydrochloric acid (0.3 ml) to 
give a solution of 10,7 mg/ml.
Chloral hydrate was administered at a dose rate of 80 mg/kg
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by slow intravenous injection i.,over a period of 3 min) ij*. a 
volume of 20 ml. sterile saline, diazepam at 2 mg/kg by intravenous 
injection, Dç/lazine at 3 mg/kg b'y intramuscular injection ann
pheno%yb enz amine at 2 mg/kg by slow intravenous injection (over 2
min) in 20 ml. sterile saline.
Experimental Procedure
Samples for P.C.V. and T.P.P. es Miration were talc en from the
dogs at rest before commencing the experiment.
Each drug was administered to all four dogs on separate 
occasions and blood samples were collected at 1^ , 30, ^0, 9^
and 120 min after drug injection,
A period of seven days was always allowed between drug 
administrations,
Results
BEHA.VIOURAL SIGNS (TABLE 8.3)
The onset of action was slower following xylazine administration, 
1^-20 min as compared to less than 3 min following chloral hydrai-e.
The behavioural signs produced by both drugs were however similar to 
those seen after acepromazine and azaperone. Diazepam on the other 
hand produced none of the behavioural signs seen following the clher 
drugs. Three of the four dogs receiving diazepam became markedly 
ataxic within 20 min of injection and began to struggle. This 
behaviour lasted between 13-20 min but the animals continued to be
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im/.7teady on their feet throughout the two hour period especially 
when disturbed for blood sampling.
PhencxybenKumine produced slight signs of tranquillisation, in 
all the dogs similar to those seen following rylazine, chloral 
hydrate, acepromazine and azaperone. These effects lasted 
throughout the two hour period.
PACKED CELL VOLUME (TADLE 8.I0)
P.C.Ve levels remained unchanged throughout the two hours 
following 2£ylazine administration and appeared to decrease slightly 
between 60 and 120 min after diazepam injection. Following chloral 
hydrate the levels were significantly below resting (pre-injection) 
values between 30 and 60 min (p 0.0^) but had returned towards
control levels by the end of the two hour period.
After phenoxybenzamine injection P.O.Vi values fell 
sigrEficontly (p 0.001 ) within 1^  min and remained decreased 
throughout the experiment.
TOTAL PLASMA PEOTEIh (TABLE 8.11 )
T.P.P, levels decreased slightly following diazepam injection 
and significantly (p 0.05) 60 min after chloral hydrate 
administration. Following phenoxybenzamine levels also dropped and 
were significantly below resting values between 30 and 90 min after 
injection (p ^  0.02).
There ’were no alterations in T.P.P. levels following xylazine 
premedicat:' 01 l.
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8,7 Discussion
.bi?om these studies, it 'would appear tlmt the fall in f,C.V, 
levels recorded following premedication with certain drugs is due 
either to uptake of red cells by the spleen or to a haemodilution 
effect since cn most occasions a decrease in ?.0.V« was accompanied 
by a fall in T.P.P, levels. Both effects could be accounted for 
by locaj. oL - adrenoreceptor blockade brought about by the drugs or 
to a centrally induced reduction in sympathetic activity.
The smooth muscle of the splenic capsule in the majority of 
species is rich in d, - adr'enoreceptors (Davies and Vithrington,
1973) and the contractions induced by adrenaline are mediated 
througn. these receptors.
Lippay, Mtchell and Potter ^195^) first described reversal of 
adrenaline-induced contractions ot the splenic capsule in cats 
using yohimbine, dibenamine and the ergot alkaloids. More recently, 
Dooley, Hecker and Webster (197^0 described the effects of excitement 
and adrenaline on the splenic capsule in sheep. They recorded 
decreases in the thickness of the spleen following both adrenaline 
and excitement and also that the increase in venous haemoglobin 
concentration which followed splenic contraction returned to control 
levels after the spleen thickness had been restored to resting 
values.
Torten and Schalm (I96J4) and Perssn^. (19^7) and Persson, Ekman, 
Lydin and Tufuesson (1973) demonstrated, an increase in venous 
haematocrit in horses following exercise and adrenaline administration. 
The increase after the latter has been shown to be due to release of
172
red blood cells from the spleen since Persson ed al (197^0 sbo^sed 
that this was abolished by splenectomy of the animals, Tamex 
and Hodgetts (1939) made similar recordings in sheep fallowing 
exercise and adrenaline administration.
The effects of various phenothiazine tranquillisers in reversing 
the adrenaline-induced rise in P.CrV, have also been reported.
Turner and Hodgetts (I960) demonstrated this effect following 
chlorpromawine (0,lj.6 to 0.7 mg/kg) in sheep, and De Moor and Van 
den Hende (I968) noted a similar effect in horses and cattle 
following injection of a mixture of propionylpromaaine and 
promethazine although in this case bhey reported that there was no 
change in plasma volume. In cattle Gartner et al (19^3) reoordcl 
decreases in venous haematocrit after chlorpromazine injection and 
noted that these changes were less in splenoctomi.sed an.imals.
Collette and Meriwether (19^3) reported that chlorpromazine, 
propionylprcmazine and promazine administered separately to dogs 
all reduced the venous haematocrit and caused splenic enlargement 
which was visible on X-ray,
Less work has been carried out using the butyrophenone 
tranquillisers but a fall in venous haematocrit has been reported 
following droperidol administration in man (Aronson, Magora, and 
Landon, 1970). A fall in haematocrit has also been recorded in 
ponies following azaperone injection (Lees and Serrano, 197&;
Serrano and Lees, 197&).
Results of the current study indicate that acepromazine and 
azaperone both produce decreases in P.O.V. in ponies and dogs cind
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that in the range of doses employed in this study these effects 
appear to be independent of dose rate. Decreasing closes of both 
drugs produced reductions .In P.ChV. levels in ponies even when no 
obvious central depressant effects were visible (0.06 mg/kg 
acepromazine and 0,09 mg/kg azaperonej and similar findings were 
recorded following two doses of acepromazine in the dogs. This 
suggests that the mechanism producing the alteration in P.C.V, 
is not related to the central depresscut activity of the drugs as 
has been previously reported, (Turner and Hodgetts, I960) and this 
aspect of the study will be discussed in more detail later.
As well as blocking the ~ adcenoreceptors locally ±1 the 
splenic capsule, acepromazine and azaperone will block peripheral 
sympathetic vasoconstrictor receptors and produce a slight decrease 
in blood pressure. This effect in turn could lead to an alteration 
in plasma volume brought about by the fall in capillary pressure and 
a transfer of protein free filtrate from, the interstitial spaces 
into the vascular system (Dalton, 1972).
Increases in plasma volume have been reported in man following 
treatment with guanethidine. and adrenergic neuron blocking agent 
and phenoxybenzamine a specific oL -■ adrenergic receptor blocker 
(Weil and Chidssey, I968), Alterations in plasma volume have c.lso 
been previously reported, following administration of certain 
tranquillisers. Turner and Hodgetts (I960) recorded that plasma 
dilution caused by a water shift across the capillary bed accounloi 
for only a small part of the fall in haematocrit produced by 
chlorpromazine injection in sheep and.De Moor and Van den Hende
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(I9c8) reported no change in plasma volume In horses after 
administration of a mixture of propionylpromazine and promethazine. 
Gartntr et ad (19^3) on the other hand recorded a fall in serum 
protein concentration following tranquillisation with chlorpromazine 
in cattle cOid Dalton (1972) reported decreases in plasma protein 
concentrations and venous haematocrit in horses after acepromazine 
injection.
In. these studies, both acepromazine and azaperone produced 
decreases in T.P.P, concentrations, ahe greater of these reductions 
occurring following injection of azaperone (0.7 mg/kg to the ponies 
and 0.3 aig/kg to the dogs). This is interesting since Lees and 
Serrano (197^) reported no similar choiiges in ponies after dose 
rates of O.Ij. mg/kg azaperone and only a small drop (1.^) in 
T.P.P. concentrations after 0.3 mg/kg. There is however no apparent
reason for the difference between the results of Lees and Serrano 
(I97&) end those recorded in this study.
The decrease in T.P.P. levels recorded in this study suggest 
that haemodilution could be responsible to some extent for the fall 
in P.C.V. noted following both acepromazine aid azaperone 
administration. However as the reduction in P.C.V. was in both 
cases much greater than the fall in T.P.P. l-his would suggest that 
some other mechanism such as relaxation of tae splenic capsule must 
also be involved.
Azaperone produced slightly more n’erlced effects on both P.C.V, 
and T.P.P. than acepromazine suggesting that of the two drugs the 
former possesses the greater 'pL - adreoi. receptor blocking activity.
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Serrano and Lees (197&) however recorded that azaperone (0,8 mg/kg) 
was less effective than acepromazine (o,1 rag/kg) in suppressing the 
pressor effects of adrenaline although it was the more potent- 
hypotensive agent of the two. They concluded therefore that 
azaperone mighi. also exert a centrally mediated depression of 
vasomotor tone. This might explain the greater effects &:i\ P.C.V. 
and plasma protein concentrations recorded in our animals after the 
higher doses of azaperone (0,7 mg/kg). Both acepromazine and 
azaperone share many pharmacological actions (chapter 7) and it is 
possible therefore that both drugs will exert some degree of central 
depression of the vasomotor centre. The exact mode of action of 
this effect is unknoym,
Further evidence that the spleen is involved in producing the 
reductions in P.C.V. levels found is provided by the experiment on 
splenectomised dogs which showed that removal of the spleen 
abolished the effects of acepromazine on P.C.V, In addition i;he 
experiment on the rabbit, known to have a very small splenic reserve, 
showed that acepromazine and azaperone produced only small decreases 
in P.C.V. The alterations which did occur in the latter experiment 
were probably due to a haemodilution effect since T.P.P. levels also 
decreased quite markedly probably due either to peripheral or central 
actions of the drugs on sympathetic tone.
Turner and Hodgetts (I960) suggested that the effect of 
tranquilliser drugs in producing a fall in P.C.V, was due not to 
their oC - adrenergic receptor blocking activity but to their 
central depressant action. They maintained that an animal in the
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no.;TTial resting state is always under a certain degree of sympathetic 
stimulation and that by administration of these drugs this adrenergic 
tone in the splenic capsule was removed and consequently that rbe 
packed cell volume would decrease.
The three dnrugs investigated in expei'lmont 1| were chosen for 
their potential central depressant qualities and lack of adr-ensrgio 
blocking actions. All have been used previously in animals to 
produce various stages of tranquillisation or narcosis at dose rates 
simrJar to or above those used in this study (Lumb and Jones, 1973)»
Jn thi.s study diazepam (2 mg/kg) failed to produce obvious 
signs of sedation in any of the dogs. This is interesting since 
Karol, Brown and Sletten (I968) reported behavioural changes in dogs 
foil offing 1 mg/kg and Dodman (personal communication) also recorded 
sedative effects in dogs at this dose level. The benzodiazepines 
in general (including diazepam) have been found to produce some 
degree of muscle relaxation and ataxia in man and this has been 
attributed to a potent central effect (Greenblatt and Shader, 1973; 
Goodman and Gilman, 1973)« This action would therefore explain 
the ataxia recorded in three of these dogs. It is possible that 
there could be a breed difference in susceptibility to these agents - 
previous workers have used mongrel dogs whereas in this study 
greyhounds were used.
The sedative effects of both xylazine and chloral hydrate on 
the other ‘•'isnd were similar to those reported by other workers in 
dogs (Lumb and Jones, 1973) and also to those of acepromazine and 
azaper^no recorded in sections 8.3 and 8.J4.
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Apart from depressant actions similar to acepromazine and 
azaperone only chloral hydrate produced a fall in P.C.V. and plasma 
protein concentrations similar to tnose recorded in our earlier 
studies (sections 8,3 and 8,^7, This was probably due to the 
central depressant action of this drug on the vasomotor centre 
resnJ.ting in a fall in blood pressure. The hypotensive effect of 
chloral hydrate is normally associated with anaesthetic doses of 
the drug (Goodman and Gilman, 1973; itmib and Jones, 1973)’ The 
loss of vasomotor tone would also accornb for the fall in plasma 
protein concentrations recorded with this drug. These could be 
caused by a transfer of fluid into the vascud.ar system across the 
capillary membranes (Dalton, 1972). The percentage decrease In 
P.C.V. compared to that in plasma protein concentrations at 60 min 
post injection was very similar (6% and 7% respectively) sugges W.ng 
that increased plasma volume was responsible for the fall in 
haematocrit.
Diazepam produced a slight decrease in both P.C.V, and plasma 
protein concentrations but this alteration was very small. In man 
the benzodiazepimies are generally considered to exhibit few 
haemodynamic properties (Greenblatt and Shader, 1973)* They have 
however been reported to produce transient hypotension in conscious 
and anaesthetised dogs (Abel, Reis and Staroscik, 1970; Bloor,
Leon and Walker, 1973) and these effects have been attributed to 
some direct action of the drugs (particularly diazepam) on post 
ganglionic adrenergic and cholinergic vasodilating mechanisms.
If this is the case then a transfer of fluid into the vascular
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system as a result of the lowered capilla.r;/ pressure cou'-d have been 
the cause of the slight alterations in P.C.V. and plasma protein 
concentrations recorded in tim s study,
Xylazine was the only one of the three drugs wbjch did not 
produce any effect on either of the parameters monitored. This is 
interesting since it is reported to have central inhibitory effects 
on the vasomotor centres of the brain stem in anaesthetised dogs 
and cats (Schmitt et ad, 1970) and has been recorded to produce a 
fall in PoC.V, in cattle (be Moor and Desmet, 1970» The dose 
rates administered in this study were higher than any of those used 
by previous workers suggesting that if anything the response in our 
dogs should have been more marked. In any of our experimentaJ. 
work however involving the use of xylazine in horses we have not 
recorded any alterations in either P.C.Vc or plasma protein 
concentrations and it would appear that further detailed studies 
into the hypotensive effects of this drug are required.
From the results in this experiment it has been shown that 
the fall in P.C.V. recorded following acepromazine and azaperone 
is not due to their central depressant effects but to an oi.
- adrenergic receptor blocking action. In order to complete this 
investigation phenoxybenzamine (a specific oC - adrenergic receptor 
blocking agent) was administered to the same four dogs. It was 
intended to demonstrate with this drug similar decreases in P^O.7, 
to those recorded following acepromazine and azaperone. Although 
phenoxybenzamine did produce highly significant decreases in both 
P.C.V, and plasma protein concentrations it also produced a degree;
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of central nervous depression only slightly less than that recorded 
following acepromazine, azaperone, xylazine and chlooral hydrate.
T’o'is central depressant action of phenoxybenzamine has been recorded 
previously in man (Lewis, 1971) and is considered to be due not to 
the oC - adrenergic blocking properties of the drug but to some 
non-specific central effect. Because of this central depressant 
effect however it was impossible to directly compare the (d - 
adrenoreceptor blocking properties of phenoDq/'benzamine with those 
of acepromazine and azaperone without the possibility of central 
acLions being involved.
Suûjmary
It would appear that the ~ adrenoreceptor blocking actions 
of acepromazine and azaperone are responsible to a great extent for 
the reduction in P.C.V, produced by both, drugs. These effects are 
probably mediated through relaxation of the splenic capsule and to 
a lesser degree haemodilution due to peripheral reduction of
vasomotor tone. Whether or not central reduction of sympathetic
tone is also involved is not certain but the effects do not appear 
to re linked to the central depressant actions of the drugs as 
assessed by the behavioural changes in the animals concerned.
9. m]ROLliîPTMALGBSIA
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9 » 1 Introduction
In the pa.st fifteen years a ni'uiiber of new drug comb.inat.1one 
have been introduced to produce a state of neuroleptanalgesia in 
various animal species, Neuroleptanalges.ia is a state of profound 
central nervous depression and analgesia (Lumb and Jones, 1973)*
The drug mixtures which resul.t in this effect combine a narcotic 
analgesic with a tranquilliser and a number of different narcotic 
analgesics and tranquillisers have been used in combination.
In the veterinary field the most commonly used narcotic 
analgesic in the United Kingdom is etorphine hydrochloride. This 
is one of a group of derivatives of 6,1)4 - endo-etheno-tetraJriydro- 
oripavine reported to have analgesic properties 3>000 - 10,000 himos 
greater than morphine on a weight basis (Lister, 196^1 Blane,
Boura, Fitzgerald and Lister, I967). The oripavines have structural 
similarity to morphine and are all derivatives of thebaine, an opium 
alkaloid with no therapeutic activity (Lister, I96J7). The 
oripavines however and especially etorphine have been shovm. to 
exert pharmacological effects on laboratory animals which are very 
similar to those of morphine (Blane et al, I967). At low doses 
they produce analgesia, depression of the respiratory and cough 
centres and inhibition of gastrointestinal motility » all sigis 
characteristic of morphine like drugs. At higher doses howevnr 
they will eventually produce recumbency (Lister, I96i|) probably d n  
to increased central depressant effects although other actions such 
as muscle relaxation may also be involved (Lees and Hillidge, 1976) .
1 8l
Etorphine has been widely used for the capture and restraint
of wild animals, its characteristics of very high potency and
therefore small volume required making it ideal for this purpose
(Harthcom and B'’igh, 1963; Pienaar, Van Mekerk, Young, Va44 V/yk
and Eairall, I966; Keep mid Keep, 196?; Wallach, Frueh and Lentz,
1967). Etorphine has been combined with a number of butyrophenone
<£-
and phenothiazine tranquillisers to produce neuroleptanlgesia 
(Harthoorn, 1963; Keep end Keep, I967).
A considerable advantage of neuroleptanalgesia combinations is 
that the actions of the narcotic analgesic can be reversed, Blane 
et al, (1967) have shown that nalorphine will antagonise the effects 
of etorphine as readily as those of morphine. However the h - 
cyclopropylmethyl - analogue of etorphine (diprenorphine) shows 
enli.anced activity as an antagonist over nalorphine in similar 
fashion to etorphine over morphine with the result that the 
antagonist supplied with etorphine can be given in equally small 
doses.
It is interesting that the effects of etorphine vary 
considerably between species, Harthoorn (1963) recorded the 
effects of etorphine at various dose rates ranging from those just 
sufficient to abolish postural reflexes to those high enough to 
produce deep narcosis in domestic animals. He reported an increase 
in heart rare in donkeys and cattle, a decrease in respiration in 
donkeys and goats and a complete abolition of postural reflexes in 
donkeys and horses resulting in the animals falling to the ground. 
Blane et (I967) on the other hand working with laboratory species
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described bradycardia aid hypotension in rats, dogs, cats and 
moniceys and attributed these effects to a morphine - type-induced 
increase in vagal tone.
■ A combination of etorphine and acepromazine was introduced 
(’Immobilon’ ? Large Animal) about ten years ago. Preliminary 
investigations carried out by Hillidge and Lees (197/) and results 
reported by other workers (Daniel and Ling, 1972; Jexokins, Crooks, 
Charleswurth, Blane and Ling, 1972; Schlarmann, Gorlitz, Wintzer 
and Frey, 1973) showed that ^Limobilon^ administered to horses 
produced marked increases in heart rate, blood pressure, muscle 
activity and muscle tone throughout the period of recumbency along 
with respiratory depression.
In this study the effects of etorphine alone on the 
cardiovascular, respiratory and endocrine systems were assessed, 
also the modifications if any which occurred in these actions 
following administration of various tranquillisers in combination 
with etorpliine.
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9.2 THE EFFECTS OF ETORPHIHE MD ' IMMDHILOH' OH MHS Cl F ACTIVITY 
AND TOHE, HEiiRT AND RESPIRATORY RATES, BLOOD PRESSTOE, P.C.V. 
PLASMA 11.'.0H0S AH'O FOR ^DREKALIHE LE\CELS IH POHIES
Materials
Etorphine Base (22.3 mg/ml). Made up in steriH.e normal saline 
for injection,
Reckitt and Colman, Pharmaceutical Division, Hull.
'Immohilon* ; large minimal - Each ml. containing 2.I4.3 mg. (0.223% 
etorphine base), 10 mg. acepromazine maleate B.P.C., chlorocresol
0.1% saline.
Reckitt and Caiman, Pharmaceutical Division, Hull.
(Revivon^ ; large Animal. Each ml. containing diprenorphine 3 mg, 
as hydrochloride, methylene blue 0.001%, chlorocresol 0.1%
Reckitt and Colman, Pharmaceutical Division, Hull.
Animals
All three ponies (Hos. 1, 2 and 3) were used in this study. 
Methods
Electrocardiograms were recorded from each pony by radio-- 
telemetry as described in Chapter 1. Average heart rates were 
then calculated at specific times by counting the number of beats
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over a 80 second period.
Arterial blood pressures were recorded as described previoasly. 
Blood samples for plasma 11-OHCS and P.C.V. determinations 
were collected as described in prior experiments, Sanples for 
nor-adrenaline estimation were collected into ice-cold heparinised 
glass tubes and centrifuged at C. Tb-'--’ plasma was removed as 
quickly as possible and stored at -13° C.
Blood samp3.es before immobilisation and after recovery were 
taken by venepuncture from the left juguJ-ar vein. Because of gross 
fasciculations during neuroleptanalgesia blood samples throughout 
this period were collected via the arterial cannula.
Respiratory rates were counted visually over 60 second periods. 
Experimental Procedure
The animals were fasted throughout the experimental period.
Blood samples for plasma 11-OHCS and P.C.V-. estimations were 
collected from all the ponies before the start of the experiment 
with as little disturbance as possible, at 3 and 20 min after 
etorphine injection and 3 min after administration of the antagonist. 
Samples for plasma nor-adrenaline measurement were taken at similar 
times from two ponies (Nos. 1 and 3)*
Heart rates and arterial blood pressure were monitored 
continuously prior to and throughout the period of recumbency 
and for 10 min after injection of the antagonist.
Contrul (resting) blood samples and heart rates were all 
taken prior to cannulation of the artery and the ponies were allowed 
to stano. for 30 lüin after this procedure before drug administration.
1 8'
Etorphine was administered intravenously at a dose rate of 
22,3yhg/kg> as rapidl.y as possible. This was equivalent to the 
amount present in the recommended dose of ’Immobilon’ and also 
that used by other workers (Daniel and Ling. 1972).
Imniobilon was injected intravenously at the recommended dose 
rate equivalent to 22.3yjg/kg etorphine and 0.1 mg/kg acepromazine.
The effects of both drugs were terminated 30 min post- 
injection by intravenous administration of the antagonist diprenor­
phine at dcse rates equivalent to 30,H g/kg»
/
ResulLs
CLINICAL SIGHS
i) Etorphine
All three ponies became recumbent within 1-1-ÿ min of etorphine 
injection and showed a marked degree of muscle activity and increased 
muscle tone. These effects lasted throughout the 30 min period of 
recumbency but muscle activity became more violent during the last 
3“10 min. Paddling of the fore and hind limbs also occured during
this time. One of the three ponies (Hu. 2) although in a gravely
depressed state made continous efforts to stand. Sweating 
occurred moderately around the head, neck, axillae and groin 
regions.
Injection of the antagonist produced visible increases in 
respiratory rate within A3 - 60 seconds and the animals were able 
to stand within 2~l\. minutes.
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ii) 'Immobilon’
All three ponies 'became recmibent within 1 min of 'Immobilon' 
injection and showed signs of increased muscle activity and tone 
throughout the initial 13 min period.
All three animals were observed tc.' be sweating moderately 
around the head, neck, axillae and groin regions within JO min. 
Muscle relaxation appeared to be bebter than with etorphine alone 
(experiment 1) and muscle tremors were occasional. Resplbatory 
rates increased within 30 - A3 seconds of diprenorphine administrat­
ion and within 3 min the animals were able to stand, Althc/agh the 
initial knock-down effect of the drug hed been counteracted, e-ll 
the ponies showed signs of tranquillisation viz. head down, ears 
and back and penile relaxation. These effects lasted for 2 - 3  
hours.
HEART RATE (FIG. 9.1)
i) Etorphine
Etorphine produced heart rates significantly elevated above- 
resting values (p ^  0.03) within 3 min of injection. The rates
remained high over the remainder of the 30 min period, increasing 
sharply between 20 and 30 min after etorphine injection and reaching 
maximum levels 2 min after diprenorphine administration. All 
these values were significantly above resting levels (p /  O.OOi). 
By 3 min post-diprenorphine the rate had begun to fall towards 
control values. Marked sinus arrythmia occurred throughout the 30 
min period (Pig. 9-A)*
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ii) ’Immobil^n'
Heart rates were significantly elevated above resting (pre­
injection) values throughour the 30 min period of recujnbenoy 
(p 0.01). The heart rates were highest during the first 10 
■min following Immobilon injection and decreased gradually imtil 
administration of the antagonist. Five minutes after diprenorphine 
injection they were still significantly elevated (p ,/ 0,02).
Marked sinus arrythymia was present throughout the JO min recumbency 
period (Fig. S.h)»
AHTEhlAL HLOOD PHESSUHE (FIG. 9-2)
i) Etorphine
Blood pressure increased after etorphine injection ~ reaching 
a peak within 6 min an.d remaining elevated throughout the JO min 
period-, All these levels were significantly elevated above 
resting (pre-injection) values (p <(_ 0.01 ). Five minutes after 
diprenorphine administration blood pressure had fallen markedly but 
was still significantly above resting values (p ^  0.02).
ii) ’Jrijinobilon'
Blood pressure increased after ’Immobilon* injection reaching 
its highest level within J min. This value was 1^0% above resting 
(pre-injection) levels. By 10 min post-injection the pressure 
began to decrease and continued to fall gradually although still 
92% above resting values immediately prior to injection of the 
antagonist.
CM
I
z
g
Puui
À-1Z
O
CO
£
z
oo
<
H
z
<
H I
z
I
û
o o oo
CO ocs| o
Bhiüuj gwnSSHHcl Qooia ivmHiw
188
PACKED CELL VOLTM0 (TABLE
i) Etorphinc
P.C.Vp levels insieris^’d s i . f  1 cantly above restin,e values 
throughout the 30 min following etorphine administration (p 0.001) 
and wore still sign]ftcankly elevated ^ min afuer diprenorphine 
injection (p 0.001),
ii) ’Immobilon'
P.C.V. increased to a significant level above resting values 
(p 0,01) within 5 min of 'Immobilon’ injection and. were still 
elevated Ip min later. Eive minuxes after administration of the 
antagonist the P.0.7. had fallen to a level significantly below 
resting values (p 0.01 ).
EESPIRATORY RATES (TABLE 9.2)
i) Etorphine
Respiratory rates fell significantly below resting values 
(p "C 0.02) throughout the 30 min period of recumbency. Cyanosis 
was apparent in pony No. 3» Within 5 min of diprenorphine injection, 
respiratory rates had increased significantly above resting values
(p {  0.05).
ii) ’Immobilon'
Marked respiratory depression was apparent in all ponies after 
'Imraobilon' injection and cyanosis was visible in one of the three 
(pony No. 3)* Respiratory rates decrea&ed significantly (p 0.0^) 
below resting values to levels of 1-2 respirations/min throughout 
the period of recumbency. After diprenorphine injection however 
the rates increased markedly to levels significantly above resting
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vaJ.uas (p 0.05).
PLASMA 11-ÛHCS (PIG. 9.3)
i ) Etorphine
Plasma 11-OIICS levels increased to a tnarimum 20 min after 
etorphine injection. These values together with those recorded $ 
min after diprenorphine administration were significantly ahove 
resting levels (p <2 0.01).
ii) ’Immohilon’
Plasma 11-OHCS levels increased gradually throughout the period 
of recumbency being significantly elevated above resting values 20 
min after 'Immobilon' injection (p 4^  0.05). Pive minutes after 
diprenorphine administration the levels were at their highest.
PLA&.MA NORAPKENAJAKS (TABLE 9.3)
i) Etorphine
Marked increases occurred in both ponies, the highest levels 
being recorded within 5 min of etorphine injection (1^1% and 18142% 
above resting values respectively). Values were still increased 
20 min later (142% and l40l|% respectively) but had fallen to almost 
resting levels within. .9 min of diprenorphine injection.
ii) ’Iromobilon'
Increase in plasma nor-adrenaline levels occurred in both 
ponies c.u-ring the period of recumbency, marimum values being 
recorded ai 5 min post Immobilon when levels were 1^0% and 14814% 
respectively above pre-injection values. By 20 min post Immobilon
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the levels v,ere considerably loxvcr than at 5 ciin post luraohilon and 
after administration of the antagonist were at or below resting 
vaincs.
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9,3 EFFECTS OF PREMEDICATIOF WITH VARIOUS TRAUQ.UILLISEHS ON THE
ACTIONS 01' ETORPHINE IN PONTES
In the previous experiments the actions of 'Immobilon* were 
compared with those of etorphine alone and it has been shox/n that 
acepromazine injected simultaneously with etorphine does modify a 
number of the effects of the latter.
It is known that the maximal central effects of acopromazine 
do not occur until between 10-1$ min after intravenous injection 
since it is at this time that drooping of the head and penile 
relaxation occur. It appeared therefore that prior administration 
of the tranquilliser and injection of etorphine at the time 
corresponding to the peak central effect of the tranquilliser would 
prove a more successful means of administering the drug combination. 
There was also the possibility that acepromazine or any phenothiazine 
tranquilliser might not be the drugs of choice for inclusion in the 
mixture and that one of the butyrophenones, in particular azaperone, 
or the unrelated drug xylazine, might be more suitable.
Tills experiment was designed to compare the actions of etorphine 
(administered intravenously) with those of:-
i) etorphine alone (i/v) after intravenous premedication with 
acepromazine, azaperone and xylazine,
ii) etorphine alone (i/v) after intramuscular premedication with 
acepromazine, azaperone and xylazine.
Effects on heart rate, respiratory rate, muscle tone and 
activity and sweating were assessed.
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juiimals
Two ponies (Nos. 1 and 3) were used in this study.
'Recordings
Heart rates were recorded by radiotelemetry as described 
previously,
Bes,piiatory rates were measured by visual estimation over a 
period of 30 seconds.
Muscle tone and activity and sweating were assessed visually 
and graded according to a scale.
1. Muscle activity
+ legs and head shalcing occasionally
+H* legs and head shaking continuously
+++ legs and head shaking violently
2. Muscle tone
+ all relaxed
++ legs relaxed
H-++ legs and neck tense
3. Sweat
4- damp around groin and axillae
4-f damp all over
4-4-4' drops of sweat on body
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Drug's
The drugs used, their dose rates, routes of administration and 
time of administration before etorphine and diprenorphine are shown 
in Table 9»U- Etorphine and diprenorphine were given at the sarae 
dose rates as previously. Acepromazine, azaperone and :rylazine 
were administered intravenously at dose rates either slightly below 
or similar to those used in other studies (Jones, 1972; Kerr ejt ad, 
1972; Hoffman, 1974; Hillidge, Lees and Serrano, 197$) and 
intramuscularly at the dose rates recommended by Aitken and Sanford 
(1972) and Lees and Serrano 
Experimental Procedure
This study was carried out on a separate occasion from the 
previous experiments and therefore for comparative procedures the 
results concerning administration of etorphine alone are reported 
again.
Heart and respiratory rates were recorded from the animals at 
rest before the experiment, throughout the period of recumbency and 
for 10 min after administration of the antagonist.
Etorphine was injected intravenously at the time of maximum 
effect of the tranquillisers and assessed in a, previous experiment 
(chapter 8). Times of etorphine administration after intravenous 
and intramuscular premedication with 3 drugs are shown in Table
9.$.
Etorphine alone was given to bofd -conies and the antagonist
g
•r!i
m
44
0
CO1 )
I
fd
<j
1 
Iw
r§
i
■B
"%
o
-p
u0
U 
g
•H
d
d 
1 
K 
g
'd
(U
d
w
A
-d-
o\
CD
rH
«
-P
C v J
C M
- P
C M ■LA
OO
0)I
I
§
t
■g
g
"S0
‘d0)
1
I
i
g
■H
-P
ü
Û)•ra
.g
II
Io
o
«H
O
raû)
a
E4
\r\
ON
m
H
«
E4
(D
a
i
&
§
d
MD
-P
O
CM
OJO
o
-p
■H
P
•H
94
was not administered until signs of recovery were seen, Following 
premedication with the tranqnillisers prior to etorphine, the ponies 
were allowed to remain recwmhcnt for f>0 min imloss showing signs 
of spontaneous movement before this.
Each uranqui11iser was administered once intramuscularly and 
once intravenously to both ponies and at least I4 days was allowed 
between exneriments.
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Be suits
1. Etorphine alone
CLIhlCAL SIGFS (TADLÏÏ 9.6)
In both ponies etorphine produced I'ecumbency lashing between 
25 ~ 30 min after this time they began to paddle violently with 
fore and hind legs. Increased muscle activity and tone and 
sweating^apparent throughout the period of recumbency.
HEAIil' RATS (TABLE 9.7)
Ebox'phine produced an increase in heart rate of 2l|.0%
(equivalent to I6J4 beats/min) at p min post injection. The rate 
then fell gradually, but was stil], elevated by 1 2 0  min after 
etorphine. Between 2^ and 30 min post-injection the rates increased 
to liil]. beats/min (an elevation of 200^o above resting values) and 
remained high until after diprenorphine injection.
Sinus arrythmia was present throughout the period of recumbency 
(Fig. 9.U).
EBSPIEATOEY RATES (TABLE 9.8)
Etorphine depressed respiration dui’ing recumbency. Rates 
increased markedly however after Injection of the antagonist being 
i;80% above resting values within 10 min.
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2, Intravenous premedd cation witli acepromazn.ne, azaperone and 
xylazine nrior to etorphine
CLIÏM'IGAL SIGNS (TABLE 9.6)
Azaperone and xylazine premedication produced satisfactory 
recumbency lasting for 30 lain only whereas following acepromazine 
reoumhency was satisfactory for up to 60 min when the experiment 
was terminated and the antagonist administered. All three drugs 
reduced the degree of muscle tone but only acepromazine and 
xylazine reduced muscle activi uy. Xylazine produced least 
sweating and acepromazine most in both ponies.
HEAET r^TE (TABLE 9.7)
The pre-etorphine heart rates were always between I;2 - I48 
beats/min. Azaperone premedication produced a maximum increase 
of 293% (173 beats/min) at 3 niin post— etorphine, acepromazine of 
23^^ (162 beats/min) at $ min post etorphine and xylazine of ^6% 
(94 beats/min) at 3 min post-etorphrne. In all cases the heart 
rates decreased gradually over the period of recumbency.
The greatest increase in hearu rate following administration 
of the antagonist was seen in the ponies premedicated with xylazine 
where rates of I38 beats/min (an increase of 187% above resting 
values were recorded). Acepromazine premedication also produced 
an increase at this time of 78% (81^. b=ats/min).
Sinus arrythmia was present in both ponies after all three 
drugs (Big. 9-U).
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RECORDS OBTAINED BY RADIOTELEMETRY : SINUS ARRYTHMIA
FOLLOVf'ING ETORPHINE WITH TRANQUILLISER PREMEDiCATION
MORSE 1 : 0-2mg ACEPROMAZINE/Kg
EC G
i'l i
SECS 
HEArrr rate 
/ m in
250-
125
HORSE 2 : 3 0mg XLAZIN£/Kg
11'E.C.G.
SECS 
HEART RATE
/min
100—
50—
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RGSPIÏÏATORY BATES (TABLE 9.8)
Respira+or^r rates were depressed thro-ughoiit recirnbency with all 
three drugs. After administration of the antagonist the rates 
increased to levels similar to Lhose recorded following etorphine 
.alone.
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3. Intraiauscular premedioat.lor.. with acepromazine, aaanerone and 
xylazine prior to etorphine
CLINICAL SIGNS (TABLE 9.6)
Azaperone premedication produced recumbency lasting fc?: approx. 
about jO min acepromazine and xylazine for approximately 60 min. 
Acepromazine and xylazine also produced complete relaxation in both 
ponies and reduced the degree of muscle activity. Xylazine and 
azaperone premedication resulted in less sweating than was seen 
following acepromazine,
HEART RA'IE (TABLE 9.9)
The greatest percentage increase in heart rate was seen 
following azaperone premedication when an elevation of 26lf/o (l6i| 
beats/min) was recorded 10 min post-otorphine. After acepromazine 
the increase was 2l[l4% (1I[I|. beats/min) 1 min post etorphine and after 
xylazine 126^ (IO6 beats/min) 1 min post-etorphine.
Sinus arrythmia was noted in both ponies (Fig. 9«U) following 
all three drugs.
RESPIRATORY RATES (TABLE 9.8)
Respiratory rates were depressed following etorphine administr­
ation in all three instances but increased after injection of the 
antagonist.
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9 .1| EFFECTS OF PREMEDICATIOE WITH aGEPHOMAZIFE OH THE
HYPERTEHSI\^ EI'TECTS OF ETORPIIIHE
Since the hypertension produoecL hy the Immobilon mixt'or'e is 
probably the most langerons side effech of Lhe nenroleptana.lgesic 
combination in that the few unexplained deaths which have occurred 
.following 'Immobilon' could be a consequence of such increases in 
blood pressure, it was decided to investigate in more detail the 
timing of tranquilliser administration prior to etorphine with a 
view to reducing this effect.
It has already been established (chapter 7) that acepromazine 
exerted a hypotensive effect in these ponies. This experiment was 
designed to assess the changes in blooa pressure produced by 
injecting etorphine at the time when these hypotensive actions of 
acepromazine were at their maximum.
Animals
Three ponies (Nos. 1, 2 and 3) were used in this study.
Methods
Arterial blood pressure were recorded as described previously.
Blood samples for plasma 11-OHCS levels and packed cell volum:cs 
were treated and the estimations carried out in the same manner as 
previously.
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Xtruffs
Acepromazlne and etorphine administered at dost rates
equivalent to those in the Immohilon mixture and diprenorphine was 
injected at the recommended dose rate (30^ju\g/kg).
Experimental Procedure
Blood pressures were recorded from the animals at rest and 
continuously throughout the study. Blood samples for plasma 11-0'ICS 
and P.O.y, estimations were taken before the experiment, ai: p and 
25 min after etorphine and 5 n%in after diprenorphine.
Etorphine was injected at 23" min after acepromasine (tl).e rime 
of maximum hypotensive effect - chs.pter 7)* The period of 
recumbency was terminated at 30 min after etorphine administration 
by injection of the antagonist.
A period of at least 10 days was allowed between experiments.
Results
CLINICAL SIGNS
As reported previously, acepromazine premedication decreased 
muscle activity and tone. The drug mixture produced moderate 
sweating in all three ponies.
BLOOD PRESSURE (TABLE 9.10 AND FIG. 9.5)
Arterial blood pressure was significantly lower 1 min post- 
etorphine than either following etorphine alone (p 0.01) or
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‘'.Ciiffiio'bi.lon ' (p ^ 0.05)c The j evels remained significantly lower
then those recorded following etorphine (p ^  0„05) and slightly
bftlcw those recorded after ’ I’limohilon’ throughont the 30 min period 
of recumbency. Within 5 m.in of injection of the antagonist the 
vaines had returned almost to resting (pre-injection) levels and were 
stilj significantly below (p 0.0^) those recorded following 
etorphine alone„
PLASFiA 11-ones (TABLE 9.11 )
Plasma 11-OHGS levels increased during the period of recumbency 
reaching maximum levels at 25 min post-etorphine injection. These
levels were higher than any recorded following etorphine or 
*Immcbilon’ administration (Fig. 9*3) e^ nd were still elevated 5 min 
after .injection of the antagonist.
PACKED CELL VOLDITE (TABLE 0.11)
Packed cell volumes increased to maximum levels within 5 min of 
etorphine injection. These values were sign.ificantly elevated above 
resting levels (p <( 0.01) but were lower thai those recorded
following etorphine or 'Immohilon- administration at the same time 
(Table 9.l). Ey 25 min post etorphine the P.G.V. had fallen slightly 
and at 5 min after antagonist .injection was significantly below 
resting (pre-experiment) levels (p 0.02).
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9*5 e f f e c t of P.RETEEA'IMEM' w i t h t h e B-ADHEWERGIC BLOCKING AGEÜT 
PEOFRAFOLOL ON THE TACHYCAEDIA PROLIJCEL BY ETORPHINE
Propranolol has been used by previous workers (Daniel and Ling, 
1972; Schlarmann et ad, 1973) to successfully reduce the tachycardia 
produced following 'Iinmobilon' administration. It was used in this 
study to compare its effect on the heart rate increase with those 
of the three tranquillisers and in particular xylazine,
Anijuals
Three ponies (Nos. 1, 2 and 3) were used in this study.
Methods
4.11 heart rates, blood pressures and blood samples were 
recorded and collected as described previously.
Drugs
Propranolol Hydrochloride," Imperial Chemical Industries Limited.
Propranolol was dissolved in saline to a concentration of 20 
mg/ml The solution was then sterilised by passing through a 
’milliporc‘ filter.
Acepromazine, etorphine and diprenorphine were administered at 
the doso rates used in the previous study.
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Propranolol was injected at a dose rate of 0.2 mg/kg. similar 
to that used hy Daniel and Ling (19?2). It vra.s injected slowly 
into the vein over a period of 2-3 min, beginning 5 min before 
etorphine administration (Sohlarmann _et al^ , 1973)- 
Procedure
Heart rates and blood pressures were recorded from the animals 
at rest and blood samples were taken for 11~0EGS, nor-adrenaline and 
P.C.V. estimation.
Acepromazine was injected as in the previous study end heart 
rates and blood pressures continually recorded. Twenty minutes 
after acepromazine, the appropriate dose of propranolol was slowly- 
injected into the vein and at 25 min post acepromazine etorphine 
was administered.
Blood samples for 11-OHCS, nor-adrenaline and P.C.V. were 
talcen 5 and 25 min post etorphine and 5 min post diprenorphine.
The period of recumbency was terminated in all three ponies 
by injection of the antagonist 30 min after etorphine had been 
given.
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Results
CLINICAL SIGNS
Injection of propranolol 5 min before etorphine produced, no 
effect on muscle activity or tone nor on the degree of sweating 
recorded (as compared to the results of experiment J4).
HEART RATE (TABLE 9-12)
Dwring the 5 min immediately following propranolol injection 
there was no alteration in heart rate recorded. Three minutes 
after etorphine administration the heart rate increased to its 
maxim^um level (123 beats/min). This was a mean increase of 207% 
above resting values and was 93% below the level recorded at the 
same time following ’Immobilon’ injection (Eig. 9*1)• Throughout 
the 30 min period the heart rate remained ahcve resting values 
being very similar to the rates recorded following xylazine 
premedication (Table 9*9) but always below those foundafter etorphine 
alone and Immobilon. Injection of the antagonist did not produce 
further elevation only a more rapid return to resting (pre- 
injection) levels. Sinus arrythmia wa.s recorded in all 3 ponies 
throughout the 30 min period of recumbency,
BLOOD PRESSURE (TABLE 9.I0)
Arterial blood pressure did not change in the 5 min following 
propranolol injection. After etorphine administration however it 
rose to maximum levels within 5 min ( 130 - 2q mni Hg).Tliis value was 
similar to that recorded in the previous experiment (experiment I4) 
but significantly (p ^  0.02) lower was reported following
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etorphine alone and 10% lower than that seen after 'Immohilon' 
injection. Over the 30 min period, blood pressirre steadily decreased 
at a faster rate than was recorded in any of the préviens experiments 
and by 5 min post diprenorphine injection had returned almost to 
control vaLuos =
PLASMA 11-OKCS (TABLE 9.13)
Plasma 11-OHOS levels increased throughout the period of 
recumbency reaching maximum levels 2.$ min post-etorphine injection. 
These values were higher than those recorded following administration 
of etorphine alone (Pig. 9»3) but similar to those seen after 
'Immobilon' and were still elevated 5 min after injection of the 
antagonist,
PACEEB CELL VOLTME (TABLE 9.13)
Packed cell volumes were increased significantly above resting 
values 9 min after etorphine injection (p ^  0.01) to levels
similar to those recorded in experiment h (Table 9*11). Within 9 
min of antagonist injection, they had fallen to values significancly 
below control levels (p ^  0.02).
PLASM NOR-ABEENALIEE (TABLE 9.li|)
Plasma nor-adrenaline concentrations increased in both animals 
reaching a maximum in pony No. 1 at 2$ min post-etorphine (h-1032%) 
and in pony No. 3 at 9 min post-etorphine (+1368%).
Within 5 min of injection of the antagonist, the levels had 
returned towards resting (pre-injection) values.
These nor-adrenaline levels are similar to those recorded in 
the same animals following etorphine administration but slightly
206
higher than those seen after 'JLimohilon' (Table 9.3)
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9 o 6 DisGJ-ssion
In these studies administration of eborphine alone produced 
a greater degree of muscle activity and tone and larger increases 
in arterial flood pressure, packed cell volumes and plasma nor­
adrenaline levels than 'Immobilon'.
The most interesting observation in these studies was that both 
etorphine and *Immobilon' cause an. increase in plasma nor-adrenaline 
levels. This suggests that etorpnine either produces a centrally 
induced increase in sympathetic activity or that it causes release 
of adrenaline and nor-adrenaline directly from the adrenal medulla 
and post— ganglionic nerve endings. Increased sympathetic tone 
could also be due to the severe degree of hypoxia which was noted 
in these experiments and which ha,s also been recorded by other 
workers in horses (Hillidge and Lees, 1971 and 1975; Schlarmann 
et alf 1973)' The respiratory effects of etorphine will be 
discussed in detail in later pages but the presence of hypoxia must 
be considered as one of the causal agents of the increase in sympath­
etic activity which would account for a number of the effects 
recorded following both etorphine and 'Immobilon' viz. elevations 
in heart rate, blood pressure, packed cell volume, muscle activity 
and sweating (Hillidge and Lees, 1971 and 1975; Daniel and Ling, 
1972; Sohlarmann ejt ad, 1973)* It is unlikely however that 
hypoxia would have developed within 1-2 min of the animals becoming 
recumbent when the majority of these effects were already marked. 
Schlarmam'i ejt ad (1973) suggested tha.t ganglion stimulation was the
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cause of the symptomatology of ’Immohilon' administra.tj.on hut such 
an effect would probably occur in all species and would not account 
for the different reactions recorded by this and other authors in 
dogs, monkeys and rats (Blane pt al, 19&7).
Although the assay employed measured only plasma nor-adrenaline 
levels it can be assumed that adrenaline levels would rise in 
parallel since either central or local actions on the sympathetic 
system would stimulate the release of both.
Under normal conditions of nor-adrenaline and adrenaline 
release both amines are rapidly removed from tissues either by 
reuptake into storage granules or by breakdown by a number of 
enzymes (principally monoamine oxidase (M.A.O.) and Catechol - 0 - 
methyl - transferase, (C.O.M.T.) found in the liver and elsewhere 
in the body (Goodman and Gilman, 1975)- Under normal bodily 
conditions plasma levels of nor-adrenaline a,re low because breakdown 
and reuptaice occur rapidly at the site of action in the tissues.
It is only when marked increased sympathetic activity occurs that 
levels of nor-adrenaline in the circulation increase since too much 
is being produced to be removed quickly (Guyton, 1971).
Examination of the plasma nor-adrenaline levels recorded in 
this study following etorphine administration suggest that initially 
a large degree of stimulation occurred and that this decreased over 
the 30 min period. Consideration of the alterations in other 
parameters monitored shows that they too fit into this pattern..
Elevated levels of circulating catecholamines normally result 
in increased heart rate and blood pressure because of ^  - adrenergic
Î09
effects on the heart andof effects on systemic blood vessels 
(Goodman and Gilman, 197h). However these effects do not always 
parallel the levels of catecholamines in the intact animal because 
of reflex responses.
Stretch receptors in the carotid sinus and aortic arch exert 
a powerful influence on the cardioregulatory centres in the brain - 
decreases in blood pressure producing increases in heart rate and 
vice versa (Rusiimer, 1972). This regulatory effect on the hearb 
is mediated through the sympathetic and parasympathetic nervous 
systems, the former supplying excitatory and the latter inhibitory 
effects. A balance between these two systems normally exists but 
can be influenced by higher centres e.g. hypothalamus or cerebral 
cortex (Bronk, Pitts and Larrabee, Guyton, 1971).
Reflex actions on the heart in response to hypertension may 
explain why the tachycardia following etorphine alone was less than 
that following 'Immobilon'. The heart slows reflexly in response 
to hypertension and therefore following etorphine administration 
when the blood pressure was very high heart rate was lower than that 
seen after 'Immobilon* injection. Because of the hypotensive actions 
of a.c-epromaaine, blood pressure after 'Immobilon* is lower and there 
is less reflex control of -the heart thus leading to more elevated 
heart rates
A second reason for the increased heart rates recorded 
following acepromazine and azaperone premedication prior to 
etorphine could be a direct effect of the tranquillisers. Aitken 
and. Sa-'iford (1972.) reported changes in heart rate in horses after
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intravenous injection of adrenaline (0.2 mg per animal) before and 
after tranquillisation with acepromazine (0.2 mg/kg). The mean 
increase in heart rate produced by adrenaline alone wa.s 10% and 
following tranquillisation with acepromazine was 105%* They 
attributed tJr.is potentiating effect to an enhancement by acepromazine 
of the jb - receptor actions of adrenaline on the heart as described 
by Sutherland (1970).
These effects of acepromazine have been discussed in some 
detail in chapter 7 with reference to the increased sweating noted 
following premedication with both acepromazine and azaperone, cXf- 
adrenergio receptor blocking drugs and members of both the 
phenothiazine and butyrophenone groups of tranquillisers have been 
shown bo produce elevated circulating plasma levels of catecholamines 
either by increasing nor-adrenaline release from nerve endings 
(Cubeddu et al, 197U; Herbaczynska .and Stabzewska, 1972) or by 
reducing the uptake of catecholamines into tissues (Hertting et al, 
19^1 )• Because of the od - adrenergic blocking properties of 
acepromazine and azaperone it is therefore possible that these 
elevated levels of catecholamines wi'U exercise their greatest effect 
on the ~ receptors.
Unfortunately in this study plasma nor-adrenaline levels were 
not estimated following acepromazine and azaperone premedication. 
Following 'Immobilon' injection howavevihere was no apparent f v r  
elevation in circulating nor-adrenaline values suggesting that the 
higher heart rates were a result of the lower blood pressure levels 
recorded. Similar hypotensive effects of azaperone would also
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explain the tachycardia noted following administra.ticn of this drug.
Towards the end of the 30 min period of recumbency following 
etorphine administration, heart rates increased markedly. This 
effect occurred at the same time as all three animals began to show 
signs of increased activity viz. paddling with all four l^gs and in 
the case of one pony trying to stand up. The tachycardia could be 
due to elevated sympathetic activity in association with tho 
movement or more probably to the animals recovering from the effects 
of the analgesic and being aware of their surroundings with associat­
ed fear.
Xylazine premedication and pre-treatment with the specific 
^  - adrenergic blocking drug propranolol both reduced the tachycardia 
following etorphine administration. The mode of action of xylazine 
is not known, although it has been reported to exert central and 
peripheral effects decreasing sympathetic tone (Schmid-t et al, 197^). 
Such an action could bring about a reduction in heart rate and would 
also produce a decrease in blood pressure due to vasodilation.
Although blood pressures were not recorded in these experiments 
previous workers have demonstrated hypotension in horses following 
administration of this drug (Kerr _et 1972; Clarke and Hall.
1969).
Propranolol blocks both D.j and receptors in the body (Lands,
Arnold, McAuliff, Luduena and Brown., 1967; Goodman and Gilman.
1975) which mediate the positive chronotropic aiid inotropic effects 
of the sympathetic system. It has been employed previously to 
reduce 'Immobilon* induced tachycardia (Daniel and Ling, 1972;
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Schla.rmaam et 1973) and in this study it proved as successful 
as xylazine in decreasing the elevation in heart rate produced hy 
etorphine.
Plasma nor-adrenaline levels following propranolol administrat­
ion remained as high as those recorded after etorphine alone because 
the former only blocks t h e - receptor sites ar.d does not interfere 
with the synthesis or release of catecholamines.
The sinus arrythmia, recorded in all three ponies following 
etorphine, 'Immobilon' and the various drug combinations was 
probably due to the influence of the medullary inspiratory centre 
on the oardioinhibitory centre (Swenson, 1970). Respiratory 
induced alterations in the activity of this cardioinhibitory centre 
result in rhythmic increases and decreases in its efferent outflow 
to the vagal nerves thus producing changes in heart rate. That the 
effect was not abolished by.../S - receptor blockade with propranolol 
further suggests that this action is centrally mediated and not due 
to local sympathetic activity on the heart.
The hypotensive effects of acepromazine have been discussed 
previously (chapter 7). It was interesting to note that 
administration of etorphine at the time corresponding to the peak; 
of this hypotensive effect greatly reduced the increase in blood 
pressure produced by etorphine. The hypertensive effect w^ as not 
abolished completely since acepromazine is a competitive - 
adrenergj.receptor antagonist and increased circulating catecholamine 
levels will still result in some degree of hypertension. In the 
practical usage of the acepromazine - etorphine mixture it would 
be of considerable benefit to use the acepromazine in advance of the
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etorphine since it is probable tAiat the majority of accidental deaths 
using the combination are a result of the excessive hypertension 
produced.
The most marked effects on blood pressure were seen when 
propranolol was administered along with acepromazine. This was 
to be expected because of the simultaneous oi and,^^ adrenergic 
blockade occuring.
An increase in sympathetic tone would also account for the 
changes in P.C.V. recorded after etorphine administration. As 
discussed previously (chapter 1) the splenic capsule is rich in 
oi - adrenergic receptors under the control of the sympathetic 
system (Davies and Withrington, 197.3). Following etorphine 
injection the P.C.V. remained elevated throughout the period of 
recumbency and after injection of the antagonist suggesting that 
an increase in sympathetic tone was present during all of this time.
'The qC. - adrenergic blocking action of acepromazine has been 
demonstrated by numerous workers and in this study to block 
sympathetic activity in the spleen (Tui'ner and Hodgetts, I96O;
De Moor and Van den Hende, I968; Gardner et aJ, 1965). With 
'Immobilon*, increases in P.C.V. still occurred probably as a 
result of the massive elevation in circulating nor-adrenaline 
levels not being completely blocked by the - adrenergic blocking 
action of the tranquilliser.
The increased muscle activity m:d tm e  recorded following 
etorphine administration are possibly further indications of increased 
sympathetic tone although Lees and îklhhidge (1976) suggested that
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they more resembled a state of tonic convulsion brought about by the 
high doses of etorphine included in the ' Immobilon ' jjiixture. This 
is further indicated by the fact that pretreatment with propranolol 
did not reduce the muscle activity or tone recorded following 
etorphine injection suggesting that peripheral sympathetic activity 
is not responsible for these alterations.
The reason for azaperone premcdioation producing no reduction 
in muscle activity throughout recujnbency and only a slight decrease 
in muscle tone when acepromazine and xylazine reduced both is not 
laiown. It would appear however that modification of these effects 
is connected with the duration ol recumbency produced by each drug 
combination. Both azaperone and xylazine administered intravenous­
ly produced satisfactory recumbency lasting for only 30 min 
reflecting their short duration of action when injected by this 
route compared to acepromazine.
Intramuscular premedication with azaperone however did not 
increase the duration of recumbency whereas xylazine administered 
by this route did. This difference could be due to the fact that 
the dose of xylazine intramuscularly was six times the intravenous 
dose whereas with azaperone there was only a two fold increase in 
dose rates by the different routes. In retrospect it would have 
been better to increase doses of each drug equally but at that 
time the dose rates chosen were according to dosage regimes used by 
other workers.
The degree of sweating recorded duiring recumbency was greatest 
following 'Immobilon' and acepromazine and azaperone premedication
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prior to etorphine. A possible explanation for the effects of 
these tranquillisers has been discussed previously (chapter ?)•
Severe respiratory depression was reported following etorphine 
administration on every occasion irrespective of pretreatment with 
any drug. This effect is well documented in both wild and domestic 
species (Pienarr _et ad, 1965; Blane _ct al, 196?; Schlarmann _et al, 
1973; Hillidge and Lees, 1971 and 19A5).
The degree of hypoxia produced has been suggested, to be due to 
three factors - the position of lateral recumbency during 
immobilisation, the reduced respiratory rate due to the central 
depressant action of the drug and the laboured character ofthe 
respirations because of the generalrsod increase in muscle tone 
(Hillidge and Lees, 1975)* These authors studied the respiratory 
effects of 'Immobilon' in detail and concluded that the degree of 
hypoxia produced must be regarded as a serious side-effect. They 
also suggested that some of the cardiovascular effects of 'Immcbilon' 
such as hypertension and increased P.C.V. might be attributed erther 
directly or indirectly to the effects of theiypoxia.
In this study respiratory depression was present throughout the 
period of recumbency vrhereas, as stated previously, plasma nor­
adrenaline levels decreased towards the end of recumbency. This 
suggests that whereas hypoxia may be a contributory factor towards 
increased sjTiipathetic tone it is not the only mechanism involved.
In their studies Hillidge and Lees (1975) recorded a 
significant fall in arterial oxygen tension and a small decrease in 
arterial pH with corresponding small increases in arterial carbon
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dioxide tension. In these experiments a degree of cyanosis was 
noticed, particularly in pony Ho. 3. This effect has also been 
reported by other workers (Schlarmann _et al, 1973) a,nd is probably 
due to a reduction in the oxygen uptake into the blood .
(hunn, 1969).
Premedication with all three tranquillisers produced little 
effect on the degree of respiratory depression recorded following 
etorphine. Since none of these drugs exhibited marked effects on 
respirations when administered alone this was not unexpected.
The sudden increase in respiratory rates after injection of 
the antagonist was probably due to the animals need to elevate 
ari;er..al oxygen tensions.
Plasma 11-0IÎ0S levels following etorphine administration were 
lower than those recorded after 'Immobilon* or acepromazine 
premedication. This could be due to the tranquilliser per se pro­
ducing an increase in 11-OHCS values. It has been reported that 
clilorpromazine increases ACTH secretion from the pituitary and 
consequently produces an elevation in plasma 11-OHCS concentrations 
(Smith _et ad, I963).
The fact that acepromazine premedication resulted in higher 
11-OHCS values than 'Immobilon' could result from the time elapsed 
between tranquilliser and etorphine administration. In chapter 7 
the effects of acepromazine per se on plasma 11-OHCS levels were 
recorded; maximum values occurring at 60 min post-injection. Peak 
levels following acepromazine premedication were noted at 0^ min 
post-injec+ion (25 min post-etorphine) suggesting that the increase 
produced by etorphine was further elevated by that produced by the
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tx-sjiqui nicer.
The increases in plasma 11--0HGS levels reported in this study 
oocnrred at the same time as the elevations in sympathetic tone as. 
estimated by plasma nor-adrenaline levels. Although James _et al 
(1970) recorded no increases in plasma cortisol levels following 
adrenaline infusion in the horse it would apnear from these and 
other results in this study that the mechanisms of control of the 
H.P.A, system may be influenced by sympathetic stimulation. Certarn 
other factors however such as the hypoxia associated with etorphine 
may a]so be involved.
Summary
From those results it would appear that etorphine administration 
results in an elevation in sympathetic nervous activity which may be 
due in part to direct central or local effects of the drug on the 
symipathetic system or to the degree of hypoxia produced. All the
changes in heart rate, blood pressure and packed cell volume 
recorded can be attributed to this alteration in sympathetic tone 
and f-o reflex mechanisms controlled by higher centres in the brain.
The tachycardia produced by etorphine injection could be 
successfully reduced by premedication with xylazine or pretreatment 
with the - adrenergic blocking drug propranolol. The hyper­
tension produced by etorphine could also be successfully reduced 
by premedication with acepromazine.
Botn acepromazine and xylazine premedication reduced the degree 
of muscle activity and tone recorded following etorphine
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administration but acepromazino and aaaperone produced a greater 
degree of sweating.
Premedication with the tranquij.lisers had no beneficial effects 
on the respiratory depression recorded following erorphiue and as 
described previously acepromazine increased plasma 11-OHOS ] evels 
above those measured after administration of etorphine alone.
10. FINAIi CONCLUSIONS
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FINAL CONCLUSIONS
The aim of this study was to determine whether measurement of 
adrenocortical and s.ynipathetic nervous activity could he successfully 
employed as a. means of assessing stress in horses.
Estimation of adrenocortical activity was carried oirb using a 
modified Mattingly (I962) fluorometric technique which successfully 
measured plasma 11-OfîCS "values in horses. S.ympathekic nervous 
activity was measured by indirect methods in all but one section of 
the study when plasma noradrenaline levels were estimated directly. 
This was due to the numerous difficulties associated with 
oat0oho.i.amine assay in plasma and. the convenience with which heart 
rate, packed cell volume and arterial blood pressure can be measured. 
Difficulties are involved in the interpretation of such indirect 
readings, including reflex responses such as when heart rate slows 
in response to increased blood pressure and vice versa (Hushmer,
1972).
The elevation in plasma nor-adrenaline levels following etorphine 
administration showed that increased sympathetic tone had occurred 
and this was probably responsible for all the alterations in the 
cardiovascular system noted at the same time. It is still not clear 
however whether this increased sympathetic activity is due to a 
direct action of the drug etorphine locally, at nerve endings or on 
the adrenal medulla, or whether it is due to central stimulation of 
the vasomotor and possibly other centres. Since propranolol, a 
specific - adrenergic blocking dru^, did not reduce the degree of
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muscle activity and tone following etorphine administration suggests 
that this effect is not mediated through the autonomic syotem hut 
could he due to a morphine like liiduced-comulsive state as reported 
hy liillidge and Lees (1976).
Etorphine produced elevations in heart rate, blood pressure, 
packed cell volume and plasma 11-OECO levels as did the minor 
surgical procedure (muscle biopsy) and physical exercise. These 
three stimuli therefore all constitute stress if this is defined as 
any stimuli resulting in elevated adrenocortical and sympathetic 
nervous activity. Etorphine however produced these effects by 
mechanical actions and consequently it is difficult to use these 
parameters to assess whether or not any emotional or psychological 
disturbance also occurred in the animals. Luring muscle biopsy 
and the exercise tests the horses appeared disturbed or excited 
i.e. they moved around restlessly and often became agitated. From 
this point of view stress was apparent both visibly and in the 
changes recorded in adrenocortical and sympathetic nervous activity.
The number of central depressant drug's tested in this study all 
possessed varied pharmacological actions which interfered with their 
assessment as efficient tranquillising dr-ugs (efficient being defined 
as drugs which would prevent or reduce any elevation in adreno­
cortical and sympathetic nervous activity produced by a stressor). 
Although azaperone successfully allowed muscle biopsies to be taken 
from all the horses viz. although it visibly appeared to reduce the 
stress the animals were undergoing, it and the other two drug's 
(acepromazine and xylazine) all produced per se effects on heart 
rate and/or packed cell volume and/or blood pressure and/or plasma.
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11-OHCS levels.
The effects of tranquiHising drugs on the changes in heart 
rate and pl-asma- 11-QIiCS—l-ovofet produced by disturbing stimuli have 
been employed previously in horses as means of assessing the 
efficacy of the drugs concerned (Aitken aid Sanford, 1972). From 
the results in this study it would appear tha/t this is not an 
ideal method. However, quantitative methods of assessing stress 
must be used in animals since no information can be obtained on 
the psychological or emotional state of the subjects. With horses 
it would appear that subjective assessment is also a useful guide 
to the degree of stress present.
Txie investigation into the ~ adrenergic blocking actions of 
several commonly used tranquilliser drugs showed tha.t the drop in 
packed cell volume, associated in particular with acepromazine and 
azaperone administration, is due mainly to relaxation of the splenic 
capsule and accumulation of red cells in the spleen and to a smai.l 
extent to haemodilution brought about by increased plasma volume. 
There was no evidence that the central depressant actions of any of 
the drugs was the cause of the reduction in P.O.V. as previously 
suggested by Turner and Hodgetts
Premedication with acepromazine and propranolol (a specific 
-■ adrenergic receptor blocker) also successfully reduced the 
cardiovascular effects of etorphine. Because 'Immobilon' is so 
widely ucuo. in the equine field and because of its potentially 
dangerous side-effeet's especially in animals which may suffer from 
cardiovascular or respiratory disease it was important to investigate
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the possibility of modifying the pharmacological actions of etorphine 
by direct effects of other drugs. By administering these agents 
at their times of pealt efficacy prior to etorphine, it is therefore 
possible to produce the same degree of neuroleptanalgesia with 
less physiological stress to the animal.
Stress must still be considered as being a difficult parameter, 
to define in the horse but measurement of adrenocortical and 
sympathetic nervous activity, if considered in conjunction with 
other physical signs can. be employed usefully as an indicator of 
this condition.
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